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Protein–RNA complexes play key roles in a variety of cellular functions such as gene expression
and its regulation. Detailed knowledge about the proteins and RNAs involved, as well as their
three-dimensional arrangements, is required for complete functional understanding.
One frequently applied method for the investigation of direct protein–RNA interactions is UV
induced cross-linking. Upon UV irradiation, covalent bonds are formed between nucleic acid bases
and amino acid residues in close spatial proximity. This way, intermolecular interactions are fixed
with high selectivity, which allows their exploration by various bioanalytical methods.
Mass spectrometry (MS) is increasingly utilized for the identification of proteins and peptides di-
rectly interacting with RNA. Following hydrolysis by RNases and endoproteinase, peptide–oligo-
nucleotide heteroconjugates are enriched with suitable chromatographic methods such as size exclu-
sion, C18 reversed phase, and titanium dioxide. Mass spectrometric analysis then identifies contact
sites on a peptide or even amino acid level.
The major challenges for this application are the generally low yield of the UV induced cross-linking
reaction and the lack of suitable tools for MS data analysis. In this work, both issues are addressed.
The incorporation of the photoreactive base analogue 4-thio-uracil was investigated with a focus on
the mass of the cross-linking products. The E. coli transcription antitermination complex NusB–
S10 bound to a BoxA containing oligonucleotide served as a model system. A novel cross-linking
pathway involving net loss of H2S from 4-thio-uracil was identified.
In addition, a novel approach for automated identification of cross-linked peptides from mass spec-
trometry data was developed. It is based on the variation of experimentally determined masses
by subtraction of the calculated masses of potentially cross-linked oligonucleotides. A subsequent
database search of the mass variants by conventional algorithms identifies cross-linked peptides.
After feasibility of the approach was established, it was further tested and optimized in the in-
vestigation of a model complex for ASH1 mRNA transport in yeast and interactions of the yeast
spliceosomal protein Cwc2 with U6 and U4 small nuclear RNAs. In both systems, several protein
regions contacting RNA were identified; in many cases, the cross-linking site could be confined to a
single amino acid.
Finally, it was demonstrated that the data analysis approach can be applied for unbiased searches
against databases containing the entire yeast proteome. After isolation of capped RNAs bound by
the protein Cbp20 under native conditions, ribosomal proteins, proteins with known RNA- or DNA-
binding properties, and metabolic enzymes were found to directly interact with RNA. This illustrates
the capability of UV induced cross-linking with MS analysis to identify novel RNA-binding proteins
and domains. Importantly, the data analysis approach represents a key development toward the
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Protein–RNA complexes play a central role in many diverse cellular functions. The most prominent
and well-studied example is the ribosome, containing and interacting with both proteins and RNA
in translation.
RNA binding proteins (RBPs) can stabilize and protect RNAs, and mediate interactions to other
proteins or RNAs in macromolecular assemblies. In addition, they can act as RNA modifying
enzymes, e.g. nucleases that hydrolyze or degrade RNA, helicases that unwind double-strands,
or transferases that directly modify nucleotides. For example, RBPs play key roles in the life
of messenger RNA (mRNA), from translation through capping, polyadenylation, splicing, nuclear
export, sub-cellular localization, translation and finally degradation.
RNAs are named according to their function and localization. The major classes are ribosomal RNAs
(rRNAs), transfer RNAs (tRNAs), messenger RNAs (mRNAs), small nuclear RNAs (snRNAs),
microRNAs (miRNAs) and small interfering RNAs (siRNAs). rRNAs are the most abundant RNAs
in the cell and the main components of the ribosome. tRNAs are the second most abundant group
of RNAs and transport amino acids to the ribosome. mRNAs contain the genetic information after
transcription and are the template for protein synthesis during translation. snRNAs, miRNAs and
siRNAs are relatively small RNAs found in eukaryotic cells. snRNAs are part of the small nuclear
ribonucleoprotein particles (snRNPs), the building blocks of the spliceosome. miRNAs and siRNAs
bind to mRNAs and block translation or induce degradation, respectively.
Protein–RNA interactions are crucial for stability and function of ribonucleoprotein (RNP) parti-
cles. Therefore, knowledge of protein–RNA contact sites is required to understand the underlying
molecular mechanisms. A single RNA binding region on a protein can be sufficient for RNA inter-
actions. Similarly, a few nucleotides or short consensus sequences within the RNA are enough to
mediate binding to RBPs.
In comparison to DNA, RNA secondary and tertiary structures exhibit a greater diversity. There-
fore, interactions of RBPs with their target RNA molecules are more complex. Some RBPs contain
conserved RNA-binding domains. Prominent examples are the RNA recognition motif (RRM [1, 2]),





Figure 1.1: Structure examples of the RNA recognition motif (RRM), the K homology (KH) do-
main, and the zinc finger (ZnF).
(a, b) Proteins are represented as cartoons in gray, RNA-binding residues as sticks in
red. Nucleotides are shown in blue sticks.
(a) X-ray structure of hnRNP A1 bound to single stranded telomeric DNA. The figure
shows details on the binding of RRM2 to deoxyadenosine and deoxyguanine involved in
stacking interactions with F17 and F59, respectively. Residue F57 inserts between the
deoxyriboses. Helix α1 lies behind the β-sheet. (pdb 2UP1 [5], representation adapted
from [2])
(b) NMR structure of the third KH domain (type I) of hnRNP K bound to the DNA
fragment TCCC. The DNA binding cleft is surrounded by the helices α1 and α2, the
GXXG loop, the β2 strand and the variable loop connecting β1 and β’. (pdb 1J5K [6],
representation adapted from [3])
(c) Crystal structure of ZnF 4 of transcription factor TFIIIA and loop E of 5S rRNA.
The ZnF is shown in gray, the zinc ion in yellow, the RNA-binding residues in red,
and the RNA in blue. The upper panel gives an overview while the lower panel shows
binding details. The bulged G75 base (green) is contacted by H119 and N120, the
ribose by K118 via hydrogen bonds. (pdb 1UN6 [7])
1.1 Protein–RNA complexes 3
The RNA recognition motif, also referred to as RNA-binding domain (RBD) or ribonucleoprotein
domain (RNP), is the most abundant RNA binding domain in higher eukaryotes. A typical RRM
contains around 90 amino acids that form two α-helices that pack on a four-stranded β-sheet with
a β1–α1–β2–β3–α2–β4 topology. The RRM binds between two and eight nucleotides, for example in
the cap binding protein Cbp20 [8, 9] or the spliceosomal U2B” protein [10], respectively. Primarily,
interactions occur between the β-sheet and the RNA, more precisely through stacking of aromatic
residues in the conserved RNP2 and RNP1 domains located in β1 and β3. This is illustrated in Figure
1.1a, where two phenylalanine residues stack with the two nucleotides bound by RRM2 of hnRNP
A1. Additional contributions to binding affinity and selectivity can stem from loops connecting the
secondary structure elements of the same RRM, other RRMs within the same protein, or different
RNA-binding protein domains [2].
Another RNA-binding domain appearing in many RBPs of diverse functions is the K homology
domain. The KH domain was first identified in and is named after the human heterogeneous nuclear
RNP (hnRNP) K protein [11, 12]. Typically, a protein contains multiple KH domains that can bind
single-stranded RNA or DNA cooperatively or independently. The KH domain comprises around
70 amino acids that form a three-stranded β-sheet and three α-helices. α1 and α2 are commonly
connected by a GXXG loop. The three-dimensional arrangement differs slightly between eukaryotic
type I KH folds and prokaryotic type II KH folds. The KH domain can accommodate four bases in
a cleft formed by the helices α1 and α2 together with the GXXG loop on one side and the β2 strand
together with a variable loop on the other. As an example, the KH3 domain of hnRNP K is shown
in Figure 1.1b. In contrast to stacking interactions in RRMs, protein–RNA contacts are primarily
hydrogen bonds [3].
The third example for common RNA-binding domains are zinc fingers (ZnF). In these structural
elements, zinc ions are coordinated by four histidine and cysteine residues within small, 20–30
amino acid long protein regions. Involvement of two or more zinc ions leads to the formation of
more extended domains. The Cys2His2 zinc finger motif is the most abundant ZnF, appearing
in about 3% of all human genes and primarily connected to DNA binding. It is composed of
an α-helix and a β-sheet bound together by Zn2+ which is coordinated by two cysteines and two
histidines at conserved positions. Cys2His2 ZnFs can bind double stranded DNA and RNA as well
as a variety of single stranded RNA structural elements. Protein–RNA contacts can involve both
hydrogen bonding and stacking interactions [4, 7]. Figure 1.1c shows an example of a Cys2His2 ZnF
of transcription factor TFIIIA binding to 5S ribosomal RNA.
Many studies have focused on RNA binding of specific RBPs in vitro. There has also been con-
siderable effort in investigating protein–RNA interactions in the complex environment of the cell.
Many approaches combine in vivo UV induced protein–RNA cross-linking with DNA sequencing
techniques to identify binding sites on the RNA level [13]. UV cross-linking in vitro, together with
mass spectrometry, has been applied in detailed structural and functional studies on RBPs. Very
recently, it was demonstrated that UV cross-linking and mass spectrometry can be combined to
identify RBPs after UV irradiation in vivo [14–16] (see below and 4.3).
4 1 Introduction
1.2 Mass spectrometry in identification of biological
macromolecules
Mass spectrometry has seen an exponential growth in applications in the field of biological macro-
molecules, especially proteomics, since the late 1990s. The expanding applications are tightly associ-
ated with technical and computational advances. A prerequisite for the success of mass spectrometry
in the biological sciences was the development of soft ionization techniques. Electrospray ionization
(ESI) and matrix assisted laser desorption/ionization (MALDI) had such a fundamental influence
that John B. Fenn and Koichi Tanaka were awarded the Nobel Prize in Chemistry in 2002. They
shared one half of the prize for their development of ESI (Fenn [17, 18]) and MALDI (Tanaka [19]),
respectively [20]. The German scientists Michael Karas and Franz Hillenkamp developed MALDI
techniques almost simultaneously [21] to Tanaka and coworkers.
Over the years, ESI became the prevalent ionization method, particularly since it allows direct
coupling of liquid chromatography to the mass spectrometer. As implied by the name, electrospray
ionization is based on generating a fine spray of charged droplets. A solution containing the analytes
continuously flows through a capillary. A potential difference is applied between the tip of the
capillary and a counter-electrode at the interface of the mass spectrometer. The resulting electric
field nebulizes the analyte solution into fine, charged droplets. The solvent evaporates while the
droplets are transferred from atmospheric pressure into the vacuum of the instrument. When the
Coulomb repulsion is greater than the surface tension, the droplet separates into smaller droplets
(Coulomb explosion). This process could repeat itself until each droplet contains a single analyte ion
(charge-residue model), further evaporation eventually leads to dissolved ions. Alternatively, free
ions could be released from highly charged droplets (ion evaporation model). The exact mechanism
might depend on the physical properties of the analyte and is still a subject of debate [22].
In the last decade, mass spectrometry (MS) has become one of the most important methods in pro-
teomics, i.e. the investigation of proteins and their biological functions. Mass spectrometry based
proteomics have proven extremely useful in qualitative and quantitative investigation of proteomes,
including differentiation of sub-cellular or tissue dependent protein distributions. MS is also ex-
tremely valuable in the investigation of various post-translational modifications. Additionally, the
composition of and interactions within macromolecular biomolecules can be investigated (MS based
proteomics reviewed in [23, 24]).
The mass determination and fragmentation of an isolated intact protein (top-down mass spectrome-
try) can yield valuable information, for example if it carries post-translational modifications. How-
ever, the bottom-up approach is more widely applied, where samples are analyzed by MS after
proteolytic digestion. A typical large-scale proteomics experiment comprises the following steps,
outlined in Figure 1.2: (1) The protein sample is prepared, e.g. by purifying proteins from a cell
lysate or by isolation of a particular protein with its interaction partners by immunoprecipitation.
(2) The protein mixture is separated by one-dimensional gel electrophoresis to decrease complexity.
(3) Proteins are hydrolyzed by endoproteinases. (4) Peptides are further separated by reversed
phase-high performance liquid chromatography (RP-HPLC) directly coupled to an ESI source of a
mass spectrometer.
The peptide masses alone are not sufficient for unambiguous identification of the corresponding
proteins in complex mixtures. Additional information is gained after dissociation of a single peptide
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Figure 1.2: Schematic workflow of a typical large scale proteomics experiment. Cultured cells (or
tissue samples) are lysed and the protein mixture is separated by SDS-PAGE. Next,
proteins in individual gel slices are in-gel digested and peptides are eluted. Peptides
are separated by RP-HPLC and subsequently analyzed by ESI-MS.
in the gas phase and monitoring the masses of the resulting fragments, a process termed tandem
mass spectrometry. This approach, the necessary instrumentation and the analysis of the mass
spectrometry data will be described in more detail below.
1.2.1 Tandem mass spectrometry
Tandem mass spectrometry or MS/MS combines two stages of MS: First, the mass of the intact
ion is determined. Next, this precursor ion is isolated and fragmented. Low-energy collision in-
duced dissociation (CID) is the most common fragmentation mode applied for large biomolecules.
Therein, fragmentation is induced by collision with inert gas such as helium, argon or nitrogen. The
measurement of the resulting product ions presents the second stage of the analysis.
Tandem MS can be carried out in three separate parts of the mass spectrometer (tandem in-space),
i.e., selection of the desired ion, fragmentation and mass determination are performed by different
components of the instruments. Since these instruments contain two mass analyzers, they are
termed hybrid mass spectrometers. Quadrupole time-of-flight (Q-ToF) instruments (see below) are
a prominent example of hybrid instruments that perform tandem in-space MS.
Tandem in-time instruments perform ion selection, fragmentation and mass determination in the
same part of the instrument but sequentially in time. This applies to linear ion traps which can be
found as stand-alone instruments. A linear ion trap is also part of most Orbitrap instruments, the
second type of hybrid instrument which will be described in more detail below.
The majority of tandem mass spectrometry experiments in proteomics are carried out with data
dependent acquisition (DDA) in the mass spectrometer. The instrument records a full scan (MS1),
measuring the masses of all species eluting from the LC at that time point. Next, the species giving
rise to the most intense signals are chosen for fragmentation. After the product ions scans (MS2,
MS/MS) have been acquired, the instrument records the next set of MS1 and MS2 scans. This cycle
is repeated over the entire duration of the chromatographic gradient. In DDA, low abundant species
are less likely to be chosen for fragmentation, an effect that increases with sample complexity.
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1.2.1.1 Quadrupole time-of-flight (Q-ToF) mass spectrometers
A Q-ToF mass spectrometer is a hybrid instrument combining a quadrupole and a time-of-flight
mass analyzer (see Figure 1.3). A quadrupole is composed of four parallel metal rods that serve as
electrodes. An electric field is generated by applying both direct current (DC) and radio frequency
(RF) potentials to the metal rods. At a given combination of DC and RF, only ions within a narrow
mass-to-charge (m/z ) ratio window pass through the quadrupole. All other ions are not confined
within the quadrupole and are removed by the vacuum system. If only a radio frequency is applied,
ions over a wide m/z range can pass through the quadrupole. The quadrupole can scan though an
m/z range by changing both DC and RF potentials while keeping their ratio constant. By detecting
at which ratio ions reach a detector, a mass spectrum can be acquired.
The time-of-flight mass analyzer separates ions according to their m/z ratio in a field-free drift
region. Ions with a small m/z ratio travel faster than those with a higher m/z ratio. Important for
resolution and mass accuracy is that the ions enter the flight path at the same time with the same
kinetic energy. The mass spectrum is recorded by detecting at which time ions reach the detector,
the time is converted to the corresponding m/z ratio. The resolution of a ToF analyzer is increased
with integration of a reflectron which serves as an electrostatic mirror. Ions with higher velocity
penetrate deeper into the repelling electric field of the reflectron, compensating differences in kinetic
energy of ions with the same m/z ratio. In addition, the flight path is increased, also leading to
higher resolution.
Figure 1.3: Schematic representation of a quadrupole time-of-flight (Q-ToF) mass spectrometer.
It contains a regular quadrupole (mass analyzer) and an RF-only quadrupole (collision
cell). Ions are directed into the time-of-flight mass analyzer by the pusher. The drift
region is increased by the reflectron which guides the ions toward the detector.
A simplified Q-ToF mass spectrometer is depicted in Figure 1.3. In a first scan (precursor ion scan),
all ions in a wide m/z range pass through both quadrupoles. The pusher applies a short pulse of
an orthogonal accelerating field to the constant ion beam passing through the second quadrupole
to direct a group of ions into the field-free drift region of the ToF. This way, the MS spectrum is
recorded. For fragmentation experiments, the first quadrupole serves as a mass analyzer, selecting
ions of the desired m/z ratio. These are subsequently fragmented in the second, RF only quadrupole
by collision with inert gas (beam-type collision induced dissociation). The product ion scan is again
recorded in the ToF mass analyzer [22].
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1.2.1.2 Orbitrap mass spectrometers with linear ions traps (LTQ Orbitraps)
Figure 1.4: Schematic representation of a LTQ Orbitrap mass spectrometer. The first mass ana-
lyzer is a linear ion trap with adjacent detectors. The orbitrap serves as mass analyzer
and detector. From the ion trap, ions can be passed to the HCD collision cell or in-
jected into the orbitrap by the C-trap. Mass spectra can be recorded in the ion trap
as well as the orbitrap. Fragmentation can be performed in the ion trap (CID) or in
the HCD collision cell.
A more recently developed class of hybrid mass spectrometers are LTQ Orbitraps. They contain a
linear ion trap (linear trap quadrupole, LTQ) and an orbitrap mass analyzer. A simplified scheme
is shown in Figure 1.4.
As implied by the name, the LTQ shares similarities to quadrupoles. It is built of four hyperbolic
rods that are typically separated into three axial sections. Ions are trapped in the axial direction
by applying different DC voltages to the three sections, and in the radial direction by RF potentials
between opposite rods within the same section. Two of the central rods have a small slit though
which ions can be ejected towards the detectors. Alternating current (AC) voltages are applied to
these rods for isolation, activation, and ejection of ions.
The ion trap is held under a low helium pressure. Ions gather kinetic energy during acceleration
by the ion optics between ESI source and ion trap (omitted from the simplified representation in
Figure 1.4). During trapping, slow collisions with the inert gas lead to decrease of kinetic energy
(cooling of ions).
In order to record a mass spectrum, the RF amplitude is increased at a constant rate from low to
high voltages. This leads to successive destabilization of ions with an increasing m/z ratio. The
AC is kept at constant frequency but increasing amplitude. This way, instable ions are directed
through the slits towards the detector.
In order to isolate ions in a narrow m/z window, all other ions are destabilized at a constant RF
amplitude by changing the AC frequency, skipping the frequency at which the ions of interest would
become instable. After isolation, this AC frequency is used to increase the kinetic energy of the
ion of interest. However, the AC amplitude is considerably smaller than during isolation so that
the ions are not ejected. Due to the increased kinetic energy of the ions, collisions with helium
lead to fragmentation (ion trap collision induced dissociation). The fragment spectrum can then be
recorded as described above.
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The applied potentials cannot stabilize ions with a small m/z ratio. This low mass cut-off typically
affects the lower third of the m/z range with respect to the uncharged precursor mass and thus
prevents the detection of small fragmentation products.
The orbitrap consists of an axial central electrode and a co-axial outer electrode. The electrostatic
field traps ions rotating around the central electrode and oscillating along its axis. Only the axial
movement is independent of kinetic energy and spatial distribution of the ions, but it is related
to the m/z ratio. The frequencies of the oscillating axial movement are detected by the current
induced between the halves of the outer electrode and are converted into m/z ratios by Fourier
transformation.
In a typical tandem MS experiment on LTQ Orbitraps, all ions entering the instrument are trapped
in the LTQ, passed on to the C-trap and injected into the orbitrap where a high resolution precursor
ion scan is recorded. Meanwhile, ions are isolated, fragmented and product ion scans are recorded
in the linear ion trap (tandem in-time, see above). Since the sequencing speed of the LTQ by far
exceeds that of the orbitrap, several product ion scans can be recorded in it while the precursor
ion scan is acquired in the orbitrap. The CID spectra can also be recorded in the orbitrap, with
the benefit of a considerably higher resolution and mass accuracy compared to the LTQ but at a
significantly lower acquisition speed.
In addition to ion trap CID, LTQ Orbitraps offer a second fragmentation mode corresponding to
beam-type CID on Q-ToF instruments, termed higher-energy collision dissociation (HCD). Ions are
again collected in the linear ion trap, the desired ion is isolated and passed to the HCD collision
cell (multipole). There, the ions are fragmented by collisions with nitrogen molecules. The product
ions are ejected into the C-trap and transferred into the orbitrap where the fragment spectrum is
recorded [22, 25]. HCD is slower compared to MS/MS in the ion trap but does not exhibit a low mass
cut-off. In addition, HCD fragmentation corresponds to beam-type CID and is beneficial for some
applications in comparison to ion trap CID (see 1.3.3.4).
1.2.1.3 Fragmentation of peptides
Figure 1.5: Nomenclature of peptide fragments resulting from backbone cleavage. Cleavage of the
alkyl carbonyl bond produces a- and x-ions, cleavage of the amide bond b- and y-ions,
and cleavage of the amino alkyl bond leads to c- and z-ions. a-, b-, and c-ions contain
the peptide N-terminus while the corresponding C-terminal ions are called x, y, and
z [26, 27].
Mass spectrometric analysis of peptides is usually carried out from acidic solutions in positive
ion mode. Fragmentation of peptides is mostly charge-directed, i.e., a proton at the cleavage site
is required. On the protonated peptide ions, charges are preferentially located on basic residues
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(arginine, lysine, histidine) and at the peptide N-terminus. The energy transferred to the peptide
upon collision with inert gas atoms or molecules can initiate redistribution of protons (mobile proton
model) prior to fragmentation [28]. However, fragmentation of protonated peptides is highly complex
and follows many different pathways [29]. Therefore, reliable prediction of observable fragments and
especially their relative intensities is still not possible to the extent that this information could be
the basis for automated peptide identification. Instead, all ions within a series are assumed to occur
with the same probability and intensities are disregarded.
Figure 1.5 shows the three possible sites of fragmentation on the peptide backbone. Cleavage of the
amide bond occurs most frequently, especially under CID conditions. The resulting spectra therefore
contain b- and y-ion series as well as a-ions that are formed after loss of CO from b-ions. Within
one series, the distance between two neighboring signals equals the mass of the corresponding amino
acid (in its chain form without the water lost during amide bond formation). Therefore, amino acid
sequences can be derived from calculated mass differences of fragment ions.
1.2.1.4 Fragmentation of RNA
Figure 1.6: Nomenclature of RNA fragments. Bases are simplified as gray spheres. In analogy to
the nomenclature of peptide sequence ions, fragments resulting from cleavage of the
phosphate backbone are termed a, b, c, or d for fragments containing the 5’ end or w,
x, y, or z if the charge is retained on the 3’ end. Loss of a base is denoted as -Bn(X),
where n is the position of the base counting from the 5’ end and X is the one letter
code of the base [30].
In contrast to the widespread application of mass spectrometry techniques in proteomics, MS is
much less frequently applied in investigation of DNA or RNA. For most questions, (DNA) sequencing
techniques are preferred as they can handle longer oligonucleotide segments, are less expensive and
provide greater multiplexing capabilities.
Mass spectrometric analysis of oligonucleotides is usually carried out from basic solutions in neg-
ative ion mode. The nomenclature follows rules similar to those of peptide fragments (see Figure
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1.6). Upon CID fragmentation, the N-glycosidic bond is often cleaved to release the nucleic acid
base, either as neutral loss or as a base anion. Additionally, backbone fragmentation predominantly
leads to the formation of c- and y-ions. For DNA oligonucleotides, loss of the base is more dom-
inant and backbone fragmentation leads to the formation of a- and (w-B)-ions. Fragmentation of
protonated DNA in positive ion mode leads to similar product ion types. It has been proposed
that the abundance of protonated bases after fragmentation correlates with the proton affinity, with
C∼G>A»T [31].
1.2.2 Data analysis in proteomics
Figure 1.7: Principles of sequence database searching. Searches follow essentially the same steps
as the experimental workflow. The sequence database is hydrolyzed in silico. Exper-
imentally, the protein is hydrolyzed into peptides and their masses are determined.
The experimental mass is used to filter for database peptides with the same calculated
mass. Theoretical fragment spectra are generated and compared to the experimentally
acquired spectrum.
Identification of a peptide from mass spectrometry data relies on matching both the mass of the
intact peptide (precursor mass) and the masses of its fragmentation products. All algorithms for
automated peptide identification could in principle allow for any combination of the 20 standard
amino acids. However, to limit calculation times and decrease the number of false positive results,
several constraints are introduced. The order in which these are applied depends on the exact
algorithm. The most popular sequence database searching approach will be described in more
detail (this and other algorithms are reviewed in [32]).
In sequence database searching (overview in Figure 1.7), MS data is searched against a protein
sequence database. The search engine uses the precursor mass and the masses of the fragments
to match a MS/MS spectrum to a database peptide. First, the protein database is digested in
silico, thus protease specificity is taken into account. This way, the amino acid on the peptides’
extreme N- or C-terminus is limited to one or a few candidates, e.g. to lysine or arginine as the
C-terminal amino acid in the case of the endoproteinase trypsin. Next, the list of peptides is filtered
for candidates with a mass corresponding to the experimental precursor mass determined in the MS
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analysis. A mass tolerance for deviation between experimental precursor and calculated peptide
masses is set according to the mass accuracy of the MS instrument.
For all candidate peptides, a theoretical fragment spectrum is generated. These spectra are com-
pared to the experimental product ion scan obtained in the MS analysis, taking the fragmentation
mode into account. For example, comparisons are mainly based on b- and y-ions for collision in-
duced dissociation. Agreement between expected and observed fragments is evaluated. Typically,
only the peptide-to-spectrum match (PSM) with the highest overlap is considered as a possible
correct match. Finally, the significance of the match is determined and expressed as a score. To
this end, the probability is calculated for the PSM to be a random event, i.e. that the peptide was
matched to the spectrum purely by chance. The exact scoring algorithms depend on the database
search engine employed. The commercial search engine Mascot (Matrix Science [33]) and the open-
source Open Mass Spectrometry Search Algorithm (OMSSA, National Center for Biotechnology
Information [34]) report E -values. This value indicates the expected number of peptides randomly
matching the spectrum with scores equal to or better than the score of the identified PSM. Conse-
quently, low E -values correspond to a high significance, i.e. the match is less likely to be a random
false positive hit.
Many post-translational modifications (PTMs) lead to a distinct mass increase of the modified
amino acid. Therefore, mass spectrometry is ideally suited for identification and localization of many
PTMs. In the database search, peptides containing a potentially modified amino acid are considered
with and without the modification. This increases the search space exponentially with each PTM,
consequently processing times are longer and false positive matches more likely. Therefore, only a
limited number of PTMs can be considered in each search. The PTM does not only increase the
mass of the protein and peptide, but also the mass of the peptide fragments containing the modified
amino acid. This shift of product ion masses is used to localize the modification in the primary
sequence.
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1.3 UV induced protein–RNA cross-linking
Figure 1.8: Possible reaction between uridine and threonine upon UV induced cross-linking. The
uracil base is excited upon absorption of UV light. Subsequently, a hydrogen atom
might be abstracted from threonine and the cross-linking product could be formed by
radical combination.
This free radical based reaction presents the most common mechanism (according to
[35] and references therein). In general, the mechanism of cross-link formation is not
fully understood, the exact mechanisms for the presented example as well as other
bases and amino acid residues might differ.
UV induced cross-linking of RNA (or DNA) to proteins is a frequently applied method for studying
direct protein–nucleic acid interactions. The approach employs the natural reactivity of the nucleic
acid bases: Upon absorption of UV light, the base is promoted into an excited electronic state.
Subsequently, chemical reactions with amino acids can lead to formation of covalent bonds between
nucleic acid bases and amino acid residues [35], so-called zero-length cross-links. The yield of UV in-
duced protein–RNA cross-linking is very low, e.g. 0.2-0.5% for cross-linked peptides from prokaryotic
ribosomal subunits after isolation by size exclusion and reversed phase chromatography [36]. Impor-
tantly, since the cross-link only consists of a single covalent bond, UV induced cross-linking only
occurs between nucleic acid bases and amino acid residues that are in close spatial proximity.
While all nucleic acid bases and amino acid residues can form cross-links, significant differences are
observed in their reactivity. In a series of studies, Shetlar et al. have systematically investigated
cross-linking yields of nucleotides and amino acids. For cross-linking of single amino acids to DNA,
they found cysteine, lysine, phenylalanine, tryptophan, and tyrosine to be the most reactive, while
alanine, aspartic and glutamic acid, serine, and threonine were unreactive [37]. In addition, the
reactivity of polynucleotides towards single amino acids (excluding proline) was tested. Polyuridylic
acid reacted with all amino acids; polythymidylic, polyguanylic, polycytidylic, and polyadenylic acid
reacted with a decreasing number of amino acids. Phenylalanine, tyrosine, and lysine were among
the amino acids with the highest yields for all five polynucleotides [38, 39].
The excited states of nucleic acid monomers have short lifetimes (picosecond range for the first singlet
state S1, microseconds for the first excited triplet state T1), while interactions in polynucleotides
can lead to longer-lived excited species [40]. The short period in which the cross-link can be formed
has an important consequence: The ribonucleoprotein complex cannot undergo major distortions
while the nucleic acid is excited. The short time for reaction initiation together with the formation
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of single covalent bonds are the reasons for the high specificity of UV induced protein–RNA cross-
linking. Direct interactions of nucleotides and amino acids in the native ribonucleoprotein complex
are fixed, enabling their investigation by various analytical methods. Cross-linking by chemical
reagents does not provide this strict specificity. Maximum distances between reacting groups are
determined by the structure of the reagent and the cross-linking chemistry. After the reagent
has reacted with the first target group, it remains reactive until cross-linking is completed by the
reaction with the second target group. In this prolonged time period, distortions of the investigated
macromolecule are more likely to lead to artificial cross-links.
Bioanalytical methods that have been applied to identify RNA-binding proteins after UV induced
cross-linking include SDS-PAGE (e.g. [41, 42]), Western blotting (e.g. [43]) and immunoprecipita-
tion (e.g. [41, 44,45]). Recently, several studies reported the identification of RNA-binding proteins
with mass spectrometry after cross-linking and purification of mRNA with oligo(dT) under strin-
gent conditions, thus removing noncross-linked proteins almost completely [14–16]. In general, mass
spectrometry based methods have the advantage that no prior knowledge about the sample protein
content is required.
Detailed investigations of the cross-linking site on the protein level have initially been carried out
by Edman sequencing after (semi-) preparative isolation of peptide–RNA oligonucleotide hetero-
conjugates (e.g. [36, 46,47]). Identification of the cross-linking site by mass spectrometry has been a
long-standing interest in our laboratory and will be described in more detail below. Knowledge of
protein regions, peptides or even amino acids directly interacting with RNA can provide valuable
information, for example about RNA-binding surfaces or novel RNA-binding domains.
1.3.1 Preparation of ribonucleoprotein complexes and UV cross-linking
Protein–RNA complexes for investigation with UV cross-linking and mass spectrometry can be
prepared through either purification of native ribonucleoproteins or by in vitro reconstitution. For
the latter, incomplete or nonspecific assembly should be excluded as it can result in artificial cross-
links.
In general, protein–RNA complexes can be purified from cell extracts or after in vitro reconstitution
with several strategies, e.g. as outlined in Figure 1.9. A protein and its interaction partners can be
isolated after introduction of a tag suitable for affinity purification, e.g. histidine tags, glutathione
S -transferase (GST) tags, or tandem affinity purification (TAP) tags. Similarly, aptamer tags
can be introduced to an RNA sequence, e.g. stem loop structures specifically bound by the MS2
bacteriophage coat protein. Additionally, antibodies that specifically bind the protein of interest or
certain RNA elements (e.g. the 5’ cap structure of snRNAs) can be employed.
The conditions during UV irradiation, i.e. sample amount and concentration, buffer constituents,
light source, and irradiation time, influence the obtained cross-links and should be carefully chosen.
Mass spectrometric identification of cross-linked peptide–RNA heteroconjugates can be prevented by
insufficient sample amounts. Cross-links can be below the detection limit or produce low intensity
signals, resulting in poor quality spectra that do not permit unambiguous identification. For in
vitro complex reconstitution, the sample volume should be kept small to avoid incomplete complex
formation due to dilution effects.
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Figure 1.9: Strategies for isolation of protein–RNA complexes. Complexes can be prepared
be affinity purification of a tagged protein (left), immunoprecipitation (middle), or
through a tagged RNA (right).
Figure originally published in [48].
In principle, UV cross-linking tolerates a wide range of buffer conditions. However, higher con-
centrations of radical scavengers like glycerine should be avoided as they might prevent cross-link
formation [49]. In addition, certain detergents like sodium dodecyl sulfate (SDS) are incompatible
with LC-ESI-MS analysis and higher concentrations should be avoided [50]. Frequent contamination
of e.g. Triton X-100, Tween and NP-40 with polyethyleneglycole (PEG) can cause substantial prob-
lems, high intensity PEG signals can completely suppress other signals in the mass spectrometer.
These detergents should be avoided completely and in general the highest grade reagents and buffer
constituents should be used.
Light sources for UV irradiation are UV lamps or monochromatic lasers [51]. The energies of the
emitted light differ substantially. Laser light can induce two photon absorption and in consequence
ionization. Ions have considerably longer life times than excited states and are more likely to lead
to unspecific reactions upon structural perturbations. The optimal irradiation time depends on the
light source and the complex under investigation. Longer irradiation may increase cross-linking
yields but can cause photodamage to both proteins and RNA (e.g. [52]).
1.3.1.1 Incorporation of substituted nucleotides
Incorporation of photoreactive base-analogues such as 4-thio-uracil, 6-thio-guanine, 5-bromo-uracil,
or 5-iodo-uracil is a strategy to increase the cross-linking yield. The absorption maxima of the
base-analogues lie at higher wavelengths (4-thio-uridine 330 nm, 6-thio-guanine 342 nm, 5-bromo-
and 5-iodo-uridine around 280 nm) compared to the native RNA bases (250-270 nm) [35]. There-
fore, complexes containing photoreactive nucleotides are irradiated at longer wavelengths, typi-
cally 312 nm for halopyrimidines and 365 nm for 4-thio-uracil and 6-thio-guanine. Especially at
365 nm, no cross-linking of the native nucleotides occurs and undesired photocleavage and oxida-
tion is reduced [52]. Halopyrimidines react via radical-based mechanisms and loss of the respective
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hydrohalogen [53]. To our knowledge, the reaction mechanisms of 4-thio-uracil and 6-thio-guanine
have not been previously investigated in detail by mass spectrometry. The observation of frequent
thymidine to cytidine transitions after cDNA sequencing of 4-thio-uracil substituted RNA suggests
a product of the UV induced reaction that alters base pairing properties of the cross-linked nu-
cleotide. The same might apply to 6-thio-guanine, where sequence reads were enriched in guanosine
to adenosine transitions [54].
Photoreactive base-analogues can be incorporated site-specifically into synthetic RNAs. The ap-
proach is therefore limited to in vitro reconstituted complexes. Site-specific labeling of RNA with
photoreactive nucleotides can be used to identify interaction sites on the RNA level. For example,
binding sites of yeast spliceosomal proteins on U5 snRNA were investigated by site-specific labeling
of U5 and identification of cross-linked proteins by immunoprecipitation [55]. MS-based cross-linking
studies on protein–DNA complexes include, for example, incorporation of 5-bromo-deoxyuridine [56]
or 4-thio-thymidine [57].
Alternatively, the photoreactive base-analogues can be incorporated randomly in vivo. The en-
hanced cross-linking yield improves results of different approaches that combine immunoprecipi-
tation, isolation of the cross-linked RNA and its analysis by cDNA sequencing (e.g. cross-linking
and immunoprecipitation (CLIP) [58, 59], cross-linking and analysis of cDNAs (CRAC) [60, 61], photo-
activatable-ribonucleoside-enhanced cross-linking and immunoprecipitation (PAR-CLIP) [54]).
1.3.2 Sample preparation for mass spectrometry, enrichment and purification
strategies
To ease interpretation of MS and MS/MS spectra of cross-linked heteroconjugates, both proteins
and RNA need to be hydrolyzed thoroughly prior to and/or following enrichment or isolation
strategies [62, 63]. Disassembly and denaturation of protein–RNA complexes can be achieved in 1M
urea or guanidine hydrochloride, larger amounts of other detergents like SDS should be avoided (see
above) [49]. As for most proteomic approaches, trypsin is favored as the enzyme for proteolysis as
it cleaves after the basic residues lysine and arginine. This usually leads to peptide fragmentation
series starting from the peptide C-terminus, aiding data interpretation. Chymotrypsin has also been
applied successfully, especially in studies of snurportin 1 and U1 snRNA as well as reconstituted
human [15.5K-61K-U4atac snRNA(-U6atac snRNA)] [47, 64–66]. Use of different endoproteinases can
lead to the identification of additional cross-linking sites within the same protein [45]. Since increas-
ing length of the cross-linked RNA oligonucleotide leads to suppression of the peptide fragment
signals, RNA hydrolysis to single or a low number of nucleotides is desirable, especially for ESI-
MS [62]. This can also be achieved by complete hydrolysis of the oligonucleotide with HF [67].
Due to the low cross-linking yield and the usually limited amounts of starting material, the purifi-
cation or enrichment of cross-linked heteroconjugates is a crucial step in the sample preparation for
mass spectrometric analysis. The high excess of noncross-linked peptides and oligonucleotides would
otherwise hinder cross-link detection and identification. Through enrichment, sample complexity
is greatly reduced, which is beneficial in maximizing the number of potential cross-links chosen for
MS/MS fragmentation and for data analysis. In addition, signal suppression by noncross-linked
RNA oligonucleotides and peptides is decreased.
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Figure 1.10: Isolation of cross-linked heteroconjugates from noncross-linked peptides by size ex-
clusion chromatography. After proteolysis under denaturing conditions, full-length
RNA together with cross-linked peptides can be isolated from peptides by size ex-
clusion. After RNA hydrolysis, noncross-linked oligonucleotides need to be removed
through suitable methods.
Purification by reversed phase high performance liquid chromatography (RP-HPLC) or size exclu-
sion (SE) chromatography as well as enrichment via immobilized metal-ion affinity chromatography
(IMAC) or titanium dioxide material have been applied successfully.
Size exclusion chromatography can be applied if proteins and RNA differ considerably in size or
for isolation of RNA with and without cross-linked peptides following proteolysis. Both approaches
were combined in cross-linking studies of the prokaryotic ribosome [36, 46,68]. In a first SE, ribosomal
RNA (rRNA) with cross-linked proteins was separated from noncross-linked ribosomal proteins.
After proteolysis, a second SE step separated rRNA with cross-linked peptides from noncross-
linked peptides. rRNA containing fractions were hydrolyzed by nucleases and cross-linked peptide–
RNA heteroconjugates were separated by RP-HPLC. Isolated cross-links were subjected to Edman
sequencing to identify the sequence of the cross-linked peptide. In many cases, the cross-linked
amino acid led to a gap in the sequence analysis and could thus be identified.
In contrast to ribosomes, the size difference between uridine-rich small nuclear RNAs (U snRNAs)
and their associated proteins is not sufficient to permit their separation by size exclusion chro-
matography. Therefore in studies of human small nuclear ribonucleoprotein particles (snRNPs),
SE was only applied after proteolysis (as outlined in Figure 1.10). RNA containing fractions were
subsequently hydrolyzed with nucleases and endoproteinases. The mixture was then separated
by RP-HPLC. Monitoring absorption at both 220 nm (peptides) and 260 nm (RNA) allowed the
detection of heteroconjugates (e.g. [64, 66]).
After size exclusion chromatography and hydrolysis of RNA-containing fractions, the mixture can
also be directly subjected to on-line LC-ESI-MS/MS. This was demonstrated in a cross-linking
study of the human U1 snRNP and the reconstituted [15.5K-61K-U4atac snRNA] complex. An
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extensive washing step was included to remove the noncross-linked RNA oligonucleotides, cross-
linked heteroconjugates and residual peptides were retained on the trapping column [63].
Figure 1.11: Enrichment of cross-linked heteroconjugates with C18 and titanium dioxide chro-
matography. The protein–RNA complex is UV irradiated, for native RNA at 254 nm.
Next, the complex is hydrolyzed under denaturing conditions with RNases and en-
doproteinases. Desalting with C18 material removes the majority of noncross-linked
RNA oligonucleotides. Finally, titanium dioxide chromatography separates noncross-
linked peptides from the cross-linked heteroconjugates. These are then subjected to
LC-ESI-MS/MS analysis.
Figure originally published in [48].
Several enrichment protocols for phosphopeptides are based on the interaction of the phosphate
groups with metal ions. These can be adapted to enrich peptide–RNA oligonucleotide heterocon-
jugates via the phosphate groups in the RNA backbone. At first, enrichment protocols were based
on immobilized metal-ion affinity chromatography (IMAC) with Fe(III) ions for cross-link to either
RNA [62, 66] or DNA [67, 69].
More recently, enrichment based on titanium dioxide (TiO2) chromatography was applied. Protocols
initially established for phosphopeptides use competitive binding with 2,5-dihydroxy benzoic acid
(DHB) to TiO2 to reduce co-enrichment of acidic peptides [70]. This approach could be directly
conveyed to cross-linked peptide–RNA oligonucleotide heteroconjugates [71]. After UV irradiation
and ethanol precipitation, the protein–RNA complexes are hydrolyzed by RNases and trypsin. The
sample is then desalted and the cross-links are subsequently enriched over TiO2 columns in the
presence of DHB [71] (see Figure 1.11). In contrast to IMAC agarose beads, titanium dioxide can be
integrated into an HPLC setup. A two dimensional LC approach, combining C18 and TiO2 columns,
has been used for enrichment and subsequent automatic spotting for MALDI-MS analysis [72].
Overall, the most frequently applied method in our laboratory is TiO2 enrichment with spin columns,
as it requires less sample amounts compared to size exclusion or reversed phase isolation and is more
selective than IMAC enrichment strategies. It also allows for the enrichment of several samples in
parallel and is compatible with LC-ESI-MS/MS analysis, which is advantageous compared to the
2D LC setup with subsequent MALDI analysis in terms of sample processing time and quality of
the obtained MS information.
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1.3.3 Mass spectrometry of peptide–RNA heteroconjugates
The efficiency of mass spectrometric analysis of UV induced protein–RNA cross-linking experiments
is closely connected to the performance of the mass spectrometer. Ionization technique, sensitivity,
mass accuracy and resolution as well as sequencing speed greatly influence the obtained results.
The MS methods that have been applied to the identification of cross-links often correlated to the
development in MS instrumentation in general.
The divergent physico-chemical properties of proteins and RNA lead to their analysis in positive
and negative ion mode, respectively. Peptide–RNA oligonucleotide heteroconjugates are usually
analyzed in positive ion mode since unambiguous identification of the cross-linked peptide is desired.
The ionization efficiency of heteroconjugates is decreased by the negatively charged phosphodiester
backbone. In consequence, identification of cross-links requires higher sample amount compared to
standard MS based proteomics experiments [52]. The negative ion mode is preferred only for mass
determination of heteroconjugates containing longer RNA oligonucleotides as it increases signal
intensities. Fragmentation of the peptide moiety in negative ion mode is poor, preventing its
identification [65].
1.3.3.1 MALDI mass spectrometry
The first mass spectrometry based analyses of cross-linked heteroconjugates were performed with
matrix assisted laser desorption/ionization (MALDI). Initially, only the mass of the intact het-
eroconjugate was determined, cross-links were identified by their mass and information derived
from complementary experiments [46, 47,64,68]. Later, fragmentation by post source decay (PSD)
was performed to acquire fragment information [65, 66]. The matrices dihydroxy benzoic acid (DHB)
and 2,4,5-trihydroxyacetophenone (THAP) provided the best results in respect to signal inten-
sity and spectrum quality [65]. Analysis was mainly done in positive ion mode, but in contrast to
LC-ESI-MS/MS, switching between positive and negative mode within the same experiment was
easier [62]. The loss of H3PO4 (98Da) can be used as an initial indicator for phosphate containing
species [65, 66,72].
1.3.3.2 ESI mass spectrometry
Electrospray ionization (ESI) mass spectrometry directly couples liquid chromatography to the
instrument (on-line LC-ESI-MS/MS). In comparison to MALDI, lower sample amounts are necessary
and the obtained sequencing results are more informative. Therefore, ESI-MS gradually replaced
MALDI-MS and is now the method of choice for the analysis of cross-linking experiments.
Various instrument types have been used for the analysis of heteroconjugates with ESI-MS: linear
ion trap (linear trap quadrupole, LTQ, [73]), triple quadrupole/linear ion trap (Q-trap, [63, 66]),
quadrupole time-of-flight (Q-ToF, [71, 74]), Fourier transform ion cyclotron resonance (FT-ICR, [73]),
or orbitrap [75].
ESI-MS analysis of cross-linked samples can be done by targeted analysis on a Q-trap instrument.
This approach requires two consecutive LC-MS runs. In the first run, the masses of the intact
heteroconjugates (precursor masses) are recorded. RNA containing species are distinguished from
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residual peptides by monitoring the loss of 79Da (PO3-) in negative ion mode. The gathered
information is then used for the second run, in which phosphate-containing species are specifically
fragmented in positive ion mode. The detection of RNA marker ions (see below), more specifically
the nucleobases, triggers the acquisition of a high resolution fragments spectrum [63, 66].
More recently, LC-MS has been carried out with Q-ToF mass spectrometers [71, 74]. Data dependent
acquisition (see 1.2.1) on Q-ToF instruments has a lower sensitivity compared to targeted exper-
iments on a Q-trap. Low intensity cross-links might not trigger MS/MS fragmentation and thus
cannot be identified. However, this type of analysis does not require two consecutive runs for the
same experiment and MS/MS spectra are more informative. In addition, only cross-links producing
RNA marker ions upon fragmentation are accessible with the targeted method; this bias does not
apply to data dependent acquisition.
FT-ICR or orbitrap instruments acquire data with high mass accuracy and resolution. CID frag-
mentation is performed in the linear ion trap of the instrument and is disadvantageous for cross-link
identification (see 1.2.1.2 and below). Nonetheless, characterization of an isolated microcin with
MS/MS in positive and negative ion mode in the LTQ was demonstrated. This species contained a
phosphoramidate group covalently linked to a peptide with seven amino acids, an adenosine, and a
propylamine [75].
1.3.3.3 RNA marker ions
Upon CID fragmentation, cross-links can produce distinctive marker ions containing intact nu-
cleotides (after neutral loss of water) and the nucleic acid bases (theoretical masses are listed in
Table B.1). This is consistent with fragmentation of pure RNA, where cleavage of the N-glycosidic
bond to produce nucleobases and of the 5’-P-O bond leading to shortened oligonucleotides is com-
mon (1.2.1.4, [76] and references within). However, this is not a reliable criterion to identify spectra of
RNA-containing species. The marker ions of uracil are usually of very low intensity, consistent with
the observation that uracil is rarely detected after fragmentation of RNA oligonucleotides due to
its low proton affinity [76]. Also, intact guanosine has never been observed in previous cross-linking
studies. Especially if only one nucleotide is cross-linked, usually no RNA signal is visible in the
MS/MS spectrum. Thus in most cases, the MS/MS spectra are dominated by peptide fragments.
Then, the cross-linked RNA moiety can only be derived from the difference between calculated
peptide and experimental precursor mass. If less complete hydrolysis of the RNA is performed
and in consequence the cross-linked RNA oligonucleotide is considerably longer, CID spectra are
dominated by RNA fragments since the phosphodiester backbone is more readily cleaved [77].
1.3.3.4 Fragmentation modes: beam-type versus ion trap CID
Collision induced dissociation (CID) on orbitrap instruments is performed in the linear ion trap
(see 1.2.1.2). There are substantial differences between beam-type CID as carried out in Q-ToF
instruments and ion trap CID fragmentation. In the latter, several collisions with low energy induce
fragmentation. In contrast, the kinetic energy of ions during beam-type CID is significantly higher
and fragmentation is typically induced by single collisions with higher energy. In consequence,
beam-type CID typically produces long y-ion series while only small N-terminal a- and b-ions are
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observed. Larger a-/b-ions are unstable and readily fragment further. In contrast, ion trap CID
usually leads to longer y- and b-ion series.
The physical properties of the ion trap presents two major disadvantages. It cannot trap all fragment
ions over the entire mass range, small ions are lost (low mass cut-off, see 1.2.1.2). In consequence,
detection of important (diagnostic) ions like RNA marker ions, immonium ions and small peptide
fragments is prevented. Secondly, the MS/MS fragment spectra are typically recorded with the
detectors adjacent to the ion trap. While this process is faster compared to MS/MS acquisition in
the orbitrap, it has the disadvantage of a considerably lower resolution and mass accuracy.
In general, ion trap CID was considered disadvantageous for protein–RNA cross-links compared to
beam-type CID (Henning Urlaub, unpublished observation). Ion trap CID is likely to cleave off
labile modifications (as for example cross-linked nucleotides). The resulting fragment, the intact
peptide, is not activated to induce further collisions due to its lower mass. In addition, the low
MS/MS mass accuracy and the low mass cut-off inhibit confident cross-link identification. The low
mass accuracy prevents unambiguous assignment of fragments as y-, b-, or RNA containing ions
(see below). RNA marker ions, which are important for confirmation of the cross-linked RNA, are
lost due to the low mass cut-off, thus preventing an important step of cross-link validation.
Orbitrap instruments offer a second fragmentation mode corresponding to beam-type CID, namely
higher-energy collision dissociation (HCD). Ions are fragmented in a multipole adjacent to the C-
trap and the MS/MS fragment spectrum is recorded in the orbitrap. Therefore, the corresponding
spectra do not exhibit the low mass cut-off and benefit from the high mass accuracy of the orbitrap.
However, the number of observed fragments was slightly higher on the Q-ToF instrument employed
in the comparison, making it the instrument of choice for analysis of protein-RNA cross-linking
experiments [78].
In addition to fragmentation techniques based on collisions (CID, HCD), other methods can be
applied. In a fragmentation study of a model peptide–RNA heteroconjugate, two alternative frag-
mentation modes were tested. Both electron capture dissociation (ECD) and electron transfer dis-
sociation (ETD) of the model heteroconjugate led to a higher number of observed peptide fragments
compared to ion trap CID. In addition, larger precursor charge states were shown to increase the
peptide sequence information after fragmentation. In accordance with observations reported from
our laboratory (see 1.3.1), it was concluded that increasing length of the cross-linked oligonucleotide
is disadvantageous for fragmentation efficiency [73].
1.3.4 Cross-link identification from mass spectrometry data
Analysis of mass spectrometry data derived from cross-linking experiments is a limiting factor of the
approach. The low yield of cross-linked heteroconjugates leads to spectra with low intensity signals,
i.e. relatively poor quality in comparison to standard proteomics experiments. The large number of
potentially cross-linked RNA oligonucleotides causes additional challenges. The observation of RNA
marker ions is largely dependent on the composition of the cross-linked RNA (see 1.3.3.3). Therefore,
they cannot be used as diagnostic ions to filter for spectra corresponding to heteroconjugates.
Helpful evidence for the presence of a cross-linked heteroconjugate can be derived from the com-
parison between the cross-linked sample and a non-irradiated control. Signals observed after UV
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irradiation but not in the corresponding control are very likely to originate from products of a UV-
induced reaction. So far, such comparisons for the identification of cross-linked heteroconjugates
have only been done manually (e.g. [71, 79]). In contrast, several standard algorithms of quantita-
tive mass spectrometry have been applied successfully to identify RNA binding proteins based on
noncross-linked peptides [14, 15]. This approach is only feasible after isolation of cross-linked proteins
under stringent conditions.
Similarly, evidence for cross-links can be gained by treating one sample with calf intestinal alkaline
phosphatase (CIP) while the other remains untreated. Comparison of the treated and untreated
samples gives a characteristic shift of 80 Da in MS, corresponding to the loss of HPO3 upon CIP
treatment. Phosphate containing species can then be distinguished from acidic peptides that are
co-enriched with IMAC or titanium dioxid. If noncross-linked peptides were separated via SE prior
to enrichment, it is unlikely that the loss of HPO3 is due to residual phosphopeptides. As an
additional or alternative indicator, mass shifts due to nuclease treatment can be monitored [62].
In principle, the fractional mass (first digit of the molecular mass) could also be used to distin-
guish cross-linked heteroconjugates from peptides and oligonucleotides. Peptides contain a higher
percentage of atoms with a mass excess, i.e. hydrogen with the mass of 1.0078Da and nitrogen
with 14.0031Da. In comparison, oligonucleotides contain more oxygen (15.9949Da) and phospho-
rus (30.9738Da) that show a mass deficiency. In consequence, fractional masses of peptides are
higher than those of oligonucleotides. Heteroconjugate fractional masses are intermediate as they
contain both peptide and oligonucleotide moieties. These differences can be used to distinguish
the three species, provided that masses are acquired on instruments with a high mass accuracy [80].
However, this approach has not been integrated in any algorithm for an automated recognition of
heteroconjugates.
Previous studies have demonstrated that the mass of a cross-linked heteroconjugate is additive, i.e.
the mass of the cross-links corresponds to the sum of the masses of its constituents, peptide and
oligonucleotide (e.g. [65]). Exceptions were observed for halopyrimidines where the corresponding
hydrohalogen is lost during the reaction. For example, the loss of HBr upon cross-linking of 5-Br-
deoxiuridine substituted DNA has been confirmed by mass spectrometry [56].
Another important exception is the observation of an additional mass of 152Da in cross-links be-
tween cysteine-containing peptides and RNA. It was first reported in a cross-linking study of snur-
portin 1 (SPN1) to U1 snRNA [66]. Various cross-links of the SPN1 C-terminus, differing in length
of the cross-linked peptide as well as oligonucleotide, were observed with an additional mass of
152Da. The same adduct has been observed in cross-links of Sm proteins to both U1 and U2
snRNAs [78] as well as a cross-link of the RNase H-like domain of Prp8 to an RNA resembling the
U4/U6 snRNA duplex [81]. Despite various efforts, neither the origin nor the exact composition of
the species leading to the observed mass adduct could be unambiguously determined (F. Richter,
C. Endler, K.K., U. Zaman, H. Urlaub, Bioanalytical Mass Spectrometry group, unpublished).
Initial computer-aided data analysis strategies compared the experimental precursor masses with the
calculated masses of all peptide–oligonucleotide combinations after in silico digest of the protein and
RNA, respectively [62, 65]. However, this might lead to a great number of putative hits, especially for
large precursor masses. Therefore, laborious manual evaluation of the results is required. Secondly,
the approach is only feasible if protein and RNA sequences of the sample constituents have been
identified.
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Interpretation of the mass spectrometry data obtained from cross-linking experiments remains chal-
lenging and laborious. So far, there has been no suitable software that can handle all effects observed
in fragment spectra of cross-linked heteroconjugates and thus can be applied for automated identi-
fication.
1.3.5 Application of UV induced cross-linking in combination with mass
spectrometry
The earliest cross-linking studies with analysis by mass spectrometry were focused on protein–DNA
complexes which will be described briefly before focusing on protein–RNA cross-linking studies.
The applied MS techniques mostly correlate to their developments in general. For example, the
first studies investigating cross-linked heteroconjugates employed MALDI while the majority of
later surveys was based on ESI-MS.
In the early 1990s, the first mass spectrometric measurements of peptide–mononulceoside hetero-
conjugates were published [82, 83]. In the first feasibility study on phosphate-containing heterocon-
jugates, Jensen et al. used MALDI-MS to determine the molecular mass of protein–DNA adducts.
They investigated cross-linking of phage T4 gene 32 protein to a (dT)20 oligonucleotide and E. coli
transcription termination factor rho to the ATP-analogue 4-thio-uridine-diphosphate. For the first
time ever, the mass of a cross-linked heteroconjugate was thus measured by mass spectrometry. Re-
markably, the masses of the intact protein–DNA adducts were detected without any purification of
the sample [84]. In a second study by Bennett et al., E. coli uracil-DNA glycosylase was cross-linked
to a (dT)20 oligonucleotide and isolated via DEAE and single-stranded DNA agarose chromatog-
raphy to measure the intact mass. In addition, after irradiation and trypsin digestion, cross-linked
peptides were isolated via DEAE chromatography. Subsequent MALDI-MS analysis identified four
peptides that cross-linked to (dT)20 [85]. Finally, a chemically synthesized peptide–oligothymidylic
acid conjugate was investigated comparing various MALDI matrices and employing ESI-MS/MS to
obtain one of the first fragment spectra of a peptide–oligonucleotide heteroconjugate [77].
The first cross-linking studies on protein–RNA complexes employing MALDI-MS were done by
Urlaub et al. [46, 68]. Bacterial 30S ribosomal subunits were UV irradiated, either without or following
2-iminothiolane labeling of lysine residues. RNA with cross-linked proteins was isolated by size
exclusion chromatography. Subsequently, the complexes were hydrolyzed by endoproteinases and
RNase T1 and the cross-links were purified by RP-HPLC. N-terminal sequencing identified the
peptide sequence, while the gap in the sequence corresponded to the cross-linked amino acid. The
mass of the intact heteroconjugate was determined by MALDI-MS. The composition of the cross-
linked oligonucleotide was derived from the difference between the heteroconjugate and peptide
masses. The cross-linked RNA sequence was identified after partial alkaline hydrolysis and treatment
with 3’ → 5’ phosphodiesterase. Analysis of the resulting hydrolysis products yielded a series of
signals where the mass differences corresponded to the RNA nucleotides and the oligonucleotide
sequence could be deducted by comparison to the primary sequence of 16S ribosomal RNA.
Another very early study on protein–RNA cross-linking focused on the interaction of Human Im-
munodeficiency Virus type 1 Tat protein with the trans-activation responsive region (TAR). Farrow
et al. cross-linked a Tat peptide to a model TAR duplex in which a bulged uridine was substi-
tuted by 4-thio-uridine. After HPLC purification and proteolytic digestion, they identified several
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cross-linked arginine-containing peptides by MALDI-MS. As the peptide sequence contained a large
number of arginines, they used peptides site-specifically labeled with 13C and 15N containing argi-
nine to identify the actual cross-linked amino acid [86].
Human spliceosomal U1 small nuclear ribonucleoprotein particles (snRNPs) and the reconstituted
[15.5K-61K-U4atac snRNA] complex of the minor spliceosome [47] have been studied extensively
by cross-linking and mass spectrometry and served as model complexes for method development
studies (see above, [62–66,72]).
The first study on cross-linking of spliceosomal complexes using mass spectrometry investigated the
human U1 snRNP [64]. Identification of the cross-linked nucleotides was achieved by primer exten-
sion analysis. Cross-linking sites appear as discrete stops of the reverse transcriptase one nucleotide
upstream to the cross-linked nucleotide, as a small peptide always remains covalently attached to
the latter. To determine which protein is cross-linked, an immunoprecipitation step was integrated
into the workflow prior to primer extension. The sequence of the cross-linked peptide was identified
by N-terminal sequencing after preparative purification of the heteroconjugates. The cross-linked
RNA was identified with MALDI-MS following the same workflow established for ribosomes (see
above).
After UV irradiation of the reconstituted [15.5K-61K-U4atac snRNA] complex followed by size exclu-
sion and microbore chromatography, the chymotrypsin specific 61K (hPrp31p) peptide SSTSVLPH-
TGY (S263–Y273) was found to be cross-linked to an oligonucleotide 5’-CAUAG-3’ (C42–G46) of
U4atac solely by the precursor mass measured by MALDI in positive reflectron mode. Fragmenta-
tion by post-source decay (PSD) confirmed the RNA sequence and identified U44 as the cross-linked
nucleotide. The peptide sequence could only be obtained by fragmentation of a different precursor
of the same peptide cross-linked to an AU dinucleotide. As mentioned above, increasing length of
the cross-linked oligonucleotide leads to stronger interference with the detection of peptide frag-
ments. Observation of a histidine-uridine heteroconjugate identified H270 as the cross-linked amino
acid. This cross-linking site had been identified in previous studies by N-terminal sequencing and
MALDI in positive linear mode [47]. Following the same experimental workflow for U1 snRNP, the
70K peptide RVLVDVER (R173–R180) was found to be cross-linked to the U1 snRNA RNase T1
specific fragment 5’-AUCACG-3’ (A29–G34). MALDI-PSD proved U30 to be the cross-linked nu-
cleotide. Furthermore, from the lack of the corresponding peptide fragment ion y6 and a signal
corresponding to the next peptide fragment ion in the series, y7, additionally carrying a uracil base,
it was concluded that L175 could be the cross-linked amino acid [65].
In a study of a partial complex of human spliceosomal U2 snRNP, Kühn-Hölsken et al. identified a
contact site between the U2-specific protein p14/SF3b114a and the region of U2 snRNA interacting
with the branch-site of the pre-mRNA [62]. This is in excellent agreement with previous studies that
demonstrated direct contact of p14/SF3b14a with nucleotide G31, which is next to the branch-site
interacting region of U2 snRNA (G33–A38) [87].
Further investigations of U1 snRNP bound to the nuclear import factor snurportin 1 (SPN1) com-
bined UV induced protein–RNA cross-linking with IMAC enrichment. MS analysis was done by
both MALDI-ToF(-ToF) and the targeted approach described in 1.3.3.2 after LC-ESI-MS. The
C-terminal peptide of SPN1 was shown to directly interact with stem loop III of U1 snRNA [66].
Several recent studies have successfully combined titanium dioxide enrichment and ESI-LC-MS/MS
analysis on a Q-ToF instrument: The structure of the NusB–S10 transcription antitermination
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complex of E. coli was studied by Luo et al. Combining their structure as determined by X-ray
crystallography and the results of UV induced cross-linking of NusB–S10 to an rrn BoxA and a
γNutR BoxA containing oligonucleotide enabled mapping of the RNA-binding surface of the NusB–
S10 complex [71]. Ghalei et al. studied box C/D sRNPs of Pyrococcus furiosus which catalyze
2’-O-methylation of ribosomal RNA. Based on the results of cross-linking experiments analyzed
by mass spectrometry, they identified the AFLR motif of the Nop5 protein directly binding to
the RNA in and around stem II of the box C/D or C’/D’ motifs. Electrophoretic gel mobility
shift assays confirmed that deletion of the respective regions in Nop5 or RNA prevents complete
formation of the sRNPs [74]. Mozaffari-Jovin et al. studied the interactions of the RNase H-like
domain of the spliceosomal protein Prp8 with an RNA construct resembling a truncated U4/U6
snRNA duplex with cross-linking and mass spectrometry. They identified two amino acids of the
RNase H-like domain that directly interact with RNA. Together with complementary experiments,
including identification of the cross-linking site on the RNA by primer extension analysis, the results
permitted modeling of the position of the U4/U6 duplex on the three-dimensional structure of the
Prp8 RNase H-like domain [81].
Bley et al. studied the interaction of the telomerase RNA binding domain (TRBD) of the telom-
erase reverse transcriptase protein with an RNA fragment resembling the three-way helical junction
CR4/5. The TRBD was expressed as a fusion protein with the maltose-binding protein and a His6
tag. The RNA was randomly labeled with 5-iodo-uridine during in vitro transcription. After UV
induced cross-linking at 302 nm, the fusion protein was isolated under denaturing conditions from
noncross-linked RNA via the His-tag. After proteolysis, the peptide–RNA heteroconjugates were
purified by gel electrophoresis. The RNA was hydrolyzed with RNases A or T1; the mixture was
then subjected to MALDI-ToF-MS. Comparison of the mass spectrum to a non-irradiated control
containing unlabeled RNA revealed signals corresponding to cross-linked heteroconjugates. The
composition of the cross-link was derived from calculating the masses of all possible combinations
of tryptic peptides and RNase specific oligonucleotides. The sample was then treated with ammonia
and phosphatase to yield peptides covalently linked to single uridines. Subsequently, the peptide
sequence was confirmed and the cross-linked residue identified by MALDI-ToF/ToF analysis after
collision induced dissociation [79].
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1.4 Objectives
Various experimental strategies have been developed for the identification of cross-linking sites on
a peptide or amino acid level by mass spectrometric analysis. These have been applied to different
purified native or in vitro reconstituted protein–RNA complexes. However, the complexes studied
so far have been relatively simple, comprising few proteins and mostly single RNAs.
While studies of protein–RNA interactions in vitro yield valuable information of direct contact sites,
they cannot account for all effects that influence interactions in the complex environment of the
cell. DNA sequencing techniques allow investigation of the contact sites on the RNA level after UV
induced cross-linking in vivo. No complementary methods allow the identification of contact sites
on the protein level at a comparable resolution, i.e. peptides or amino acids.
To close the gap between relatively simple protein–RNA complexes and an unbiased identification
of interaction sites on a peptide or even amino acid level by mass spectrometry after in vivo cross-
linking, substantial improvements to the approach are necessary. The method faces two major
challenges: the generally low yield of the UV induced reaction and a lack of data analysis tools that
allow unbiased searches for cross-linked heteroconjugates.
The low cross-linking yield can be partially overcome by incorporation of photoreactive nucleotides
in vitro or in vivo. However, the mass of the cross-linking product and its fragmentation behavior
during MS analysis has to be known. Therefore, one aim of this project was the detailed investigation
of one candidate for RNA labeling, 4-thio-uracil, in a simple test system.
Due to the rapid growth in the number of mass spectrometry applications, especially in proteomics,
MS instrumentation has seen major improvements in the past decade. Sensitivity, resolution, mass
accuracy, and sequencing speed have been increased significantly. Since the constant improvements
might also affect the MS based identification of protein–RNA cross-links, another aim of this study
was the evaluation of emerging instrumental advancements. One instrument in particular, the
LTQ Orbitrap Velos, was to be tested extensively. It was reported to exhibit a significant increase
in sensitivity in proteomics applications, especially for a particular type of fragmentation (HCD).
The question was whether these improvements would also be beneficial for the mass spectrometric
analysis of cross-linked heteroconjugates.
The second major challenge in investigation of UV induced protein–RNA cross-linking is data anal-
ysis. Existing manual spectra interpretation or computer-aided strategies were limited to a low
number of protein sequences. Without a suitable data analysis approach, cross-links cannot be
identified in extended ribonucleoprotein complexes or even entire cells. Therefore, the major aim
of this PhD project was the development of data analysis workflows that would allow automated
identification of cross-links in searches against larger protein databases and eventually entire pro-
teomes.
These method development strategies had to be evaluated in biological systems, for which appropri-
ate test systems had to be found. In addition, specific questions raised in two collaborations were
to be resolved with UV cross-linking combined with MS. Experimental strategies for sample prepa-
ration, cross-linking, enrichment, and MS analysis had to be evaluated and, if necessary, optimized
to allow identification of cross-links in the respective ribonucleoprotein complexes.

2 Materials and Methods
2.1 Materials
2.1.1 Chemicals and solvents
acetonitrile, LiChrosolv Merck, Darmstadt, Germany
acetonitrile, Chromasolv Sigma-Aldrich, Steinheim, Germany
agarose Serva, Heidelberg, Germany
ampicillin Roth, Karlsruhe, Germany
Bacto agar Becton, Dickinson and Company, Sparks, MD, USA
Bacto peptone Becton, Dickinson and Company, Sparks, MD, USA
Bacto yeast extract Becton, Dickinson and Company, Sparks, MD, USA
bromophenol blue Merck, Darmstadt, Germany
Coomassie Brilliant Blue Sigma-Aldrich, Steinheim, Germany
G-250
DHB Aldrich, Steinheim, Germany
EGTA Roth, Karlsruhe, Germany
formic acid Sigma-Aldrich, Steinheim, Germany
glucose Merck, Darmstadt, Germany
kanamycin Roth, Karlsruhe, Germany
LB-medium capsules MP Biomedicals, Illkirch, France
methanol, LiChrosolv Merck, Darmstadt, Germany
α-lactose Merck, Darmstadt, Germany
TFA Roth, Karlsruhe, Germany
trypton Merck, Darmstadt, Germany
urea Sigma-Aldrich, Steinheim, Germany
water, LiChrosolv Merck, Darmstadt, Germany
xylene cyanol FF Sigma-Aldrich, Steinheim, Germany
YEP Broth ForMedium, Norfolk, UK
All other chemicals/solvents were obtained from Fluka, Merck, Sigma-Aldrich or Roth in p.a. (pro
analysis) grade. All buffers were prepared with water purified by deionization and filtration in
a Milli-Q Biocel century system equipped with a Millipak 0.22 μm filter (both Millipore, Merck,
Darmstadt, Germany). Buffers were sterilized with bottle top or syringe filters.
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2.1.2 Commercial buffers and solutions
acrylamide for protein gels Rotiphorese Gel 30 (30% acrylamide, 0.8% bis-acrylamide);
Roth, Karlsruhe, Germany
Bradford staining solution Bio-Rad Protein Assay; Bio-Rad, Munich, Germany
ECL solutions Amersham ECL Western Blotting Detection Reagents;
GE Healthcare, Munich, Germany
ethidium bromide Roth, Karlsruhe, Germany
PCI solution Roti phenol/chloroform/isoamyl alcohol (25:24:1);
Roth, Karlsruhe, Germany
Pfu buffer (10x) Promega, Mannheim, Germany
PNK buffer (10x) New England Biolabs, Frankfurt, Germany
protein marker Precision Plus Protein Standards (Unstained or All Blue);
Bio-Rad, Munich, Germany
2.1.3 Buffers
AGK 10 mM Hepes pH 7.9, 1.5 mM MgCl2, 50 mM KCl, 10% glycerol
CBB 25 mM Tris pH 7.9, 150 mM NaCl, 1 mM Mg(OAc)2,
1 mM imidazole, 2 mM CaCl2, 2 mM DTT
CEB 25 mM Tris pH 7.9, 150 mM NaCl, 1 mM Mg(OAc)2,
1 mM imidazole, 25 mM EGTA, 0.02% NP40, 2 mM DTT
CE 10 mM cacodylic acid pH 7.0, 0.2 mM EDTA pH 8.0
PCR buffer, 10x 100 mM Tris pH 8.7, 500 mM KCl, 25 mM MgCl2
SDS running buffer, 1x 25 mM Tris, 192 mM glycine, 0.1% SDS
SDS sample buffer 60 mM Tris, 1 mM EDTA, 16% glycerine, 2% SDS,
0.1% bromophenol blue, 50 mM DTT
TBE, 1x 0.1 M boric acid, 0.1 M Tris, 2 mM EDTA, pH 8.3
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2.1.4 Enzymes and enzyme inhibitors
benzonase benzonase nuclease; Novagen, Merck, Darmstadt, Germany
lyticase Sigma-Aldrich, Steinheim, Germany
phusion DNA polymerase 15 ng/μl; Department of Cellular Biochemistry
PreScission protease 10 mg/ml; Department of Cellular Biochemistry
protease inhibitors EDTA free Protease Inhibitor Cocktail tablets;
Roche, Mannheim, Germany
RNase A RP A grade;
Ambion, Applied Biosystems, Darmstadt, Germany
RNase T1 biochemistry grade;
Ambion, Applied Biosystems, Darmstadt, Germany
rRNasin RNase inhibitor Promega, Mannheim, Germany
T4 polynucleotide kinase New England Biolabs, Frankfurt, Germany
Taq DNA polymerase 4.8 mg/ml; Department of Cellular Biochemistry
trypsin sequencing grade modified trypsin;
Promega, Mannheim, Germany
2.1.5 Proteins, peptides and (oligo)nucleotides
ATP, [γ-32P]-labeled PerkinElmer, Waltham, MA, USA
BSA standards Bradford: Albumin Standard;
Thermo Fisher Scientific, Schwerte, Germany
LC-MS: BSA Protein Digest Standard;
Protea Biosciences, Morgantown, WV, USA
carrier DNA DNA, MB-grade from fish sperm; Roche, Mannheim, Germany
DNA primers Eurofins MWG Operon, Ebersberg, Germany
dNTPs New England Biolabs, Frankfurt, Germany
GluFib [Glu1]-Fibrinopeptide B, human, synthetic;
Aldrich, Steinheim, Germany
RNA oligonucleotides Dharmacon, Thermo Fisher Scientific, Epsom, UK
2.1.6 Antibodies
anti-rabbit IgG Peroxidase-conjugated AffiniPure Goat Anti-Rabbit IgG;
Jackson ImmunoResearch, West Grove, PA, USA
Peroxidase Anti-Peroxidase P-2026; Sigma-Aldrich, Steinheim, Germany
antibody
TAP tag antibody CAB1001; Pierce, Thermo Fisher Scientific, Schwerte, Germany
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2.1.7 Other materials
bottle top filters Filtropur BT50 0.2; Sarstedt, Nümbrecht, Germany
C18 column material C18 AQ 120Å 5 μm or 3 μm;
Dr Maisch GmbH, Ammerbuch, Germany
Calmoduline beads Calmodulin Affinity Resin; Agilent, Böblingen, Germany
chromatography columns Econo-Pac Chromatography Columns;
(gravity flow) Bio-Rad, Munich, Germany
dialysis cassettes Slide-A-Lyzer 3.5K;
Pierce, Thermo Fisher Scientific, Rockford, IL, USA
film (autoradiography) Carestream Kodak BioMax MR Film;
Sigma-Aldrich, Steinheim, Germany
film (ECL) High Performance Chemiluminescence Film;
GE Healthcare, Munich, Germany
glutathione sepharose GE Healthcare, Munich, Germany
IgG beads IgG Sepharose 6 Fast Flow; GE Healthcare, Munich, Germany
microtiter plates for black polypropylene 96 well microplates (# 655209);
cross-linking Greiner Bio-One, Frichenhausen, Germany
Ni-NTA agarose Qiagen, Hilden, Germany
RNA isolation columns MicroSpin G-25; GE Healthcare, Munich, Germany
syringe filters Filtropur S 0.2; Sarstedt, Nümbrecht, Germany
titanium dioxide column titansphere 5 μm;
material GL Sciences, Tokyo, Japan
WB nitrocellulose membrane Protran BA 83; GE Healthcare, Munich, Germany
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2.1.8 Instruments and laboratory equipment
autoclaves Varioklav steam sterilizer H+P;
Thermo Fisher Scientific, Schwerte, Germany
centrifuges benchtop centrifuges:
eppendorf centrifuge 5415R; Eppendorf, Hamburg, Germany









Heraeus/Sorvall: Thermo Fisher Scientific, Schwerte, Germany
clean bench HeraSafe; Heraeus, Thermo Fisher Scientific, Schwerte, Ger-
many
cross-linking apparatus build in-house, operated with four 8 W lamps
254 nm: G8T5; Sankyo Denki, Japan
365 nm: F8T5BL; Sankyo Denki, Japan
film developer Kodak X-OMAT 2000 Processor;
Carestream, Stuttgart, Germany
gel documentation Gel Doc 2000; Bio-Rad, Munich, Germany
gel electrophoresis Mini-PROTEAN Tetra system
Mini-SUB CELL GT
both Bio-Rad, Munich, Germany
LC-MS see 2.2.9
PCR thermo cycler T3 Thermocycler; Biometra, Göttingen, Germany




all Thermo Fisher Scientific, Schwerte, Germany
scintillation counter Tri-Carb 2100TR; Beckmann, USA
spectrophotometer Ultrospec 3000 pro;
Amersham Pharmacia Biotech, Cambridge, UK
Biophotometer; Eppendorf, Hamburg, Germany
thermomixers Thermomixer comfort
ThermoStat plus
both Eppendorf, Hamburg, Germany
ultra centrifugal mill ZM 200; Retsch, Haan, Germany
WB transfer cell Mini Trans-Blot Electrophoretic Transfer Cell;
Bio-Rad, Munich, Germany
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2.2 Methods
If not noted otherwise, methods were according to standard protocols [88] with modifications as
described.
2.2.1 Media and plates for cell cultures
All media and solutions for plates were prepared with deionized water and sterilized by autoclaving
(121◦C, 15min, 15 psi).
2.2.1.1 LB medium
LB (lysogeny broth) medium contained 1% tryptone, 0.5% yeast extract, and 1% NaCl (all w/V).
2.2.1.2 YPD medium
YPD (yeast extract, peptone, dextrose) medium contained 1% yeast extract, 2% peptone, and 2%
glucose (all w/V). For YPD agar, 2% (w/V) Bacto agar was added prior to autoclaving.
For large-scale yeast fermentation, YPD was prepared from YEP Broth by autoclaving and addition
of glucose (filtered sterile) to a final concentration of 2% (w/V).
2.2.1.3 YMM dropout medium
YMM (yeast minimum media) dropout contained 0.67% yeast nitrogen base without amino acids,
2% glucose, and 0.2% drop-out powder (all w/V), 2% agar was added for YMM plates. The pH was
adjusted by addition of NaOH. Drop-out powder for –URA selective plates contained 2 g each of the
following: adenine, alanine, arginine, asparagine, aspartic acid, cysteine, glutamine, glutamic acid,
glycine, histidine, isoleucine, lysine, methionine, phenylalanine, proline, serine, threonine, tyrosine,
tryptophan, and valine. In addition, it contained 4 g leucine. The powder was ground for complete
mixing.
2.2.1.4 Auto-inducing medium
Auto-inducing medium ZYM-5052 was prepared according to [89]. The 1000x trace metal solution
was a kind gift of Dr. Sunbin Liu (Department of Cellular Biochemistry). Other stock solutions
were prepared as listed below and sterilized by autoclaving. Medium was prepared as listed below






50x 5052 glycerol 25%
glucose 25%
α-lactose 10%




for 1 l auto-inducing medium
solution volume compound final concentration
ZY 956 ml trypton 1%
yeast extract 0.5%
1 M MgSO4 2 ml MgSO4 2 mM
50x 5052 20 ml glycerol 0.5%
glucose 0.05%
α-lactose 0.2%




1000x trace metals 200 μl 0.2x
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2.2.2 Standard molecular biology methods
2.2.2.1 Agarose gel electrophoresis of DNA fragments
Agarose gel electrophoresis was carried out for separation and visualization of DNA fragments.
Agarose (1.2% w/V) was dissolved in 60ml 0.5x TBE by heating. For later visualization, 3 μl
ethidium bromide (1% w/V) were added to the solution while it was cooling. DNA samples were
mixed with 6x DNA gel-loading buffer and fractionated at a constant voltage of 150V in 0.5x TBE
as running buffer. DNA was visualized by UV illumination.
6x DNA gel-loading buffer
0.25% bromophenol blue
0.25% xylene cyanol FF
15% Ficoll (Type 400; Pharmacia)
H2O
2.2.2.2 PCI extraction
Phenol-chloroform-isoamylalcohol extraction was used to separate DNA/RNA from proteins. The
sample was mixed with one volume PCI solution by vigorous shaking. Phases were separated
by centrifugation at 13 000 rpm for 5min. The upper aqueous phase, containing RNA/DNA, was
transferred into a clean microfuge tube. Optionally, the aqueous phase was again extracted by
addition of one volume chloroform, vigorous shaking and phase separation by centrifugation as
above. RNA/DNA was isolated from the aqueous phase by ethanol precipitation.
2.2.2.3 Ethanol precipitation
Proteins, RNA/DNA or protein–RNA complexes were precipitated by addition of 2.5 to 3 volumes
ethanol and 1/10 volume 3M NaOAc and incubation at –20◦C for at least 30min. Macromolecules
were pelleted by centrifugation at 13 000 rpm and 4◦C for 30min. The pellet was washed with 80%
ethanol and centrifuged as above. The supernatant was discarded and the pellet was dried in a
centrifugal evaporator.
2.2.2.4 5’ labeling of RNA
RNA oligonucleotides were 5’ labeled with [γ-32P]-ATP and T4 polynucleotide kinase (PNK) by
incubation of the reaction mixture for 70min at 37◦C.
reaction mixture for 5’ RNA labeling
1.5 μl RNA oligonucleotide 5 pmol
1.5 μl H2O
1 μl 10x PNK buffer
5 μl [γ-32P]-ATP 8.3 pmol
1 μl T4 polynucleotide kinase
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After incubation, 40 μl CE-buffer were added to the mixture. Free [γ-32P]-ATP was removed by
isolation with MicroSpin G-25 columns (GE Healthcare, Munich, Germany), used according to the
manufacturer’s protocol. The crude product was further purified by PCI extraction after adjusting
the volume to 200 μl by addition of 150 μl CE buffer. The RNA pellet was redissolved in CE buffer.
2.2.3 Standard protein biochemical methods
2.2.3.1 Determination of protein concentration
Protein concentrations were determined with the method originally developed by Bradford [90]. It is
based on the absorption maximum shift of Coomassie Brilliant Blue G-250 from 465 to 595 nm when
the dye binds to protein in acidic solution. The commercially available Protein Assay (Bio-Rad)
was used according to the manufacturer’s protocol.
BSA protein standards were prepared, typically eight standards ranging from 0 to 15 μg/ml final
concentration. The sample was diluted so that the final concentration was within the concentration
range of the standards. The standard curve and the sample concentration were calculated by the
spectrophotometer.
2.2.3.2 Denaturing polyacrylamide gel electrophoresis (SDS-PAGE)
Denaturing polyacrylamide gel electrophoresis was used for separation and visualization of proteins
by Coomassie staining or Western blotting. Gels for SDS-PAGE were prepared and run in a Mini-
PROTEAN Tetra system (Bio-Rad, Munich, Germany). Typically, gels with a 5.5% stacking gel
and a 15% separating gel were prepared following the recipe below. Samples were mixed with SDS
sample buffer (1:1 V/V) and heated to 95◦C for 5min prior to loading. Gels were run at 30mA per
gel with 1x SDS running buffer.
4x buffer for stacking and resolving gels
Tris SDS pH
stacking gel 1.5 M 4% 8.8
resolving gel 0.5 M 4% 6.8
5.5% stacking gel 15% separating gel
H2O 2.95 ml 2.5 ml
30% acrylamide solution 950 μl 5 ml
4x buffer 1.25 ml 2.5 ml
10% APS 20 μl 35 μl
TEMED 20 μl 35 μl
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2.2.3.3 Colloidal Coomassie staining
Proteins separated by SDS-PAGE were stained with colloidal Coomassie [91] over night and destained
by several rinses with water. Colloidal Coomassie was prepared with water and methanol in LiChro-
solv quality.
Colloidal Coomassie
Coomassie Brilliant Blue G-250 0.08% (w/v)
phosphoric acid (conc.) 1.6% (v/v)
ammonium sulfate 8% (w/v)
methanol 20% (v/v)
2.2.3.4 Western blotting for immunodetection of proteins
For immunodetection of proteins by specific antibodies, the protein sample was first separated
by SDS-PAGE. Proteins were then transferred onto nitrocellulose membranes by electrophoresis
(1 h at 65V and 4◦C for 1mm gels) in Western transfer buffer (20mM Tris, 150mM glycine). The
membrane was washed with TBS-T (50mM Tris pH7.5, 150mM NaCl, 0.1% Tween-20) and blocked
with 5% (w/V) fat-free milk powder in TBS-T at 4◦C over night. The membrane was then incubated
with primary antibody (1:500) in 5% milk/TBS-T for 1 h at room temperature. The membrane
was washed with TBS-T (5x 10min) before incubation with the secondary antibody (typically
1:60 000) in 5% milk/TBS-T for 1 h at room temperature. The membrane was washed with TBS-T
as mentioned above and immunodetected proteins were visualized by enhanced chemiluminescence
according to the manufacturer’s protocol (Amersham ECL Western Blotting Detection Reagents;
high performance chemiluminescence film; both GE Healthcare, Munich, Germany).
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2.2.4 Expression and isolation of the NusB–S10 protein complex
The NusB–S10 complex was purified following the published protocol [71] with slight modifications.
A glycerol stock of an E. coli BL21(DE3) strain containing plasmids encoding for NusB and S10
was kindly provided by Xiao Luo (Strukturbiochemie, Prof. Markus C. Wahl, Freie Universität
Berlin).
The E. coli strain was grown in autoinducing medium in the presence of 100 μg/ml ampicillin and
25 μg/ml kanamycin to an OD600 of 0.5 at 37◦C and subsequently over night at 20◦C. Cells were
harvested by centrifugation at 5 000 rpm and 4◦C for 30min. Cell pellets were washed once with
binding buffer (50mM Tris pH7.5, 150mM NaCl), centrifuged as above, and resuspended in binding
buffer supplemented with protease inhibitors. Cells were disrupted by sonication and cell debris
were pelleted at 15 000 rpm and 4◦C for 30min.
Glutathione sepharose was equilibrated with binding buffer. The NusB–S10 complex was trapped
on glutathione sepharose through the N-terminal GST tag of S10 by incubation at 4◦C for 3 h. The
protein complex was eluted with binding buffer supplemented with 15mM reduced glutathione. The
eluate was incubated with PreScission protease (1mg/ml; 1:100 w/w) at 4◦C over night to cleave off
the GST tag. In the second purification step, the complex was trapped on Ni-NTA agarose via the
N-terminal His6 tag of NusB. Ni-NTA agarose was pre-equilibrated with binding buffer containing
20mM imidazole prior to incubation with the sample for 90min at 4◦C. Beads were washed with
binding buffer containing 50mM imidazole and the protein complex was eluted with binding buffer
supplemented with 500mM imidazole. The eluate was concentrated by centrifugation.
In the final isolation step, the protein complex was injected onto a gel filtration column (Superdex 75
10/300 GL; GE Healthcare, Munich, Germany). Eluent was binding buffer with 2mM DTT.
Coomassie stained SDS-PAGE gels of the protein fractions were used to choose fractions where
NusB and S10 were present in a 1:1 ratio.
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2.2.5 Introduction of a C-terminal TAP tag to the yeast protein Cbp20 by
homologous recombination
The applied protocol described in the sections below follows established procedures [92] with slight
modifications unless noted otherwise. Dr. Kum-Loong Boon (Department of Cellular Biochemistry)
gave technical support in the experiments.
2.2.5.1 Generation of DNA
DNA template was the pBS1539 plasmid which was constructed to introduce a C-terminal TAP tag
and contains a URA3 selective marker from Kluyveromyces lactis [93]. The pBS1539-psc plasmid
used here, which contains a PreScission instead of the TEV cleavage site, was provided by Dr.
Kum-Loong Boon.
The TAP cassette was amplified by polymerase chain reaction (PCR). Primers, reaction mix and
PCR program are listed below. In the primer sequences, regions homologous to the pBS1539-psc
plasmid are underlined. The 5’ ends are homologous to the target gene CBP20.
forward primer:
5’-TCA GAC CAG GTT TCG ATG AAG AAA GAG AAG ATG ATA ACT ACG TAC CTC
AGT CCA TGG AAA AGA-GAA GAT-3’
reverse primer:
5’-TAT ATA TAT ATC TGT GTG TAG AAT CTT TCT CAG ATA TAA ATT-GAT TGA
TTT ACG ACT CAC TAT AGG GCG A-3’
250 μl PCR mix
25 μl 10x Pfu buffer
20 μl dNTPs (2.5 mM)
1.25 μl forward primer (100 μM)
1.25 μl reverse primer (100 μM)
195 μl H2O
5 μl DNA (pBS1539-psc)




50◦C 50 s 34 cycles
72◦C 2.5 min
72◦C 3 min
Formation of PCR product was confirmed by agarose gel electrophoresis. The PCR product was
isolated with phenol-chloroform extraction. To this end, 240 μl PCI solution (1:1 V:V) were added
and mixed by vortexing. Phases were separated by centrifugation at 13 000 rpm for 10min. DNA
was precipitated from the aqueous phase with 2.5 volumes of ethanol and 1/10 volume of 3M




To construct the yeast strain expressing TAP tagged Cbp20 (Cbc2p), the PCR product containing
the C-terminal TAP tag cassette was transformed into yeast strain BJ2168 with the lithium acetate
(LiOAc) method [94, 95].
Transformation mix was prepared by mixing 35 μl DNA solution, 36 μl 1M LiOAc and 240 μl PEG3350
solution (50% w/V), and 40 μl denatured fish sperm carrier DNA (2mg/ml; DNA, MB-grade from
fish sperm, Roche, Mannheim, Germany).
Competent yeast cells for transformation were prepared from a 50ml overnight culture grown to
an OD600 of 0.6-1.0. Cells were spun down by centrifugation at 4 000 rpm and 4◦C for 3min,
subsequently washed with 1ml H2O and centrifuged as above. Cells were resuspended in 400 μl
100mM LiOAc.
50 μl cell suspension were incubated with the transformation mix on a rotating wheel at room
temperature for 30min, followed by a heat shock at 42◦C for 20min. Cells were pelleted by brief
centrifugation, the transformation mix was removed and cells were resuspended in 125 μl H2O. Cells
were plated on –URA selective plates and incubated for 2-3 days at 30◦C. The transformants were
restreaked onto a fresh –URA selective plate for further validation.
2.2.5.3 Yeast colony PCR
Correct insertion of the TAP tag construct into the yeast strain was confirmed by yeast colony
PCR. Forward primer was the same as above, homologous to the chromosomal sequence and the
inserted TAP cassette (latter underlined in primer sequence). The reverse primer was homologous
to the ProtA sequence (underlined). PCR products were verified by agarose gel electrophoresis.
forward primer:
5’-TCA GAC CAG GTT TCG ATG AAG AAA GAG AAG ATG ATA ACT ACG TAC CTC
AGT CCA TGG AAA AGA-GAA GAT-3’
reverse primer:
5’-CCT TAA ATC AGG TTG ACT TCC CCG CGC A-3’
PCR mix (14 samples)
36 μl 10x PCR buffer
57.6 μl dNTPs (2.5 mM)
3.6 μl forward primer (100 mM)








50◦C 50 s 34 cycles
72◦C 2.5 min
72◦C 3 min
2.2.5.4 Confirmation of TAP tag inclusion by Western blot
Yeast clones confirmed by yeast colony PCR were further investigated by Western blotting. For
sample preparation, 2ml overnight cultures cultivated in YPD broth were harvested by centrifu-
gation at 3 500 rpm and 4◦C for 4min. Cell pellets were resuspended in 500 μl 0.2M NaOH and
incubated on ice for 10min. Subsequently, 27.5 μl TCA (100% w/V) were added and the cell lysate
was further incubated on ice for 10min. Proteins were spun down at 13 000 rpm for 30 s. Protein
pellets were resuspended in 35 μl dissociation buffer (0.1M Tris pH6.8, 4mM EDTA pH8.0, 4%
SDS, 20% glycerol, 20mM DTT). After addition of 15 μl 1M Tris, the sample was boiled at 95◦C
for 10min. Cell debris were removed by centrifugation (10 s at 13 000 rpm). Proteins were sepa-
rated by SDS-PAGE, and the TAP tagged protein was detected by Western blotting by peroxidase
anti-peroxidase antibody and visualized by enhanced chemiluminescence (ECL).
2.2.5.5 Confirmation of TAP tag inclusion by sequencing
The yeast strain confirmed to express TAP tagged protein by Western blotting was further verified
by DNA sequencing. Yeast DNA for PCR prior to sequencing was prepared from 50ml yeast
culture cultivated in YPD. Cells were harvested at 4 000 rpm and 4◦C for 3min. Cell pellets were
washed once with 10ml deionized water, centrifuged as above and resuspended in 10ml SE buffer
(0.9M sorbitol, 0.1M EDTA pH8.0). 50 μl lyticase (20mg/ml) were added and the cell suspension
was incubated for 30–60min at room temperature. Cells were spun down at 5 000 rpm for 5min,
resuspended in 500 μl lysis buffer (0.1M Tris pH8.0, 50mM EDTA, 1% SDS) and 32 μl 4M NaCl
were added. In order to break the cells, glass beads were added to the cell suspension and the sample
was vortexed for 1min. Cell debris and glass beads were removed by centrifugation at 5 000 rpm for
5min. DNA was isolated by PCI extraction and ethanol precipitation.
Two PCRs were prepared as described in 2.2.5.1 with the same forward primer. In the first PCR, the
same reverse primer as in 2.2.5.3 was used. The reverse primer for the second PCR is listed below.
It is homologous to the URA3 sequence in the TAP cassette. PCR products were visualized by
agarose gel electrophoresis and sequenced (SEQLAB Sequence Laboratories, Göttingen, Germany).
The obtained sequencing results showed no mutations in the coding region.
reverse primer 2:
5’-AGA GAA TCA GCG CTC CCC AT-3’
2.2 Methods 41
2.2.6 Yeast cell culture and extract preparation
A cell culture of the yeast strain containing a C-terminal TAP tag on CBP20 was grown in a
150 l fermenter (INFORS-HT, Bottmingen, Switzerland) by Thomas Conrad (Bioreactor Facility,
Department of Cellular Biochemistry). Cells were inoculated in YPD in the presence of 50mg/l
ampicillin and 10mg/l tetracycline to an OD600 of 5.7. Cells were washed once with water, col-
lected in a nozzle separator (GEA Westfalia Separator Group, Oelde, Germany) and harvested by
centrifugation at 4 500 rpm and 4◦C for 10min.
Cell pellets were resuspended in 0.7 volumes AGK buffer and cell droplets were flash frozen with
liquid nitrogen. Cell beads were ground in an ultra centrifugal mill and cell debris were pelleted
by centrifugation at 17 000 rpm and 4◦C for 30min in a SS-34 rotor. Optionally, polysomes were
pelleted by ultracentrifugation at 37 000 rpm at 4◦C for 60min in a T-865 rotor. Cell extracts were
flash frozen in liquid nitrogen and stored at –80◦C.
2.2.7 TAP tag purification
The original protocol for TAP tag purification [93] was further optimized and simplified by Dr.
Kum-Loong Boon to the TAP tag with PreScission cleavage site.
TAP tag purification for cross-linking and subsequent MS analysis was typically done with 10ml
yeast extract, corresponding to about 350mg of protein. The first step of TAP tag affinity purifi-
cation was performed with IgG beads and elution by PreScission protease cleavage of the ProteinA
part of the TAP tag. In the second purification step, complexes were trapped on Calmoduline beads
via the Calmoduline binding peptide part of the TAP tag.
300 μl IgG beads (600 μl bead suspension) were equilibrated with 5ml AGK prior to addition of
sample. Protein–RNA complexes were bound by incubation at 4◦C for 2 h. The IgG column was
washed with 20ml CBB. Complexes were released from IgG by incubation with 12 μl PreScission
protease in 2ml CBB supplied with 1 μl RNasin at 4◦C over night. The sample was eluted by gravity
flow and addition of 1ml CBB.
200 μl calmoduline beads (400 μl bead suspension) were equilibrated with 5ml CBB. The sample
was incubated with the beads at 4◦C for 1 h. The beads were washed with 20ml CBB. The sample
was eluted by incubation with 1ml CEB for 5min, elution was repeated twice in total.
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2.2.8 UV induced protein–RNA cross-linking
2.2.8.1 Cross-linking of labeled RNA and visualization of cross-linking products by SDS-PAGE
Cross-linking of proteins to RNA previously labeled with [γ-32P]-ATP was carried out with a large
excess of protein over RNA (>100fold) to ensure complete binding of RNA by protein. Experi-
ments were typically carried out with 1-2 pmol labeled RNA. Protein(s) and RNA were mixed and
incubated on ice for 30min for complex formation. After cross-linking, samples were mixed with
SDS sample buffer and directly subjected to SDS-PAGE. Cross-linking products were visualized by
autoradiography.
2.2.8.2 Standard protocol for cross-linking and enrichment of cross-linked heteroconjugates
for LC-ESI-MS/MS
The standard protocol for cross-linking and titanium dioxide enrichment was developed in our
laboratory [71] and further optimized in the course of this thesis. Titanium dioxide enrichment fol-
lows procedures initially established for the enrichment of phosphopeptides [70]. Buffers for desalting
and titanium dioxide enrichment were prepared with water, methanol and acetonitrile (ACN) in
LiChrosolv/Chromasolv quality.
For reconstitution, RNA and protein were mixed in appropriate buffer, typically in a 1:1 molar
ratio. The sample was incubated on ice for 30min for complex formation. Reconstituted or isolated
complexes were UV irradiated, typically for 10min at 254 nm, in 100 μl aliquots in a microtiter plate
placed on ice at a distance of 1 cm from the light source. Irradiated complexes were immediately
ethanol precipitated.
Pelleted complexes were dissolved in 50 μl 4M urea, 50mM Tris pH7.9 and diluted to 1M urea,
50mM Tris pH 7.9 with 150 μl 50mM Tris pH7.9. RNA hydrolysis was typically achieved with
1 μl each of RNases A (1 μg/μl) and T1 (1U/μl) in a 2 h incubation at 52◦C. In some cases, 1 μl
benzonase (25U/μl) was used instead of or in addition to RNases, for which MgCl2 was added to
the digestion buffer to a final concentration of 1mM. Benzonase hydrolysis was typically carried
out at 37◦C for 1 h. Proteolysis was performed with trypsin, usually at an enzyme-to-protein ratio
of 1:20 (w/w), in overnight incubation at 37◦C. In general, incubations with enzymes were carried
out in thermoshakers with mixing at 500 rpm.
Both C18 and TiO2 spin columns were packed in-house. A pipette tip (epT.I.P.S. 0.5-10 μl; Eppen-
dorf, Hamburg, Germany) was prepared with a piece of regular coffee filter around 2mm2 in size as
a frit. C18 material, suspended in methanol, or TiO2 material, suspended in 80% ACN, 0.1% TFA,
was added to give a column of about 1.5 μl volume.
Desalting and removal of noncross-linked RNA fragments was carried out directly after hydrolysis.
10 μl ACN and 2 μl 10% FA were added to the sample to reach a final concentration of 5% ACN
and 0.1% FA. All washing, loading and elution steps were performed by centrifugation at 5 000 rpm
for 5min. The C18 column was washed and equilibrated by passing 60 μl each of the following four
solutions: 95% ACN, 0.1% FA; 80% ACN, 0.1% FA; 50% ACN, 0.1% FA; 0.1% FA. The sample
was loaded on the column in 60 μl aliquots, washed twice with 60 μl 0.1% FA and eluted stepwise
with two times 60 μl 50% ACN, 0.1% FA and 60 μl 80%ACN, 0.1% FA. The eluate was dried in a
centrifugal evaporator.
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Next, titanium dioxide enrichment was performed to remove noncross-linked peptides. All washing,
loading and elution steps were performed by centrifugation at 3 000 rpm for 5min. The TiO2 spin
column was equilibrated with 60 μl buffer B (80% ACN, 5% TFA). The sample was dissolved in 60 μl
buffer A (200mg/ml DHB in 80% ACN, 5% TFA) and loaded onto the spin column. Washing with
buffer A (3x 60 μl) removed residual noncross-linked peptides, followed by extensive washing with
buffer B (5x 60 μl) to remove DHB which is not compatible with LC-ESI-MS/MS analysis. Enriched
peptide–RNA heteroconjugates were eluted with ammonia (0.3 M, 3x 40μl) and the sample was dried
in a centrifugal evaporator.
For LC-ESI-MS/MS analysis, sample pellets were dissolved in the presence of 2 μl 50% ACN, 0.1%
FA and diluted to a final concentration of 10% ACN, 0.1% FA by addition of 10 μl 0.1% FA. Of the
12 μl sample volume, 5 μl were injected for a single LC-MS/MS run.
2.2.8.3 Cross-linking of NusB–S10 to 4SU-substituted RNA
Cross-linking experiments with the NusB–S10 complex and the synthetic, 4SU substituted oligonu-
cleotide 5’-CAC UGC UC(4SU) (4SU)(4SU)A ACA AUU A-3’ were carried out with 2 nmol each
of the protein complex and the RNA oligonucleotide in binding buffer. After incubation on ice for
30min, the mixture was irradiated at 365 nm for 5min. Hydrolysis and enrichment were carried
out according to the standard protocol with 2 μl each of RNases A and T1 and trypsin at a ratio of
1:20 (w/w). LC-ESI-MS/MS was carried out on the Q-ToF Ultima.
2.2.8.4 Cross-linking of the ASH1 complex
ASH1 complexes were prepared by Roland Heym (Prof. Dierk Niessing, Institute of Structural
Biology, Helmholtz Zentrum München) and isolated by gel filtration according to the published
protocol [96]. Both ASH1 complexes contained a 51 nucleotide section of zip-code element E3 of
the ASH1 mRNA (5’-AUGGAUAACUGAAUCUCUUUCAACUAAUAAGAGACAUUAUCA
CGAAACAAU-3’). The ASH1-FL complex consisted of full-length She3p and She2p, while the
ASH1-short complex contained the C-terminus of She3p (92 amino acids; termed She3p-short from
here onwards) and She2p. In reference to protein, 120 μg ASH1-FL and 100 μg ASH1-short were
used for initial experiments. Protein buffer was 20mM Hepes pH7.8, 200mM NaCl, 2mM MgCl2,
2mM DTT. Complexes were UV irradiated at 254 nm for 10min. Hydrolysis and enrichment were
carried out according to the standard protocol with 2 μl each of RNases A and T1 and trypsin at a
ratio of 1:20 (w/w). LC-ESI-MS/MS was carried out on the Q-ToF Ultima.
Experiments with LC-ESI-MS/MS analysis on the LTQ Orbitrap Velos were carried out with 20 μg
ASH1-FL and 25 μg ASH1-short in each control and UV irradiated sample. Cross-linking, hydrolysis
and enrichment were carried out according to the standard protocol with 10min irradiation at
254 nm, 1 μl each of RNases A and T1 and trypsin at a ratio of 1:20 (w/w).
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2.2.8.5 Cross-linking of Cwc2
Cwc2 protein and in vitro transcribed U4 and U6 snRNAs were prepared by Dr. Jana Schmit-
zová (Macromolecular Crystallography Group, Department of Cellular Biochemistry) according to
published protocols [97].
Cwc2–RNA complexes were reconstituted in vitro by incubation of 100 μg Cwc2 with 1.5 μg RNA
(U6 snRNA, U4 snRNA, or a synthetic oligonucleotide resembling internal stem-loop of U6) for
30min on ice. The protein buffer contained 20mM Hepes pH7.5, 100mM NaCl and 1mM DTT.
UV irradiation time was typically 10min. Hydrolysis and enrichment were carried out according
to the standard protocol with 1 μl each of RNases A and T1 and trypsin at a ratio of 1:50 (w/w).
LC-ESI-MS/MS was carried out on the LTQ Orbitrap Velos.
2.2.8.6 Cross-linking of protein–RNA complexes after TAP tag purification
For cross-linking of protein–RNA complexes isolated from yeast extract by TAP tag purification,
different variations were performed (see 3.4.2).
Experiments were typically started with 10ml yeast extract (∼ 350mg protein) for both UV irradi-
ated and control samples. For cross-linking of extract, samples were dialyzed against AGK buffer
without glycerin. Cell extract, IgG or Calmoduline eluate was cross-linked for 2min in petri dishes
placed on ice with a liquid depth of around 1mm.
Sample preparation for LC-ESI-MS/MS with C18 and titanium dioxide chromatography was essen-
tially done according to the standard protocol. RNA hydrolysis was performed with 1 μl benzonase
for 30min at 37◦C and 2 μl each of RNases A and T1 for 60min at 52◦C. Proteolysis was achieved
by incubation with trypsin (1:50 w/w) at 37◦C over night. Samples were typically split on two C18
columns to prevent overloading. All other steps followed the standard protocol.
Alternatively, samples were prepared for MS analysis with size exclusion, C18 and optionally TiO2
chromatography. To this end, samples were ethanol precipitated after cross-linking of the IgG
eluate. Pelleted complexes were dissolved in the presence of 20mM Tris pH7.5 and 1% SDS. The
sample was diluted 1:10 with 20mM Tris pH7.5 to a final concentration of 0.1% SDS and hydrolyzed
with trypsin (1:50 w/w) at 37◦C over night. Size exclusion chromatography was performed with a
Superdex 200 column (PC 3.2/30, 2.4ml, Amersham Biosciences) in a SMART system (Pharmacia
Biotech). Samples were injected in 50 μl aliquots. Running buffer was 20mM Tris pH7.5, 150mM
NaCl, 1.5mM MgCl2 and flow rate 40 μl/min, absorption at both 254 and 280 nm were monitored.
Fractions of 100 μl were automatically collected. Fractions showing high absorption at both 254
and 280 nm were pooled and ethanol precipitated. Samples were dissolved, hydrolyzed and desalted




Mass spectrometric analysis was carried out by sample injection into a nano-liquid chromatography
(nano-LC) system directly coupled to the electrospray (ESI) source of a mass spectrometer. Three
different mass spectrometers were used in this thesis:
• Q-ToF Ultima (Waters, Manchester, UK)
• LTQ Orbitrap Velos (Thermo Fisher Scientific, Schwerte, Germany)
• Q Exactive (Thermo Fisher Scientific, Schwerte, Germany)
Both Q-ToF and Velos were coupled to an Agilent LC-system (Agilent 1100 series, Agilent Tech-
nologies, Böblingen, Germany), the Q Exactive was coupled to an EASY-nLC II (Thermo Fisher
Scientific). Details for LC separation and MS analysis are described below.
All columns used in nano-LC separation were packed in-house by Uwe Pleßmann (Bioanalytical Mass
Spectrometry Group) with C18 AQ 120Å material (Dr. Maisch GmbH, Ammerbuch, Germany;
particle size 5 μm except for analytical column in EASY-nLC II, there 3 μm).
LC solvents were prepared with water and acetonitrile in LiChrosolv or Chromasolv quality.
2.2.9.1 Nano-LC separation (Agilent)
Samples were loaded onto a C18 trapping column (length ∼ 2 cm, inner diameter 150 μm) with a flow
rate of 10 μl/min in 3% buffer B (buffer A: 0.1% FA; buffer B: 95% ACN, 0.1% FA) and washed for
5min under the same conditions. Subsequently, a linear gradient of 3 to 36% buffer B was started
with a flow rate of 300 nl/min. The gradient eluted the analytes from the trapping column onto
the analytical column (length ∼ 15 cm, inner diameter 75 μm). On the analytical column, analytes
were separated and eluted into the ESI source of the mass spectrometer. Elution time was 37min
(60min gradient) or 97min (120min gradient). Finally, buffer B was raised to 95% for 7.5min to
elute any residual species and then lowered back to 3% to equilibrate the column for the next run.
2.2.9.2 Nano-LC separation (EASY-nLC II)
Washing and elution followed the same principles as described above. After loading onto the trap-
ping column (length 4 cm, inner diameter 100 μm), samples were washed with a total volume of
25 μl buffer A at a maximum pressure of 280 bar. The linear gradient was from 4 to 36% buffer B
within 92 min at a flow rate of 250 nl/min. The analytical column was 10 cm long with an inner
diameter of 50 μm. Final elution was carried out at 95% buffer B for 8min, column equilibration
was internally managed by the LC system.
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2.2.9.3 ESI-MS/MS analysis on the Q-ToF Ultima
Prior to analysis of each set of samples, the instrument was calibrated by direct injection of
10 fmol/μl GluFib. Correct calibration and functionality of the instrument was confirmed by a
LC-MS/MS run of a BSA digest (injection of 50 fmol).
The instrument was operated in data dependent acquisition mode with a Top3 method. MS survey
scans were recorded in the m/z range of 350 to 1600, acquisition time was 1 s. The three most
intense precursors were chosen for fragmentation with CID (minimum intensity 40 counts; charge
states 2, 3 and 4; isolation width +/- 1.5 m/z ; m/z range 50-2000; acquisition time 3x 1 s) and
subsequently excluded from re-fragmentation for 180 s (dynamic exclusion).
2.2.9.4 ESI-MS/MS analysis on the LTQ Orbitrap Velos
The instrument was operated in data dependent acquisition mode with a Top10 method. MS survey
scans were recorded in the m/z range of 350 to 1600 at a resolution of 30 000. The ten most intense
precursors were chosen for fragmentation with HCD (minimum intensity 5 000; charge states 2, 3
and 4; isolation width +/- 1 m/z ; normalized collision energy 45) and subsequently excluded from
re-fragmentation for 20 s (dynamic exclusion). MS/MS fragment spectra were recorded with a fixed
first mass of 100 m/z and a resolution of 7 500.
2.2.9.5 ESI-MS/MS analysis on the Q Exactive
The instrument was operated in data dependent acquisition mode with a Top12 method. MS survey
scans were recorded in the m/z range of 350 to 1600 at a resolution of 70 000. The twelve most
intense precursors were chosen for fragmentation with HCD (minimum intensity 10 000; charge states
2, 3 and 4; isolation width +/- 1 m/z ; normalized collision energy 30) and subsequently excluded
from re-fragmentation for 20 s (dynamic exclusion). MS/MS fragment spectra were recorded with
a fixed first mass of 100 m/z and a resolution of 17 500.
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2.2.10 MS data analysis
2.2.10.1 Peptide identification with Mascot
Standard database search was typically done with Mascot (Matrix Science, [33]) as search engine.
Raw data was processed and converted into text-based format. Q-ToF Ultima data was recalibrated
and processed with MassLynx V4.0 (Waters) and converted into .pkl. Orbitrap data was converted
into .msm by Raw2MSM version 1.10 [98].
Mascot search parameters are listed below. Typically, searches were performed against the respec-
tive taxonomy with phosphorylation as PTM to identify the latter, against the entire NCBI database
without phosphorylation to identify additional contaminants, or against a reduced database contain-
ing U1 snRNP proteins and sequences for NusB, S10, She2p, She3p, and Cwc2 (respective sequences
were added for the corresponding experiment). Searches against the entire NCBI database served
as controls to exclude false positive cross-linking results if the corresponding spectrum resulted from
a contamination like keratin.
Mascot search parameters
enzyme trypsin
max. missed cleavages 2
precursor monoisotopic
MSMS search on
peptide charge 2+, 3+
peptide tolerance 50 ppm (Q-ToF) or 10 ppm (Orbitrap)
MSMS tolerance 0.2 Da (Q-ToF) or 0.02 Da (Orbitrap)
instrument ESI-Quad-Tof (Q-ToF) or ESI-Trap (Orbitrap)





2.2.10.2 Identification of cross-links with 94 Da adducts using Mascot
After identification of the cross-linking product producing a 94Da shift of peptide fragments, this
particular observation was used to define an additional PTM in Mascot. The PTM was defined
with a sum formula of C9H11N2O8P (306.0253Da, corresponding to [4SU –H2S] or [U –H2O]) and
a neutral loss of C5H9O7P (212.0086Da) which leaves C4H2N2O (94.0167Da, corresponding to
[(4SU)’ –H2S] or [U’ –H2O]) as a shift of the peptide fragments. The modification site was defined
on the peptide C-terminus. This way, peptides cross-linked close to the C-terminus and showing
this particular shift after fragmentation could be identified in searches against small databases or
the entire proteome.
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2.2.10.3 Online tools for calculation of monoisotopic masses
Monoisotopic masses of peptides and their fragments, RNA oligonucleotides and their fragments,
as well as peptide–RNA adducts were calculated with several tools available online.
ProteinProspector University of California, San Francisco;
http://prospector.ucsf.edu
Peptide Mass Calculator University of Leuven;
http://rna.rega.kuleuven.ac.be/masspec/pepcalc.htm
Mongo Oligo Mass Calculator University at Albany;
http://rna-mdb.cas.albany.edu/RNAmods/masspec/
mongo.htm
Molecular Mass Calculator University at Albany;
http://rna-mdb.cas.albany.edu/RNAmods/masspec/mole.htm
2.2.10.4 Identification of cross-links by manual spectra interpretation
MS/MS spectra of noncross-linked peptides were excluded by a standard database search. Spectra
of residual RNA were excluded by characteristic groups of fragments 18Da apart (neutral loss of wa-
ter). Additionally, precursor and fragment masses of noncross-linked RNA have a smaller fractional
mass than peptides. Remaining unassigned spectra of reasonable quality were annotated manu-
ally. Typically, a peptide sequence tag was derived from fragment series in the higher m/z range.
The sequence tag was compared to the sequences of the proteins under investigation. Theoretical
fragment masses of corresponding tryptic peptides were manually compared to the experimental
spectrum. Once a match was confirmed, the cross-linked RNA was derived from the difference
between experimental precursor and calculated peptide mass.
2.2.10.5 Identification of cross-linked peptides after precursor variant generation by a perl
script
LC-ESI-MS/MS data of cross-linking experiments with NusB–S10 and ASH1 were analyzed after
precursor variant generation with a perl (www.perl.org) script written by Dr. Petra Hummel (IT &
Electronics Service). This script was developed, tested and optimized in the course of this thesis and
details can be found in the results section (see 3.1.2.4). Briefly, the LC-MS/MS data was analyzed
as described below.
Input for the perl script was data in .pkl format created by MassLynx V4.0 after processing of MS
raw data.
The presence of RNA marker ions was not used as a filter. For the report of observed marker
ions, mass deviation was set to 0.1Da, the (relative) intensity threshold to 15% (NusB–S10) or 20%
(ASH1) and 5% for the second A marker. The (absolute) intensity threshold for noise filtering was
set to 3.
For NusB–S10, precursor mass variants were created for all combinations of A, C, G, U and 4SU.
Separate searches were performed with combinations of A, C, G and U and combinations of all five
nucleotides with at least one 4SU in the sequence. For ASH1, precursor mass variants were created
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for all oligonucleotides length 1-4 from the RNA sequence 5’-AUGGAUAACUGAAUCUCUUUC
AACUAAUAAGAGACAUUAUCACGAAACAAU-3’.
The output of the perl script contained several files: One .csv file summarized parameters chosen
while running the script, including all RNA sequences used to create the precursor mass variants.
The file also listed all precursors whose fragment spectra were filtered or did not contain any marker
ions. A second .csv file contained all precursors with RNA marker ions above the threshold in the
corresponding spectrum. For each spectrum not excluded by the low mass or fractional mass filter,
one .pkl file was created that contained the experimental precursor and all its variants, each with
the MS/MS fragment information reduced by the noise filter.
.pkl files were searched with Mascot (parameters see above). Initial searches were performed against
a small database (see above). Spectra of cross-link candidates were researched against the respective
proteome (E. coli for NusB–S10 or S. cerevisiae for ASH1).
2.2.10.6 Identification of cross-linked peptides with OpenMS and OMSSA
Cross-linking experiments of ASH1, Cwc2 and yeast protein–mRNA complexes after TAP tag isola-
tion were analyzed with OpenMS [99, 100] and OMSSA [34] as search engine. Data analysis workflows
were developed in the course of this work and are explained in more details in the results sec-
tion. Workflows are based on OpenMS tools written especially for our purpose as well as existing
tools. Code was written and TOPPAS pipelines were assembled by Timo Sachsenberg (Prof. Oliver
Kohlbacher, Applied Bioinformatics Group, Eberhard Karls University, Tübingen).
MS data in Thermo proprietary .raw format was converted into the open .mzML format [101] with
msconvert, part of the ProteoWizard [102] software bundle. Q Exactive data was processed with
the OpenMS tool FileFilter with the option "sort" for correct assignment of MS1 and MS2 spectra.
MS data recorded in profile mode, i.e. MS1 spectra of Velos measurements and both MS1 and
MS2 of Q Exactive measurements, were centroided with the OpenMS tool PeakPickerHiRes. If
automatic XIC filtering was desired later, an additional processing step was included: LC-MS data
of control and UV irradiated sample were aligned to correct for small retention time shifts. The
corresponding pipeline is shown in Figure 2.1. The pipeline requires the .mzML files of both control
and UV irradiated sample as input. Output file is the control .mzML with transformed retention
times.
After data processing and before creating precursor mass variants, the MS data was reduced by iden-
tification (ID) and extracted ion chromatogram (XIC) filters if desired. The ID filter pipeline (Figure
2.2) performed a standard database search with OMSSA to identify noncross-linked peptides, the
corresponding MS/MS fragment spectra were removed from the MS data file. The database con-
tained contaminant sequences (those distributed with MaxQuant [103]) as well as decoy sequences.
The latter were used to determine a false discovery rate (FDR) and were created with the OpenMS
DecoyDatabase tool by reversing the target sequences from the original database. A peptide hit
was considered a confident match and subsequently used for filtering if the FDR was below 0.01.
Parameters for the OMSSA search are listed below. Input file is an .mzML, output files are an
.idXML file containing the peptide matches used for filtering, and a reduced .mzML. The output
.idXML can be annotated to the input .mzML to retrace the peptide identifications.
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Figure 2.1:
Pipeline for retention time alignment
of LC-ESI-MS/MS data of control and
UV irradiated sample (screenshot from
TOPPAS). First, in both measurements
peptides (features) are identified in the
two-dimensional retention time versus
m/z map by FeatureFinderCentroided.
Based on the features, maps of both
measurements are aligned by Map-
AlignerPoseClustering and the retention
time transformations are applied by
MapRTTransformer. Importantly, the
control is transformed relative to the UV
irradiated sample and not vice versa.
OMSSA search parameters
precursor mass tolerance 10 ppm
fragment mass tolerance 0.1 Da
min/max precursor charge 2/5
precursor charge determination believe input file
variable modifications oxidation (M)
carbamylation (K), carbamylation (N-term)
phospho (S), phospho (T), phospho (Y)
enzyme trypsin
max number missed cleavages 2
The XIC filter was applied to remove MS/MS spectra of precursors that appeared in both control
and UV irradiated sample at comparable intensity (default: fold change less than two). This filtering
step was done with the OpenMS RNPxlXICFilter specifically created for our purpose. Input are the
.mzML files of both samples. The tool then calculates the intensity of a precursor in both control
and UV irradiated sample in a small retention time window. If the intensity in the UV irradiated
sample is less than twofold higher than in the control, the corresponding spectrum is filtered and
not written into the output, the reduced .mzML file of the UV irradiated sample.
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Figure 2.2: ID filter pipeline for removal of MS/MS spectra with confident peptide identification
(screenshot from TOPPAS). OMSSAAdapter submits the OMSSA searches and re-
trieves the search result. PeptideIndexer determines whether identified peptides corre-
spond to target or decoy sequences. FalseDiscoveryRate determines the false discovery
rate for each identification. Finally, IDFilter keeps only identifications below a certain
false discovery rate, typically 0.01. Confident identifications that pass this criterion
are reported in an .idXML output file. Finally, MS2FilterByPositionOverlap removes
the MS/MS spectra that gave rise to the confident identifications from the .mzML file,
the reduced .mzML is output of the pipeline.
The crucial step of the data analysis, precursor mass variant generation and database searches,
were performed with the RNPxl tool, another OpenMS tool specifically created for our purpose.
The tool takes an .mzML file as input. This file can be a reduced .mzML from any of the filtering
steps described above or the original .mzML containing all raw data. Output files are an .idXML
and a .csv file, both containing the database search results and RNA marker ion intensities for all
MS/MS spectra contained in the input .mzML. The .idXML file can be used to annotate the search
results to the MS data in .mzML in TOPPView, while the .csv file can be opened in programs
like Microsoft Excel, e.g. to add notes about manual validation. Parameters for the RNPxl tool
are shown in Figure 2.3, the values correspond to the optimized parameters for yeast protein–RNA
complexes after TAP tag purification. OMSSA search parameters are essentially as described for
the ID filter with two important differences: The database is a limited database or the proteome
of the respective organism, it does not contain contaminant or decoy sequences as those would
increase analysis time and lead to false positive matches. For similar reasons, phosphorylation is
not considered as a variable peptide modification.
52 2 Materials and Methods
Figure 2.3: Parameters of the RNPxl tool (screenshot from TOPPAS). length determines the maxi-
mum length of RNA combinations to be considered for precursor variant generation.
sequence allows the input of a nucleotide sequence if only those combinations that ap-
pear in the sequence should be considered. When left empty, all combinations from the
nucleotides defined below are calculated. target_nucleotides allows the definition of any
nucleotide (RNA, DNA, substituted or labeled with stable isotopes) by its sum formula.
The mapping option is used to define an input sequence that is randomly labeled, then
the labeled and the native nucleotide are mapped on the same letter in the input se-
quence. restrictions are used to require a certain nucleotide in all sequences considered
for precursor mass variants. The parameters shown here would only allow sequences
that contain at least one uracil. In the modifications field, all modifications are listed
that should be considered for each of the nucleotide combinations. The parameters
shown here resemble a standard experiment where the 152 adduct is also expected. All
modifications have to be given as sum formulas. precursor_mass_threshold sets the
(uncharged) threshold for the low mass filter, while precursor_variant_m/z_threshold
sets the m/z threshold for the precursor mass variants that are written in the output
file. If CysteinAdduct is set to "true", 152 is considered as an adduct without any
nucleotide. in_OMSSA_ini and in_fasta require the paths of the OMSSA parameter
file and the database (in .fasta format), respectively. Finally, marker_ion_tolerance
sets the mass tolerance for the determination of the presence and intensity of RNA
marker ions.
2.2 Methods 53
2.2.10.7 Validation of cross-links
Cross-link candidates obtained from manual spectra interpretation or database search after precur-
sor variants generation were validated in several steps. Validation criteria were refined and expanded
in the course of this project and are described in detail in the results section. Important validation
criteria are briefly listed below.
Correct assignment of monoisotopic peak and charge state were confirmed by evaluating the survey
scan preceding the fragment spectrum under investigation. When data from a non-irradiated control
was available, extracted ion chromatograms were compared to confirm that the precursor was not
present in the control at significant intensity. Results of an independent Mascot search for peptide
identification confirmed that the fragment spectrum did not yield any true positive hit for a noncross-
linked peptide. Failure to meet any of the above mentioned criteria led to exclusion of the candidate
as a false positive.
The experimental fragment spectrum was compared to predicted fragments of the candidate peptide.
Peptide fragment masses were calculated from the amino acid sequence with ProteinProspector.
In TOPPView, Orbitrap data was directly annotated with search results, experimental signals
corresponding to calculated fragments were automatically highlighted. Remaining high intensity
signals were manually compared to RNA fragments or peptide–RNA adducts.
Cross-link candidates were rejected when several high intensity signals could not be explained by
calculated fragments of the candidate cross-link. Particular emphasis was on peptide fragment series
in the higher m/z range, high intensity immonium ions, and RNA marker ions. Cross-linked RNA
with two or more nucleotides should yield marker ions of significant intensity, marker ions for A,




UV induced protein–RNA cross-linking and its investigation by mass spectrometry is based on the
following key steps:
• isolation or reconstitution of the protein–RNA complex(es)
• UV irradiation
• sample preparation for mass spectrometry (enrichment of cross-linked heteroconjugates)
• analysis by mass spectrometry
• data analysis
While several experimental strategies have been developed for UV cross-linking and mass spectrom-
etry, there was further need for optimization and adaptation, especially for more complex biological
systems. In addition, while advances in mass spectrometry instrumentation have led to great ad-
vances, they have also resulted in a call for adjustments and re-evaluations of existing experimental
and data analysis strategies.
In the course of this work, all of the key steps were addressed. Experimental workflows were adjusted
and optimized for ribonucleoproteins that had not been previously investigated by UV cross-linking
and mass spectrometry. However, the major focus of this work was on data analysis. At the be-
ginning of this project, MS data derived from cross-linking experiments was analyzed manually.
MS/MS spectra were assigned by hand, a time-consuming process that requires considerable exper-
tise in spectra interpretation. While feasible for small ribonucleoproteins and a limited number of
spectra, increasing complexity and MS data amounts called for a new approach. Thus, in parallel
with investigations of novel aspects in UV cross-linking and optimization of experimental workflows
for several ribonucleoproteins, a data analysis strategy was developed and refined which eventually
allowed the identification of cross-linked peptides in searches against entire proteomes.
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3.1 Cross-linking products of 4-thio-uracil and a novel approach for
automated data analysis
One of the major constraints in UV induced protein–RNA cross-linking is the low cross-linking
yield. A strategy to increase the cross-linking yield is the use of photo-reactive nucleotides, e.g.
4-thio-uracil, 6-thio-guanine, or halopyrimidines such as 5-bromo-uracil.
In order to identify cross-linked peptide–RNA oligonucleotide heteroconjugates by mass spectrome-
try, the mass of the cross-linking product has to be known. For native RNA, cross-linking is mainly
additive, i.e., the mass of the cross-linked heteroconjugate is the sum of the peptide and oligonu-
cleotide masses (e.g. [65]). However, it was unknown whether the same is true for RNA substituted
with carbonothioyl-containing bases.
We set out to address the two major constraints of cross-linking experiments: The use of a photo-
reactive base-analogue, 4-thio-uracil (4SU), was investigated with a focus on cross-linking yield and
mass of cross-linking products. In parallel, an approach for the automatization of data analysis
was developed. For the intended experiments, a simple test system was needed. The NusB–S10
complex from E. coli was chosen since it had been investigated previously by protein–RNA cross-
linking and mass spectrometry in our laboratory [71]. It plays an important role in transcription
antitermination and has an enhanced affinity for BoxA-containing RNA. Co-expression of the protein
complex had been established and could be reproduced. More importantly, the rrn BoxA-containing
oligonucleotide used in the previous study is short and contains several uracils. Therefore, the
variant of the same oligonucleotide synthesized with 4-thio-uracils at specific positions could be
obtained.
More precisely, a 19mer RNA oligonucleotide containing the core rrn BoxA element (underlined) was
cross-linked to the NusB–S10 complex. Cross-linking to the unsubstituted oligonucleotide (upper
sequence) had been previously investigated [71]. We compared these results to cross-linking to the
same oligonucleotide in which three uracils in the BoxA element were replaced by 4-thio-uracil
(lower sequence).
5’-CAC UGC UCU UUA ACA AUU A-3’
5’-CAC UGC UC(4SU) (4SU)(4SU)A ACA AUU A-3’
3.1.1 Influence of 4-thio-uracil on the cross-linking yield of the NusB–S10-complex
The influence of 4-thio-uracil on the cross-linking yield of the NusB–S10 complex was investigated
by cross-linking of 32P-labeled oligonucleotides to the protein complex. Two 19mer oligonucleotides,
with and without 4SU, were 5’-labeled with [γ-32P]-ATP and cross-linked to the NusB–S10 complex.
Cross-linking products were separated by SDS-PAGE and visualized by autoradiography (see Figure
3.1). UV irradiation of the proteins in complex with the unsubstituted oligonucleotide (lane 2) at
254 nm led to cross-linking products of both proteins, while no protein bands were observed in the
non-irradiated control (lane 1). In contrast, the non-irradiated control of the complex with the 4SU-
substituted oligonucleotide already contained cross-linking products (lane 3). This illustrates the
high reactivity of 4SU: It cross-links under ambient light, even when protected from light as much
as possible during the experiment. Increasing irradiation time at 365 nm (1, 2, 5, and 10min; lanes
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Figure 3.1: Autoradiography of NusB–S10 cross-linked to 32P-labeled BoxA containing RNA
oligonucleotides with and without 4-thio-uracil. The upper panel shows the autora-
diography after 15min exposure of a Phosphorimager screen, the lower panel shows
details of the cross-linking products after 1 h exposure. Lanes 1 and 3 correspond to
non-irradiated controls of complexes with unsubstituted and 4SU substituted RNA, re-
spectively. Lane 2 shows cross-linking of NusB–S10 to unsubstituted RNA after 10min
irradiation at 254 nm. Lanes 4-7 show cross-linking products of the complex with 4SU-
substituted RNA after UV irradiation at 365 nm for the time periods indicated above
the gel lanes. Figure originally published in [104].
4–7) produced higher amounts of cross-linking products. However, a high excess of RNA remains
uncross-linked, independent of substitution and irradiation time, and despite the high excess of
protein used. This exemplifies the generally low yield of UV induced cross-linking.
The majority of cross-linking products observed after denaturing gel electrophoresis were binary
protein–oligonucleotide complexes of either NusB or S10 and the oligonucleotide. Both unsubsti-
tuted and 4SU-containing RNA also showed higher-order cross-links. Their exact nature cannot be
determined in our experiments.
Detailed investigation on the cross-linking products (lower panel in Figure 3.1) allowed for compar-
ison of the cross-linking yields of the complexes with unsubstituted (lane 2) and 4SU-substituted
(lane 7) RNA after the same irradiation period. Quantitative analysis of cross-linking product
band intensities revealed that the cross-linking yield decreased by about 10% for NusB, while it
increased by approximately 50% for S10. Thus, for the S10 protein, 4SU significantly enhances the
cross-linking yield. At 254 nm, all nucleotides of the 19mer could undergo cross-linking. In contrast,
only the three 4SU nucleotides were excited by irradiation at 365 nm. The slight decrease in the
cross-linking yield of NusB could be due to it forming cross-links to nucleotides outside the triple U
stretch. Upon substitution and irradiation at higher wavelengths, these cross-links might not form,
consequently decreasing the cross-linking yield. However, our experiments clearly illustrate the
potential of 4SU to increase the cross-linking yield for some proteins.
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3.1.2 Development of a novel approach for automated data analysis
Identification of peptide–RNA oligonucleotide cross-links from mass spectrometry data has been
done by manual spectra interpretation (see 2.2.10.4). Interestingly, the majority of fragments in the
MS/MS spectra of cross-linked heteroconjugates correspond to the cross-linked peptide. In some
cases, intense marker ions of the RNA bases or nucleotides are observed. Rarely, adducts of peptide
and RNA or their fragments are detected. Based on these observations, we developed an idea for
the identification of cross-linked peptides by database search.
3.1.2.1 Anticipated RNA combinations and modifications
We expected to identify cross-linked RNA with a maximum length of four nucleotides. No longer
RNA sequences had been identified in cross-links after titanium dioxide enrichment and LC-ESI-
MS/MS analysis. The number of RNA sequences to be considered can be calculated as k combina-
tions of n elements with repetition according to the following equation [105]:
c̄kn =
(




In our case, n corresponds to the number of nucleotides and k to the oligonucleotide length. Conse-
quently, the number of possible RNA sequences from the four standard nucleotides with a maximum





















In addition, the RNA can have different modifications, i.e., the 5’ and 3’ end can be both hydroxyl,
one hydroxyl and one phosphate, or both phosphate; all of these can additionally have a neutral
loss of water, e.g. due to the formation of cyclic phosphates on the ribose. Therefore, each of the
69 sequences can have six modifications, which leads to a total of 414 potential RNA masses to
be considered. The problem is further complicated when taking the 152 adduct (see 1.3.4) into
account: Each of these combinations can be considered with and without additional 152. When
also considering 152 alone as a cross-linking adduct, the result is 829 potential RNA masses. In





















Multiplied with the six modifications (but disregarding the 152 adduct), this leads to 750 potential
masses of the cross-linked RNA.
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Figure 3.2: Schematic, simplified comparison of the MS and MS/MS spectra of the same peptide
with and without cross-linked RNA. The peptide (precursor) mass is shifted by the
mass of the RNA as a consequence of cross-linking. In contrast, the MS/MS spectra
might not exhibit any obvious differences; in extreme cases the cross-link spectrum
contains no trace of the RNA.
3.1.2.2 Cross-linked RNA and standard database search
Theoretically, MS/MS spectra of cross-linked heteroconjugates contain enough peptide fragments to
enable the cross-linked peptide to be identified by algorithms employed in the analysis of standard
proteomics experiments. In extreme cases, there might not be any obvious difference between the
MS/MS spectrum of the same peptide, whether it is cross-linked or not. In such cases, the only
evidence for the cross-linked RNA is the precursor mass shifted by the mass of the cross-linked
RNA, schematically shown in Figure 3.2. This mass shift must be taken into account for database
search.
In principle, the cross-linked RNA could be treated as any other post-translational modification
(PTM). These are defined by their mass and the site(s) of modification. For example, phosphoryla-
tion is defined with an additional mass of 79.9663Da (HPO3) on typically either serine, threonine, or
tyrosine. The mass of anticipated cross-linking products is known and we do not expect to identify
novel products automatically. However, the number of potential RNA masses by far surpasses the
number of PTMs considered in the analysis of a typical proteomics experiment.
The number of PTMs to be considered in a single database search is always limited, e.g. to nine
PTMs in Mascot. Therefore, over 80 searches would have to be performed to consider all 750
potential RNA adduct masses in an experiment with 4SU-labeled RNA. But the combinatorial
problem is even greater: The mass is only the first variable that needs to be defined. The second is
the site of modification. While there are certain amino acids that seem to be more reactive in UV
induced cross-linking, all amino acids could be modified. However, performing over 80 searches for
each of the 20 amino acids is not feasible.
The problem could be simplified by defining the cross-linking site on the peptide N-terminus. Beam-
type CID typically leads to a long y-series and only a few a- and b-ions containing the peptide N-
terminus. Therefore, the N-terminal fragments could be disregarded for automated identification.
In addition, the frequent loss of the cross-linked RNA from the peptide upon fragmentation could
be accounted for by defining the RNA mass as a neutral loss. Similarly, loss of 97.9769Da (H3PO4)
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is defined as a neutral loss for phosphorylation as it is often observed. The database search engine
then considers peptide fragments both with the PTM and with PTM and neutral loss.
This strategy could have been employed for the identification of cross-linked peptides with standard
database search engines such as Mascot without the need for additional programs, scripts, etc.
However, combining the results of many similar searches would not have been trivial. Therefore,
we developed an alternative approach, described below. Cross-linked RNA as a PTM in database
search was later applied successfully to one specific cross-linking product (see Sections 2.2.10.2 and
3.1.3).
3.1.2.3 The precursor variant approach
MWcross−link = MWpeptide + MWRNA (3.4)
MWpeptide = Mexperimental −MWRNA (3.5)
The strategy for PTM identification could not be transferred directly to cross-links. However, we
developed an idea based essentially on the same observations: MS/MS spectra of cross-links contain
mainly peptide fragments and the precursor mass shift by the cross-linked RNA has to be taken
into account. For automatization, the problem was approached from the opposite direction: The
masses of all potential RNA adducts could be subtracted from the experimental precursor mass (i.e.,
changing the perspective from Equation 3.4 to 3.5). The obtained precursor mass variants could
then be submitted into database search. Only the precursor mass variant resulting from subtraction
of the mass of the actual cross-linked RNA oligonucleotide should yield a true positive hit in the
database search; all other variants should give no hits or false positive results.
Figure 3.3: Schematic representation of precursor variant generation. The masses of potentially
cross-linked RNA (here the nucleotides A, C, G, and U) are subtracted from the
experimental precursor mass. The masses of the MS/MS fragments are copied without
any modification. The original experimental precursor mass is kept as a control.
The idea is illustrated in Figure 3.3: Precursor mass variants are generated by subtraction of all
potential masses of cross-linked RNA. The unaltered MS/MS information is copied to each of the
precursor mass variants and to the original precursor mass. If the cross-linked RNA is a U nucleotide,
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Figure 3.4:
Schematic description of data analysis with a
perl script. Raw data is processed and con-
verted into the text-based .pkl file format. Small
precursors (< 600Da) and precursors of short
oligonucleotides (precursor < 1750Da and frac-
tional mass < 0.2) are filtered. The remain-
ing precursor masses are compared to masses of
RNA oligonucleotides, and agreement is noted
in a .csv file. Noise signals below a threshold
of three counts are removed from the MS/MS
spectra. Precursor variants are generated by
subtracting the masses of all possible nucleotide
combinations, i.e., 1-4 nucleotides, 5’ and 3’ end
both phosphate, hydroxyl/phosphate, or both
hydroxyl; and neutral loss of water. For par-
tially 4SU-substituted RNA, this corresponds
to 750 RNA masses. For each spectrum, the
original precursor together with its variants are
written in a separate .pkl output file. Precur-
sor variants < 250Da are filtered from the out-
put .pkl files. All .pkl files are submitted into
a Mascot search and Mascot search results are
evaluated manually.
Figure originally published in [104].
we would only expect a database search result for the corresponding precursor variant (precursor
mexp-m[U]), all other variants should give no (or false positive) results. If the MS/MS spectrum
results from fragmentation of a noncross-linked peptide, only the original precursor mass should
yield a true positive database search result. Thus, the original precursor mass serves as a control.
3.1.2.4 Implementation of the precursor variant approach
For the implementation of the precursor variant approach, we received support from Dr. Petra
Hummel (IT & Electronics Service). She realized the initial idea as well as all subsequent optimiza-
tions in the form of a perl script according to our specifications; its final workflow is outlined in
Figure 3.4.
MS data from cross-linking experiments was converted into the text-based .pkl format by data pro-
cessing in MassLynx V4.0, the vendor software of the Waters Q-ToF Ultima. For each MS/MS
spectrum, the .pkl format contains a header line with precursor m/z, precursor intensity, and pre-
cursor charge state. Below, the fragment information is listed in the form of fragment m/z versus
intensity. This format allowed for easy processing with the perl script.
Calculating the masses of all precursor variants and subtracting them from the precursor masses
was easily implemented with the perl script. For each MS/MS spectrum, a separate .pkl output file
was created with the original precursor mass and all its variants, each combined with the MS/MS
fragment information. This was the only way to ensure that database search results could be traced
back to the original precursor masses. Consequently, a separate search was performed for each
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spectrum, and only the best-scoring hit had to be evaluated further, while all other matches could
be considered false positives.
When considering all combinations of 1–4 nucleotides, calculated RNA masses can be larger than
the experimentally observed precursors. In addition, we do not expect to identify any peptide with
fewer than three amino acids. The smallest tryptic peptide with three amino acids is GGK, with a
monoisotopic mass of 260.1484Da. The search of negative and extremely small precursor variants
would be unnecessary. Thus, we included a filter that would prevent small precursor variants (below
250Da) from being written into the output .pkl file.
In order to reduce the overall data amount, several filtering steps were added into the script.
MS/MS data were reduced by filtering noise signals below a certain intensity threshold (default:
3 counts). During data acquisition, singly charged precursors were excluded from fragmentation and
only precursors above m/z 350 were recorded. Both singly charged and small precursors are not
expected to lead to confident peptide identifications and are typically excluded from fragmentation
during data acquisition in any proteomics experiment. However, data reprocessing often revealed
singly charged precursors that were sequenced due to incorrect charge state assignment during
data acquisition. The corresponding spectra were of poor quality or corresponded to chemical
contaminants. We included a filter into the perl script that would disregard all precursors with
a mass below 600Da. Finally, a filter removed precursor masses of small RNA oligonucleotides
according to their fractional mass (precursor mass < 1750Da and fractional mass < 0.2). These
parameters were chosen conservatively according to published data (see [78, 80] and 1.3.4). For larger
masses, the differentiation based on fractional mass is no longer unambiguous. Larger precursors
were compared to the masses of oligonucleotides with a maximum length of 10; agreement was
reported in a .csv file, but the precursors were not excluded from subsequent analysis.
Several approaches were taken to reduce the overall number of precursor mass variants to be created
and thus later on searched. An option was included to accept an RNA sequence as input. Precursor
mass variants are then generated for nucleotide combinations that actually appear in the input
sequence. Especially for short RNAs, this can greatly reduce the number of precursor mass variants.
Next, the precursor variants to be created were grouped:
1. all combinations of A, C, G, and U with the following modifications: none, –H2O, –HPO3,
–H3PO4, +HPO3, +HPO3–H2O
2. all combinations as in (1) with the 152 adduct
3. all combinations of A, C, G, U, and 4SU containing at least one 4SU in sequence, same
modifications as in (1)
The perl script was set up to ask for an input sequence first and whether combinations should
be calculated from the input sequence without and/or with 152 adducts, i.e., similar to group 1
and/or group 2, but limited to combinations appearing in the input sequence. Next, the user is
asked whether combinations from group 1, 2, and/or 3 should be considered for the precursor mass
variants. This way, the generated precursor variants can be chosen according to the experiment. If
desired, precursor variants for each group can be created individually by running the script several
times. While this leads to a decreased number of precursor variants in each search and thus might
decrease the likelihood of false positives, the approach requires one search per group and spectrum.
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In order to limit false positives and search time, we usually chose the different groups individually
for precursor variant generation.
Another criterion to search for spectra containing RNA is the observation of RNA marker ions (see
1.3.3.3). Cross-links to RNA with at least two nucleotides typically produce intense marker ions,
especially of the RNA bases adenine, guanine, and cytidine. The presence of both RNA marker
ions and a peptide fragment series allows an experienced user to quickly assess a MS/MS fragment
spectrum as a highly promising candidate for cross-link identification. However, this requires manual
evaluation of all spectra contained in the measurement. Therefore, an automatic annotation of RNA
marker ion intensities was included in the perl script.
To this end, signal intensities of the nucleic acid bases and nucleotides (see Table B.1) were checked
within a certain mass tolerance. If one marker ion was observed above a certain threshold, e.g.
20% relative intensity, intensities for all marker ions present in the spectrum were reported in the
output .csv file. These could be used to prioritize spectra for data analysis. Since the adenine
marker ion and the tyrosine immonium ion have very similar masses (m/z 136.0623 and 136.0757,
respectively), these can only be distinguished with high resolution instruments. The Q-ToF Ultima
does not provide the necessary resolution. Therefore, the presence of adenine was only reported
if both marker ions (base and nucleotide) were present: one above 20% and the second above 5%
relative intensity.
Unfortunately, not all spectra of cross-links contain marker ions, especially those with single nu-
cleotides. Therefore, the absence of marker ions cannot be used to exclude spectra of noncross-linked
species. We still included it as an option in the perl script; if desired, precursor mass variants would
only be created for spectra containing RNA marker ions. However, this option was not used in data
analysis for this work.
3.1.3 Cross-linking products of 4-thio-uracil in the NusB–S10–BoxA RNA complex
In order to investigate the cross-linking products of 4-thio-uracil (4SU) by mass spectrometry and
to test our novel data analysis approach, we cross-linked the NusB–S10 protein complex from E.
coli to a synthetic RNA containing the rrn BoxA element. Three uracils of the oligonucleotide had
been replaced by 4SU; the sequence was 5’-CAC UGC UC(4SU) (4SU)(4SU)A ACA AUU A-3’.
The mass of the intact oligonucleotide and thus complete labeling was confirmed by ESI-MS.
Equal molar amounts of protein complex and RNA oligonucleotide were incubated for in vitro
complex formation, cross-linked at 365 nm for five minutes, enriched with C18 and titanium dioxide
chromatography according to our standard protocol, and investigated by LC-ESI-MS/MS on the
Q-ToF Ultima. Data analysis was carried out with the perl script described above, assuming
additive behavior of peptide and RNA masses in the cross-linking product, and manual spectra
interpretation.
3.1.3.1 Additive cross-linking product of 4-thio-uracil
Initially, searches were performed after precursor mass variant generation with RNA combinations
containing at least one 4SU nucleotide in the sequence. The only significant result obtained was
a cross-link of the carbamylated NusB peptide SFGAEDSHKFVNGVLDK (S113–K129) to a 4SU
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Figure 3.5: MS/MS fragment spectrum (smoothed and centroided) of carbamylated NusB peptide
SFGAEDSHKFVNGVLDK (S113–K129) cross-linked to [(4SU)(4SU) –HPO3]. Inter-
nal ions are indicated by their amino acid compositions, but not annotated to the
peptide sequence above the spectrum. Since all peptide fragments and internal ions
are observed without carbamylation, determination of the carbamylation site is in-
conclusive. The spectrum does not contain any obvious hint towards the cross-linked
RNA or amino acid. The presence of carbamylation and the cross-linked 4SU dinu-
cleotide without terminal phosphate is derived solely from the difference between the
experimental precursor and calculated peptide mass.
dinucleotide without terminal phosphate. The cross-link was validated manually; the spectrum is
shown in Figure 3.5 (general explanation of spectra annotation in B.1). However, some ambiguity
remained: Mascot identified K121 as carbamylated; manually b9 and several internal ions containing
K121 were annotated without carbamylation. Since several cross-links of the same peptide with and
without carbamylation were identified later (see Table 3.5), it was concluded that the cross-link is
a true positive result. Furthermore, the cross-link illustrates that 4SU can form cross-links that are
additive with respect to mass, as it has been observed for unsubstituted RNA.
3.1.3.2 Identification of a novel, 4-thio-uracil specific cross-linking product
Several variations of the perl script and Mascot searches were carried out to test the feasibility of
the approach. Among other things, searches were performed with precursor variants generated from
unsubstituted nucleotides. Interestingly, we observed several matches for different peptides with a
mass difference corresponding to a cross-linked [U –H2O] nucleotide. Among these was the same
peptide found cross-linked before, NusB peptide SFGAEDSHKFVNGVLDK. The corresponding
spectrum is shown in Figure 3.6. A Mascot search of precursor mass variants generated for RNAs
with at least one 4SU did not yield any search results for this spectrum, whereas a search with
precursor variants for unsubstituted RNA resulted in a single match. The peptide was identified
with a Mascot score of 16 and an E -value of 0.023. No other precursor variant led to a match.
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Figure 3.6: MS/MS fragment spectrum (smoothed and centroided) of NusB peptide SFGAED-
SHKFVNGVLDK (S113–K129) cross-linked to [4SU –H2S]. Internal ions are indicated
by their amino acid compositions, but not annotated to the peptide sequence above the
spectrum. The cross-linked RNA is derived from the difference between experimental
precursor and calculated peptide mass. The spectrum does not allow unambiguous
identification of the cross-linked amino acid. The distance between y7 and the signal
at m/z 968.56 is 224.10Da, this could correspond to phenylalanine (147Da) plus 94Da
(see 3.8) minus NH3. This could hint to F122 as the cross-linked amino acid.
The precursor mass variant that gave rise to the match was m/z 617.3228; the original experimental
precursor mass was 719.3312 with a charge state of three. The difference between experimental
precursor mass and precursor mass variant was 306.0252, corresponding to [U –H2O]. The peptide
was confirmed by manual validation; the cross-linked nucleotide could not be explained at that point.
The Mascot search was repeated and the database was changed from a small database (see 2.2.10.1)
to the E. coli proteome in the NCBI database. A search with 4SU-containing precursor variants led
to nine matches, none of which were significant and thus all could be considered false positives. A
search with precursor variants of unsubstituted RNA resulted in 45 matches. The validated peptide
was the best-scoring hit, again with a score of 16, and an E -value of 11. The second best scoring hit
had a score of 9 and an expect value of 16. Manual evaluation of both candidates revealed that the
validated peptide had considerably more peptide fragment matches; thus, the second candidate was
a random hit/false positive. In general, similar observations were made in the evaluation of Mascot
search results for precursor mass variants: Candidates later validated manually typically were the
only matches in the search against the small database. Searches against the E. coli proteome usually
confirmed the hit.
Manual spectra interpretation, performed in parallel to the novel data analysis workflow, revealed
another peptide with the same mass difference. The spectrum shown in Figure 3.7 contains a
fragment series easily recognized by experts in spectra interpretation. A partial sequence tag,
derived from fragments larger thanm/z 500, quickly led to S10 peptide LIDQATAEIVETAKR (L17–
R31). The difference between calculated peptide and experimental precursor mass was 306.0446Da.
This also hinted at [U –H2O] (calculated mass 306.0253Da) as the cross-linked nucleotide. More
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Figure 3.7: MS/MS fragment spectrum (smoothed and centroided) of S10 peptide LIDQAT-
AEIVETAKR (L17–R31) observed as adduct with [4SU –H2S]. All observed y-ions
except for y1 are shifted by a mass of 94.0Da, later interpreted as the 4SU base minus
H2S. Due to the shift, K30 was identified as the cross-linked amino acid.
astonishingly, the signals above m/z 500 were all shifted by 94Da with respect to the calculated
peptide fragment series. Closer inspection of the spectrum revealed that the same was true for all
observed y-ions except for y1.
The possibility that the cross-linked nucleotide was actually [U –H2O] had to be excluded. The ab-
sorption maxima of native nucleotides (250–270 nm) are far from that of 4-thio-uridine (330 nm) [35].
With UV irradiation carried out at the even higher wavelength of 365 nm, unsubstituted nucleotides
are not excited and consequently not able to form cross-links. A modified nucleotide [4SU –H2S]
would have the same elemental composition as [U –H2O] and, consequently, exactly the same mass.
Moreover, cleavage of the N-glycosidic bond in [4SU –H2S] would lead to a molecule with the
composition C4H2N2O and a mass of 94.0167Da. Cleavage of the N-glycosidic bond under our
fragmentation conditions can be considered a likely fragmentation pathway, as the same cleavage
leads to the nucleic acid base marker ions frequently observed. Potential structures for both the
newly identified and the additive cross-linking products of 4-thio-uracil are shown in Figure 3.8.
Another peptide cross-linked to 4SU via the loss of H2S is GPIPLPTR (G38–R44). Close manual
inspection of the MS/MS fragment spectrum revealed b2, a3, and b3 shifted by 94Da. The sequence
ion y7 was observed without a shift, while the signal at m/z 944.57 corresponds to the intact peptide
plus [(4SU)’ –H2S]. Therefore, the N-terminal G38 was identified as the cross-linked amino acid.
This finding was particularly interesting since glycine had not been identified as the cross-linked
amino acid before. Cross-linking of glycine might be a consequence of the considerably higher
reactivity of 4SU.
The shift of the majority of peptide fragments as in the case of peptide LIDQATAEIVETAKR
(see Figure 3.7) might hinder or completely prevent identification of the cross-link based on the
regular peptide sequence ions. Therefore, a novel "post-translational" modification was defined
in Mascot. The modification was defined with 306Da on the peptide C-terminus. A neutral loss
3.1 Cross-linking products of 4-thio-uracil and a novel approach for automated data analysis 67
Figure 3.8: Possible structures of 4SU cross-linking products. Additive cross-linking (upper reac-
tion) leads to a reaction product where the peptide (amino acid) is bound to 4SU,
probably via C5 or C6 of the 4SU base. Cross-linking might lead to hydrolyzation of
the C5–C6 double bond; the mass of the reaction product equals the sum of the masses
of the single reactants. Alternatively, 4SU reacts with an amino acid residue under net
loss of H2S (lower reaction). The mass of the cross-linking product equals the mass
of the peptide (amino acid) plus 306Da. Neither the exact structure nor the exact
cross-linking site on the base can be determined by mass spectrometry. Thus, the
structure represents one of several possible product structures. Upon fragmentation
with collision-induced dissociation (CID), the N-glycosidic bond is cleaved, leading to
peptide fragments shifted by 94Da.
(212Da) was added that would leave 94Da as the observable shift of peptide fragments (for details,
see 2.2.10.2). When a regular database search was performed including this modification, the
cross-linked peptide LIDQATAEIVETAKR was identified successfully. In contrast, the spectrum
of cross-linked peptide GPIPLPTR (see Figure 3.9) contains only a few shifted peptide fragments
and was identified after application of the precursor variant approach. In a regular database search
with the newly defined modification, it would not be identified because it is cross-linked on its
N-terminus. Therefore, the standard database search with the novel modification and the precursor
variant approach present complementary strategies for the identification of peptides cross-linked to
[4SU –H2S] with a corresponding shift of peptide fragments by the mass of [(4SU)’ –H2S].
3.1.3.3 Observation of peptides with a 258 Da adduct
In further tests of data analysis parameters, enzyme specificity was set to "unspecific". Interest-
ingly, this yielded a result for DVPYKVAINEAIELAK (NusB); the difference between experimental
precursor and calculated mass of the unspecific peptide suggested [G –H2O] as the cross-linked nu-
cleotide. As unsubstituted uracil, guanine should be unreactive under the irradiation conditions
of this experiment. Manual assignment of the corresponding spectrum (Figure 3.10) led to the
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Figure 3.9: MS/MS fragment spectrum (smoothed and centroided) of S10 peptide GPIPLPTR
(G38–R44) cross-linked to [4SU –H2S]. Cleavage N-terminal to proline leads to high
intensity signals as expected (proline effect). Interestingly, b2, a3, b3, and the intact
peptide are observed as adduct with [(4SU)’ –H2S], i.e. shifted by a mass of 94Da.
This identifies G38 as the cross-linked amino acid.
Figure 3.10: MS/MS fragment spectrum (smoothed and centroided) of NusB peptide SDVPYK-
VAINEAIELAK (S96–K112) observed as adduct with 258Da. The peptide fragment
signals y12 and y14 as well as internal ion PYK are observed as partially shifted by
258Da. This suggests K101 as the cross-linked amino acid.
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conclusion that the peptide was tryptic and not unspecific as suggested by the database search. In
consequence, the mass difference between experimental precursor mass and calculated peptide mass
changed to 258.0597Da. Since y12, y14 and two internal ions containing K101 were observed shifted
by the same mass, K101 was identified as the cross-linked amino acid. The same mass difference
was found for several peptides after it was included as an additional option for precursor variant
generation (see Table 3.1, Figures B.2 and B.1). Therefore, we initially interpreted this mass as
a 4SU-specific cross-linking product [104]. However, it was later shown by Dr. Uzma Zaman (Bio-
analytical Mass Spectrometry Group; unpublished) that this adduct is UV induced but observed
independently from irradiation wavelength and RNA substitution.
3.1.3.4 Feasibility of the precursor variant approach
After the observed cross-linking products had been adapted into our data analysis workflow, either
as modifications for standard Mascot search or as masses for precursor mass variation, all cross-
linked peptides reported were identified unambiguously by the novel data analysis approach. If
precursor variants were searched against a small database (14 proteins, see 2.2.10.1), the cross-
linked peptide was the only hit. In searches against the E. coli proteome, the cross-linked peptide
was typically the best-scoring match. Other hits could be excluded as false positives, either due to
low scores, manual evaluation of peptide fragment matches, or simply because the corresponding
protein was not contained in the sample. Table 3.1 summarizes all peptides of NusB and S10 that
were found cross-linked and/or observed with the 258Da adduct. Table A.1 additionally lists the
corresponding mass values.
Table 3.1: Cross-links of the NusB–S10 complex
protein position peptide aa RNA figure
NusB I87–R95 IALYELSKR K94 258 adduct B.1
S96–K112 SDVPYKVAINEAIELAK K101 258 adduct 3.10
K101 [4SU –H2S] -
S113–K129 SFGAEDSHKFVNGVLDK - 258 adduct -
F122 [4SU –H2S] 3.6
- [(4SU)A –H2S] -
- [(4SU)C –H2S] -
SFGAEDSHKFVNGVLDK - [4SU –H2S] -
(carbamylated) - [(4SU)(4SU) –HPO3] 3.5
- [(4SU)A –H2S] -
S10 L17–R31 LIDQATAEIVETAKR K30 [4SU –H2S] 3.7
G38–R44 GPIPLPTR G38 [4SU –H2S] 3.9
L73–R89 LVDIVEPTEKTVDALMR - 258 adduct B.2
LVDIVEPTEKTVDALM(Ox)R - [4SU –H2S] -
protein: name of the cross-linked protein
position: position of the cross-linked peptide in the protein sequence
peptide: sequence of the cross-linked peptide
aa: one-letter code and position of the cross-linked amino acid
RNA: composition of the cross-linked RNA/observation of the 258Da adduct
figure: reference to figure showing a representative spectrum of the cross-link
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3.1.4 Comparison of obtained cross-linking results to cross-linking with
unsubstituted RNA
In this section, the identified cross-links will be compared to the preceding study focused on the
same biological system. In addition, the obtained insights on cross-linking of 4-thio-uracil will be
summarized. A more general discussion on the cross-linking technique and method development
will follow in Chapter 4.
Figure 3.11: Comparison of NusB cross-links to unsubstituted [71] and 4-thio-uracil substituted
rrn BoxA containing RNA oligonucleotides. The sequence of the oligonucleotide is
given, the core BoxA element is underlined, and nucleotides substituted by 4SU are
in red. Nucleotide numbers are indicated above the sequence. Cross-linked peptides
with their positions in the respective protein are given, with NusB peptides above and
S10 peptides below the sequence. Peptides found cross-linked to the 4SU-substituted
oligonucleotide are shown in red boxes, peptides cross-linked to unsubstituted RNA
with a gray background. Lines between the peptide and RNA sequence indicate
potential cross-link positions on the RNA.
We identified several cross-links of the NusB–S10 complex to the rrn BoxA containing RNA oligonu-
cleotide 5’-CACUGCUCUUUAACAAUUA-3’ with three uracils (underlined) substituted by 4-
thio-uracil. These results were compared to cross-linking results with the same, unsubstituted
oligonucleotide previously obtained in our laboratory [71]. Since the 258Da adduct is not a clear
product of a cross-linking reaction to RNA, peptides found exclusively with this adduct are not con-
sidered for this comparison. As uracil is by far the most reactive nucleic acid base, we assume that
all cross-links of the unsubstituted RNA occurred via U for the subsequent comparison. Identified
cross-links of both experiments are summarized in Figure 3.11.
Our cross-linking results for the NusB protein show a great overlap with the cross-links to un-
substituted RNA. Peptide SDVPYKVAINEAIELAK (S96–K112) had been found cross-linked to a
[CU] dinucleotide. Complementary experiments led to the conclusion that either the C6–U7 or the
C8–U9 stretch of the rrn BoxA oligonucleotide was cross-linked [71]. We found the same peptide
cross-linked to 4SU. Since the nucleotide at position 9 was one of the substituted nucleotides, it is
possible that it formed cross-links to the peptide in both experiments.
The second NusB peptide identified as cross-linked to the 4SU-substituted RNA, SFGAEDSHK-
FVNGVLDK (S113–K129), contains a missed cleavage site of trypsin. Previous experiments had
identified the peptide FVNGVLDK (F122–K129) without a missed cleavage site as cross-linked to
unsubstituted rrn BoxA containing RNA. The missed-cleaved peptide SFGAEDSHKFVNGVLDK
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had been found cross-linked to the γ NutR BoxA containing RNA oligonucleotide 5’-CACCGCUCU
UACACAAUUA-3’. There are two possible explanations for this observation: K121 might be not
very accessible to trypsin, especially with a cross-link in close proximity, e.g. F122. Therefore, hy-
drolysis might be hindered or prevented. Alternatively, K121 itself might be cross-linked, prevent-
ing cleavage by trypsin completely, whereas unsubstituted rrn BoxA cross-links to the neighboring
F122. Since neither data set allowed for unambiguous identification of the cross-linked residue, this
hypothesis cannot be proven nor rejected.
Peptide FVNGVLDK (F122–K129) had been found cross-linked to a [UU] dinucleotide. Cross-
linking of NusB alone had led to a cross-link of the same peptide to a [UUU] trinucleotide, which
has to be the triple U stretch substituted in our experiment. Complementary experiments with the
γ NutR BoxA oligonucleotide indicate U11 as the cross-linked nucleotide [71]. Peptide SFGAED-
SHKFVNGVLDK (S113–K129) was found cross-linked to [(4SU)A –H2S] as well as [(4SU)C –H2S],
indicating that it might cross-link to positions 9 and 11 of the oligonucleotide. The results for the
unsubstituted RNA do not allow for the exclusion of the possibility that the protein region contacts
both nucleotides.
Overall, the cross-linking results for NusB with both unsubstituted and 4SU-substituted rrn BoxA
containing RNA oligonucleotides are in excellent agreement on both protein and RNA level. The
NusB cross-linking yield did not differ significantly between unsubstituted and 4SU-substituted rrn
BoxA containing RNA oligonucleotides (see Figure 3.1), which indicates that both protein regions
exhibit high cross-linking reactivity, even with the less reactive unsubstituted uracils. The two
NusB residues K101 and F122 identified in our study as cross-linked to 4SU were later shown to
be significant for binding of NusB to BoxA by NMR chemical shift mapping. Moreover, a F122D
mutant did not exhibit any detectable BoxA binding [106]. This illustrates the capability of UV
induced cross-linking with mass spectrometry to identify direct interaction sites on an amino acid
level.
In contrast to the results for NusB, cross-linking of S10 to the 4SU-substituted RNA differs substan-
tially from cross-linking to unsubstituted RNA. S10 peptides LKAFDHR (L10–R16), FTVLISPH-
VNK (F49–59), and DQYEIR (D63–R68) had been identified as cross-linked to the unsubstituted
rrn BoxA containing RNA oligonucleotide [71]. In our study, peptides LIDQATAEIVETAKR (L17–
R31), GPIPLPTR (G38–R44), and LVDIVEPTEKTVDALMR (L73–R89) were found cross-linked
to the same oligonucleotide substituted with 4SU.
Peptide DQYEIR (D63–R68) had been identified as cross-linked to an [AAU] trinucleotide and it
had been concluded that it was cross-linked to the AAU-stretch close to the 3’ end of the oligonu-
cleotide, probably via U17. Since the corresponding uracil was not one that was substituted in
our experiment, we could not have identified the same cross-link. The same is true for peptide
FTVLISPHVNK (F49–K59) that had been found cross-linked to [AAUU]: Oligonucleotides with
this composition only appear at the 3’ end of the rrn BoxA containing RNA oligonucleotide. In
contrast, peptide LKAFDHR (L10–R16) had been found cross-linked to an [AU] dinucleotide. From
results of complementary experiments [71], the cross-link had been mapped to the UA stretch con-
taining the U11, substituted in our experiment. If the same cross-linking behavior was expected
for both unsubstituted and 4SU-substituted RNA, this peptide should have been identified in our
experiment. However, because we identified completely different peptides cross-linked to the 4SU-
substituted RNA, the cross-linking behavior is clearly different.
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There is currently no further satisfactory explanation for the discrepancy of S10 cross-linking results
between unsubstituted and 4SU-substituted rrn BoxA containing RNA oligonucleotides. Interest-
ingly, the cross-linked S10 residue G38 is in direct proximity to residues that interact with NusB
(and 16S rRNA in the 30S subunit), namely residues R27 and P39 [71]. Therefore, it is located at
the binding interface of both proteins. The role of this binding interface and the additional peptides
found cross-linked to 4SU in RNA binding could only be answered by additional biochemical and
structural studies.
An interesting detail of the cross-linking results with 4SU (see Table 3.1) is the high number of
peptides with a missed cleavage site. More precisely, lysine residues with C-terminal peptide bonds
that were not hydrolyzed by trypsin. Due to peptide sequence ions observed as adducts with RNA
fragments, K101 of NusB and K30 of S10 were identified as cross-linked residues. This might
indicate an increased reactivity between 4SU and lysine residues.
Overall, cross-linking experiments of the NusB–S10 complex to 4-thio-uracil substituted rrn BoxA
containing RNA oligonucleotide provided valuable insights into UV-induced cross-linking in com-
bination with mass spectrometry in general. It was shown that 4-thio-uracil has the potential to
increase the cross-linking yield and that the cross-linking products can be identified by mass spec-
trometry. A non-additive cross-linking product of 4SU was identified; 4SU can undergo UV-induced
reactions with amino acids via net loss of H2S and the resulting cross-linking product displays in-
teresting behavior under collision-induced dissociation conditions. The N-glycosidic bond between
the modified base and ribose is cleaved, leaving a stable adduct of peptide (fragments) and a cross-
linked base that is extremely useful in the identification of the cross-linked amino acid residue.
Most importantly, the precursor variant approach proved feasible for automated identification of
anticipated cross-links, greatly improving the data analysis procedure for future projects. Since
the majority of cross-links could be identified in searches against the background of the entire pro-
teome, the approach was a valuable step towards the identification of cross-links in more extended
ribonucleoprotein complexes.
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3.2 Instrumental and data analysis improvements and their
implications for cross-link identification
The basic idea for automatization of data analysis based on precursor variant generation proved its
feasibility in cross-link identification in the NusB–S10 complex. The practical realization with a perl
script provided a useful tool, almost completely replacing ab inicio manual spectra interpretation.
In collaboration with the group of Prof. Oliver Kohlbacher (Applied Bioinformatics Group, Uni-
versität Tübingen), the approach was next integrated into the mass spectrometry data processing
environment OpenMS. This created the opportunity to directly combine precursor variant gener-
ation with preceding and subsequent data analysis steps, thus enabling further automatization of
the entire data analysis workflow.
At the same time, the laboratory obtained an LTQ Orbitrap Velos mass spectrometer. Compared
to the preceding LTQ Orbitrap generation, it had been reported to provide higher sensitivity and
scan speed. In addition, the instrument contained an improved cell for higher-energy collisional
dissociation (HCD) [107]. The Orbitrap Velos was evaluated for the analysis of cross-linking experi-
ments.
Both developments in instrumentation and data analysis will be described in detail before illustrating
the achieved improvements exemplified by cross-link identification in the ASH1 complex.
3.2.1 LTQ Orbitrap Velos mass spectrometer
Mass spectrometric analysis of UV induced protein–RNA cross-linking experiments had been car-
ried out on a Q-ToF Ultima mass spectrometer. It was preferred to the LTQ Orbitrap XL mass
spectrometer also available in our laboratory due to the unfavorable characteristics of CID spectra
and insufficient sensitivity of HCD (see 1.3.3.4).
A newer generation of orbitrap instruments, the LTQ Orbitrap Velos [107], showed improvement in
scan speed and sensitivity. Ion transmission from atmospheric pressure was improved by introducing
the stacked ring ion guide or S-lens. More effective ion transmission in turn increased the overall
sensitivity of the instrument. The HCD collision cell was re-engineered: Additional electrodes
changed the electric field distribution to allow for more efficient extraction of ions from the HCD cell.
Thus, sensitivity and scan speed of HCD fragmentation were significantly increased. In addition,
CID sensitivity, fragmentation efficiency, and scan speed were increased by introduction of a dual-
pressure linear ion trap.
Initial reports on the performance of the Orbitrap Velos suggested that the instrument was capable
of analyzing complex samples with a high-high strategy, i.e. both MS survey and MS/MS (CID
or HCD) fragment spectra are recorded in the orbitrap at high resolution [107]. Therefore, after an
Orbitrap Velos became available in our laboratory, it was expected that the advancements would
enable the analysis of cross-linking experiments on this instrument with HCD fragmentation.
3.2.2 Integration of the precursor variant approach into the OpenMS environment
A collaboration with the Applied Bioinformatics Group (Prof. Kohlbacher, Universität Tübingen)
was initiated for further automatization of data analysis based on the established precursor variant
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approach. Together with other bioinformatics laboratories, they have developed and are constantly
improving OpenMS [99, 100], a library of algorithms and tools for the analysis of LC-ESI-MS/MS
data. OpenMS offers various building blocks for different steps of LC-ESI-MS/MS data analysis
that can be combined into analysis pipelines. Due to this feature, it was possible to create a specific
building block for precursor variant generation that could then be combined with existing algorithms
to create a data analysis routine for our cross-linking data. Programming of the necessary code was
primarily done by Timo Sachsenberg (Kohlbacher laboratory).
OpenMS itself is a freely available, open source software package. Consequently, it is based on open
mass spectrometry data formats like .mzXML [108] and .mzML [101]. Mass spectrometry data must
be converted from vendor formats to one of these open formats before using OpenMS.
The development of an OpenMS data analysis workflow was first based on Q-ToF data. However,
both the initiation of the collaboration and first measurements on the Orbitrap Velos were done
almost in parallel, so the focus was quickly set entirely on Orbitrap data. The age of the Q-ToF
Ultima implies an outdated data structure that presented various challenges in different stages
of analysis with OpenMS. While initial results proved that Q-ToF data could be analyzed with
OpenMS, different data structure issues would have had to be resolved for complete analysis. Since
Velos data was more straightforward to process and soon proved to yield better cross-linking results
(see below), complete reproduction of cross-link identifications obtained with the perl script was
abandoned.
Similarly, the perl script was set up to generate precursor variants from the text-based .msm file
obtained from Velos data after conversion with Raw2MSM [98]. The script was easily modified for
.msm files by Petra Hummel. However, the significantly higher number of MS/MS fragment spectra
made manual submission of Mascot searches unfeasible, e.g., a single measurement of the ASH1-
short complex (see below) contained 2677 MS/MS spectra. Therefore, efforts were completely set
on analysis of Velos data with OpenMS.
All data processing steps described for the perl script were essentially transferred into a novel
OpenMS tool named RNPxl. Prior to precursor variant generation, precursors below 600Da and
precursors corresponding to small oligonucleotides according to their fractional mass were filtered.
Precursor variants were then generated as described, i.e. for all RNA sequences of one to four
nucleotides and with the modifications –H2O, –HPO3, –H3PO4, +HPO3, and +HPO3-H2O. Ad-
ditionally, all RNA combinations were considered with and without the 152Da adduct. Precursor
variants were omitted from further analysis if they were below m/z 250. As in the perl script, the
original precursor mass was included with all its variants to identify noncross-linked peptides even
after precursor variant generation.
Two steps contained in the perl script were omitted from RNPxl: The noise filter was not integrated
because Orbitrap data contains considerably fewer noise signals. The comparison of precursor
masses to larger RNA oligonucleotides was also omitted from the data analysis workflow because
the information obtained had not provided any practical use.
Most importantly, and in contrast to the perl script, the RNPxl tool was designed to automatically
submit the database searches. The actual database search was carried out with OMSSA (Open
Mass Spectrometry Search Algorithm [34]) instead of Mascot. The main reason for this change was
the higher speed of the OMSSA search engine. In addition, OMSSA is a freely available open source
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Figure 3.12: Data analysis workflow with the RNPxl tool. Raw data in the .raw vendor format
is converted into the open .mzML format by msconvert. The OpenMS tool RNPxl
generates the precursor variants, submits the database searches into OMSSA, and
summarizes the search results into a single .idXML file. These can be annotated to
the raw data in .mzML format in TOPPView.
program and can be installed alongside OpenMS, thus running both programs on the same machine.
In contrast, Mascot is a commercial search engine and is typically run on separate dedicated servers.
While OpenMS could also be set up to submit the searches to Mascot, the implementation is less
straightforward due to the separate locations in which the programs are run.
In contrast to the perl script, the RNPxl tool took the raw mass spectrometry data in .mzML format
as input files. Internally, one MS/MS data file per spectrum containing the precursor variants was
generated for submission of database searches. The search results were automatically summarized
into an .idXML file, retaining only the best scoring match for each precursor variant .mzML file.
In other words, only the best hit for each spectrum was reported in the .idXML file. This file was
used to annotate the search results to the raw MS data in the OpenMS graphical user interface
TOPPView. The entire data analysis workflow is outlined in Figure 3.12.
Data analysis of the cross-linking experiments described in this and the following section were
done with the basic functionalities described above. In the developmental phase, precursor variant
generation and database searches were performed by our collaborators. The final version of the
RNPxl tool was designed to enable analysis of a wide range of UV induced cross-linking experiments
and to provide the user with many opportunities to influence the precursor variant generation.
Several options were included to allow the user to determine the RNA combinations that would be
used for precursor variant generation. First of all, nucleotides can be defined by a one-letter code
and their sum formula. Thus, experiments with photo-reactive nucleotides like 4-thio-uracil, DNA,
or nucleotides labeled with heavy stable isotopes can be analyzed. As for the perl script, RNA
combinations can be limited to those appearing in an input RNA sequence. RNA combinations
can also be required to contain a certain nucleotide. For example, cross-linking experiments with
4-thio-uracil and UV irradiation at 365 nm should only yield cross-links to RNA containing at least
one 4SU. For such experiments, the tool can be set up to only create precursor mass variants for
corresponding RNA oligonucleotides, disregarding all combinations without 4SU. The maximum
length expected for the cross-linked oligonucleotide can also be chosen freely. Additionally, the
modifications to be considered for each RNA combination can be defined. Therefore, any effect
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observed in cross-linking experiments can be integrated, e.g. the loss of H2S from 4SU upon cross-
link formation.
The thresholds for the mass filters, i.e., the filters of small precursor masses prior to precursor
variant generation and the m/z threshold for precursor variants to be included in the output file,
were also included as parameters that can be adjusted by the user. The database search parameters,
e.g. protein database and mass deviation, have to be defined by the user as well. The final version
of RNPxl is described in more technical details in 2.2.10.6, with Figure 2.3 showing the parameters.
3.2.3 Cross-linking of ASH1
Cross-linking of a model complex for ASH1 mRNA transport in budding yeast was carried out with
both experimental and data analysis setups, i.e. the combination of Q-ToF Ultima and perl script
as well as Orbitrap Velos and OpenMS.
The ASH1 model complex had been studied by our collaborators, the group of Prof. Dierk Niessing
(Institute of Structural Biology, Helmholtz Zentrum München). This tertiary complex contained
the two proteins She2p and She3p, and a 51 nucleotide section of zip code element E3 of the ASH1
mRNA. She2p is an RNA-binding protein that interacts with all four zip code elements of ASH1
mRNA. ASH1 -E3 zip code alone can mediate mRNA transport in vivo. Our collaborators identified
She3p as a novel RNA-binding protein and showed synergistic binding of She2p and She3p to zip
code containing RNAs with significantly higher affinity and specificity than the individual proteins.
UV induced cross-linking with labeled RNA and denaturing gel electrophoresis proved that both
proteins directly interact with RNA (see [96] and references therein).
Analysis of cross-linking products with mass spectrometry was intended to provide more detailed
information on the interaction sites of both proteins. Two model complexes were prepared by
Roland Heym (group of Dierk Niessing): The first complex, termed ASH1-FL, contained full-length
She3p, She2p, and the RNA. The second complex, termed ASH1-short, contained the C-terminus
of She3p (92 amino acids, positions 334–425, termed She3p-short, sufficient for synergistic RNA
binding [96]), She2p, and the RNA. We obtained complexes that had been isolated by gel filtration.
The complexes were UV irradiated at 254 nm for 10minutes and enriched according to our standard
protocol (see 2.2.8.4). Starting amounts for experiments with Q-ToF analysis were 120 μg ASH1-FL
and 100 μg ASH1-short (protein amounts). Experiments with analysis on the Orbitrap Velos were
carried out with significantly lower amounts due to the higher sensitivity of the instrument, i.e.
20 μg ASH1-FL and 25 μg ASH1-short.
Data from the Q-ToF Ultima was analyzed after precursor variant generation by the perl script.
Mass variants were only created for RNA sequences that actually appear in the RNA used in the ex-
periment, namely 5’-AUGGAUAACUGAAUCUCUUUCAACUAAUAA GAGACAUUAUCA
CGAAACAAU-3’. This reduced the number of RNA combinations from 69 to 45. Database
searches were performed with Mascot. Orbitrap data was analyzed with OpenMS and OMSSA
searches without limiting the RNA combinations.
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3.2.4 ASH1 cross-links identified after LC-ESI-MS/MS measurement on the
Q-TOF and data analysis with the perl script
All cross-links identified in the ASH1-FL and the ASH1-short complexes in the initial experiments
with the Q-ToF/perl script setup are listed in Table 3.2, with corresponding mass values given
in Table A.2. In both complexes, She2p peptide IGSNLLDLEVVQFAIK (I164–K179) was found
cross-linked to uracil. No cross-link of She3p was identified in ASH1-FL. The cross-linked peptide
GPLGSMGNSSNNK identified after cross-linking of ASH1-short contains the N-terminus of the
shortened She3p (positions G334–K340) and a stretch of six amino acids (underlined) that are not
part of She3p, but remained after cleavage of a GST tag introduced for protein isolation.
Table 3.2: Cross-links of the ASH1 complexes identified after analysis on the Q-ToF Ultima.
protein position peptide aa RNA figure FL short
She2p I164– IGSNLLDLEVVQFAIK F181 [U] 3.13 + +
K179 I*GSNLLDLEVVQFAIK F181 [U] - + +
*carbamylated
She3p G334– GPLGSMGNSSNNK S337–N339 [AAU –HPO3] 3.14b - +
-short K340 G*PLGSMGNSSNNK - [U] 3.14a - +
*carbamylated
GPLGSM*GNSSNNK - [U] - - +
*oxidized
protein: cross-linked protein
position: position of the cross-linked peptide in the protein sequence
peptide: sequence of the cross-linked peptide
aa: one-letter code and position of the cross-linked amino acid
RNA: composition of the cross-linked RNA
figure: reference to figure showing representative MS/MS fragment spectrum
FL/short: identification of the cross-link in ASH1-FL and ASH1-short, respectively
Cross-links of She2p peptide IGSNLLDLEVVQFAIK were identified after database searches with
high confidence. In all cases, Mascot searches after precursor variant generation unambiguously
identified the peptide as the best-scoring match in searches against a reduced database (see 2.2.10.1)
or the S. cerevisiae proteome as contained in the NCBI database. The cross-linked peptide was
identified with high Mascot scores, the unmodified peptide scored between 62 and 72, and scores
for the carbamylated peptide were 49 to 59.
A spectrum of this cross-link is shown in Figure 3.13. Close manual inspection revealed that the
y-series was partially shifted by the mass of [U –H3PO4] and [U]. Since the smallest y-ion observed
with an RNA adduct is y4, it was concluded that F181 was the cross-linked amino acid.
The spectrum also exemplifies the influence of RNA-adducts on the fractional mass of peptide
fragments. Fractional masses of fragments in the same m/z range can indicate absence or presence
of RNA (fragments). For example, the signals at m/z 1029.44, 1030.51, and 1046.64 show increasing
fractional masses. The signal at m/z 1046.64 was annotated as y9 in the Mascot search results.
Manual spectra interpretation revealed the signal at m/z 1030.51 corresponding to an adduct of y7
with [U –H3PO4] and m/z 1029.44 as y6 with [U]. Thus, the effect on the fractional mass typically
increases with the size of the RNA adduct. This observation can be extremely helpful in manual
spectra interpretation. It must be noted that a- and b-ions also exhibit a fractional mass smaller
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Figure 3.13: MS/MS fragment spectrum (smoothed and centered) of She2p peptide IGSNLL-
DLEVVQFAIK (I164–K179) cross-linked to [U]. The y-series is partially shifted by
[U –H3PO4] or [U] starting with y4. This identifies F181 as the cross-linked amino
acid. An intense signal is observed at m/z 227.06, which corresponds to the RNA
fragment [U –H3PO4] .
(Details of spectra annotation are described in B.1.)
than that of y-ions (e.g., compare a5/b5 pair at m/z 457.26 and 485.27 to y4 at m/z 478.30). a- and
b-ions are rarely observed in the higher m/z range after beam-type CID (see 1.3.3.4). Therefore,
large signals with fractional masses significantly below those of calculated/observed y-ions of the
cross-linked peptide are very likely to correspond to RNA adducts.
Two spectra of She3p-short peptide GPLGSMGNSSNNK (GPLGSM from cleavage of GST and
She3p positions G334–K340) are shown in Figure 3.14. In 3.14a, the peptide was found carbamy-
lated on its N-terminus. The spectrum does not contain any trace of the cross-linked RNA; its
presence and composition was deducted solely from the difference between experimental precursor
and calculated peptide mass. In contrast, the MS/MS spectrum of the same, unmodified peptide
cross-linked to [AAU –HPO3] (3.14b) is dominated by RNA signals. The marker ion for adenine
at m/z 136.06 is the most intense signal. RNA signals for adenosine, adenosine after loss of water,
uridine after loss of phosphoric acid, as well as for the [AU] dinucleotide with loss of HPO3 and
H3PO4 were observed. They all exhibit a higher intensity than any of the peptide fragments; only
the intact peptide produces an intense signal. The signal at m/z 768.13 corresponds to an adduct of
y4 with [U –H2O], this places the cross-link on either S337, N338, or N339. Due to the low intensity
of peptide fragment signals, the cross-linking site cannot be narrowed down further, as it cannot be
excluded that other peptide–RNA adducts were present but not detected.
In summary, it can be concluded that both She2p and She3p-short directly interact with ASH1
mRNA zip-code element E3 in the ASH1-short complex. The results from analysis on the Q-ToF
do not allow for final conclusions about whether the same is true for the ASH1-FL complex.
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(a) Cross-link to [U].
(b) Cross-link to [AAU –HPO3].
Figure 3.14: MS/MS fragment spectra (smoothed and centered) of She3p-short peptide GPLGSM-
GNSSNNK (G334–K340) cross-linked to (a) [U] and (b) [AAU –HPO3]. While the
spectrum of the cross-link to [U] does not contain any RNA signals, the cross-link to
[AAU –HPO3] produces dominating RNA (marker) ions.
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3.2.5 ASH1 cross-links identified after LC-ESI-MS/MS measurement on the
Orbitrap Velos and data analysis with OpenMS
Cross-linking experiments of the model complexes for ASH1 mRNA transport were the first to be
analyzed on the Orbitrap Velos and consequently the first Orbitrap data that were evaluated after
precursor mass variant generation with OpenMS and OMSSA database searches.
Figure 3.15: MS/MS fragment spectrum of She2p peptide IGSNLLDLEVVQFAIK (I164–K179)
cross-linked to [U]. The y-series is partially shifted by [U] and/or [U –H3PO4] starting
with y4. Thus, F181 is identified as the cross-linked amino acid.
The same cross-link of She2p peptide IGSNLLDLEVVQFAIK to [U] that had been identified in the
previous experiments analyzed with the Q-ToF Ultima was found cross-linked. The corresponding
fragment spectra are highly similar (compare Figures 3.13 and 3.15). In both cases, the y-series
was observed as partially shifted by [U] and/or [U –H3PO4]. Because the shift was observed for y4
but not for y3, it was concluded that F181 was the cross-linked amino acid. The exact number of
observed a-, b-, and y-ions, as well as relative signal intensities, do show differences between both
spectra. However, it has to be noted that the precursor charge state observed on the Q-ToF was
2 while it was 3 in the measurement on the Orbitrap Velos. MS/MS fragment spectra of the same
species but obtained after fragmentation of different charge states often show similar differences in
number and relative intensities of peptide fragments and RNA–peptide adducts, even if they are
recorded within the same measurement on the same instrument (data not shown). Therefore, the
similarities between the MS/MS fragment spectra after either beam-type CID in the Q-ToF or HCD
in the Orbitrap Velos, as exemplified here with the cross-link of IGSNLLDLEVVQFAIK to [U], led
to the conclusion that fragmentation of cross-links under both conditions are comparable.
The cross-link of the N-terminus of She3p-short identified in the Q-ToF measurement was also
confirmed in the analysis on the Orbitrap Velos (see Figure B.3 and Table 3.3), although with
different RNA sequences. This could be due to less reproducible RNA hydrolysis or cleavage during
enrichment, chromatography, or ionization. On the peptide level, previous cross-linking results
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Figure 3.16: MS/MS fragment spectrum of She2p peptide YLSSYIHVLNK (Y27–K37), oxidized
at H33, cross-linked to [AAU –HPO3].
could be completely reproduced with the Orbitrap Velos, even though the amounts of starting
material were considerably lower (only 17% for ASH1-FL and 25% for ASH1-short). In addition, a
surprisingly high number of additional cross-links were found after analysis on the Orbitrap Velos
that were not identified before. Most cross-links were confidently identified and manually validated.
Example spectra for each cross-linked peptide are shown in the Appendix, observed cross-links are
summarized in Table 3.3, and corresponding mass values are given in Table A.3. However, three
interesting cross-links will be described in more detail below.
Figure 3.16 shows the MS/MS fragment spectrum of She2p peptide YLSSYIHVLNK (Y27–K37).
It was identified as cross-linked to [GGU –H3PO4] after a database search of the precursor variants.
However, the spectrum clearly shows an intense adenine marker ion and several signals corresponding
to an [AU] dinucleotide; in contrast, no G marker ions are observable. The experimental precursor
m/z was 751.6308 (z=3); subtraction of the calculated peptide mass of 1335.7186Da leads to a
mass difference of 916.1504Da. Thus, the cross-linked RNA should contain three nucleotides. From
the marker ions it was concluded that the RNA should contain only A and U. Consequently, the
RNA should be either [AAU] or [AUU]. [AAU –HPO3] has a calculated mass of 902.1746Da and
thus lies in the same range as the observed mass difference. The synthetic RNA oligonucleotide
used in the experiments has AAU at its 3’ end and does not contain a 3’ phosphate, therefore
[AAU –HPO3] could originate from there. Subtracting the calculated mass of [AAU –HPO3] from
the mass difference between experimental precursor and calculated peptide mass leaves 13.9758Da.
Interestingly, close inspection of the fragment spectrum revealed all peptide fragments containing
H33 were shifted by the same mass, i.e., y5–y10 and b7–b8, as well as the signal at m/z 1350.7045
corresponding to the intact peptide plus 13.9781Da. Initially, it was assumed that the shift could
result from methylation with a monoisotopic mass of 14.0156Da. However, the mass deviation
between the calculated mass of the methylated peptide cross-linked to [AAU –HPO3] and the
experimental mass would be 17.7 ppm. The mass accuracy of the Orbitrap Velos is typically well
below 5 ppm; therefore, methylation had to be excluded. Finally, it was concluded that the histidine
was likely oxidized to 2-oxo histidine. The corresponding mass shift would be 13.9793Da, which is
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in excellent agreement with the observed differences in both peptide fragments and precursor mass.
The mass difference between the calculated mass of the peptide containing 2-oxo histidine cross-
linked to [AAU –HPO3] and the experimental mass is 1.6 ppm, which lies within the expected mass
accuracy of the Orbitrap Velos. This example illustrates the importance of cross-link validation and
how an iterative approach in testing and confirming or excluding different assumptions leads to the
final conclusion about cross-linked peptide, RNA, and their modifications.
Figure 3.17: MS/MS fragment spectrum of She2p peptide LSALDEEFDVVATKWHDK (L223–
K240) cross-linked to [U +152]. Signals corresponding to internal ions are marked
with an asterisk and not annotated further. The y-series is completely shifted by
different RNA adducts starting with y4, which leads to identification of W237 as the
cross-linked amino acid.
Another intriguing observation was that She2p peptide LSALDEEFDVVATKWHDK (L223–K240)
cross-linked to [U +152]. In contrast to all other peptides observed with the 152 adduct, this
peptide does not contain a cysteine residue. Close manual inspection of the spectrum revealed a
high number of y-ions shifted by different RNA adducts, all containing 152Da as an additional
mass. Since regular y-ions were only observed for y1 to y3, it was concluded that W237 was the
cross-linked amino acid. This cross-link presents the first (and so far only) observation of a cross-link
with the additional mass of 152Da that cannot be connected to a cysteine residue.
3.2.5.1 Introduction of non-irradiated controls for validation
Negative controls are common for many analytical methods to exclude false positive results due to
unexpected effects. For example, negative, i.e. non-irradiated, controls were included in the gel-
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(a) XIC of m/z 689.0138. (b) Annotated fragment spectrum.
Figure 3.18: Extracted ion chromatograms (XICs) and MS/MS spectrum of She2p peptide IGS-
NLLDLEVVQFAIK (I164–K179) cross-linked to [U –H2O]. The XIC of the UV irradi-
ated sample shows a clear signal, while the control XIC shows only background noise.
The peptide sequence is confirmed by almost complete coverage with N-terminal a-
and b-ions and C-terminal y-type fragments. The y-series is shifted by 94Da starting
with y4, corresponding to the uracil base minus water. Through the shift, F181 is
identified as the cross-linked amino acid.
based comparison of cross-linking yields of native versus 4SU-substituted RNA to the NusB–S10
complex (see 3.1.1). However, such controls were not previously included in mass spectrometric
analysis of cross-linking experiments. The low sensitivity of the Q-ToF Ultima together with the
low cross-linking yield and the usually very limited sample amounts did not permit any further
division of the starting material.
The significantly higher sensitivity of the LTQ Orbitrap Velos led us to prepare non-irradiated
controls along with the irradiated sample in every experiment. This strategy was first tested for
feasibility with the ASH1 complex.
Measurement of a non-irradiated control followed by the cross-linked sample allows for a straight-
forward and unambiguous validation of cross-link candidates: Extracted ion chromatograms (XICs)
are calculated for the precursor mass of the cross-link candidate in both the control and UV irradi-
ated sample. In other words, intensities of all ions in a certain mass range are summed and plotted
against retention time. The mass range is adjusted to the mass error of the instrument around the
calculated precursor mass of the cross-link.
An example for XIC comparison is shown in Figure 3.18a. XICs for the precursor mass of a cross-link
candidate are calculated in both the control and UV irradiated sample. While the chromatogram
of the irradiated sample shows a clear signal, the intensity in the control is an order of magnitude
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smaller. Therefore, the precursor must be of a species formed as a consequence of UV irradia-
tion. The peptide sequence obtained from the database search was confirmed by comparison of
predicted and experimental fragments (Figure 3.18b). Interestingly, the 94Da shift observed for
4SU-substituted RNA was also found here (see below).
3.2.5.2 4-thio-uracil and native uracil form similar cross-linking products
Figure 3.19: Possible structures of 4SU and uracil cross-linking products. Upon UV irradiation,
both uracil and 4SU cross-link with a net loss of H2O or H2S, respectively. The
resulting cross-linking product has a mass of 306.0253Da. Upon fragmentation with
CID or HCD, an adduct of 94.0167Da remains on the peptide, corresponding to
cleavage of the N-glycosidic bond.
In previous experiments on cross-linking 4SU-substituted RNA to NusB–S10, several cross-links
were observed that showed an overall mass of the cross-linked RNA of 306Da and a partial shift
of the peptide fragments by 94Da (see 3.1.3.2). Our conclusion was that H2S was lost upon cross-
linking and fragmentation of the N-glycosidic bond but not the cross-linking bond led to the observed
adduct in the peptide fragments.
In our cross-linking experiments of the ASH1 complex, we observed the same mass adducts, i.e.,
306Da for the precursor and 94Da for the peptide fragments. An example is shown in Figure
3.18b. Therefore, we believe that both 4SU and native uracil undergo similar or even the same
cross-linking reactions with a net loss of H2S or H2O, respectively (see Figure 3.19). Since it is clear
that the sulfur atom is lost in 4SU, we propose that the carbonyl oxygen at C4 is lost in native
uracil. However, this could only be proven in additional experiments, e.g. with 18O labeled uracil.
Mass spectrometry allows only for conclusions about the elemental composition of the products,
the exact structure and connectivity, especially to the cross-linked peptide, cannot be determined.
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Therefore, the actual cross-linking product could be an isomer of the structure shown in Figure
3.19.
3.2.5.3 Significant improvement of cross-link identification after measurement on the
Orbitrap Velos and data analysis with OpenMS
Table 3.3 summarizes all cross-links identified after measurement on the Orbitrap Velos and data
analysis with OpenMS. Overall, six regions of She2p, four regions of She3p and the N-terminus of
She3p-short were identified as cross-linked, combining the results of both ASH1-FL and ASH1-short.
Compared to the single peptide regions of both She2p and She3p-short identified after analysis with
the Q-ToF Ultima, there was a remarkable improvement. Since starting amounts were decreased
significantly in experiments analyzed with the Orbitrap Velos, the results illustrate the increased
sensitivity and sequencing speed of the Orbitrap Velos even more drastically. Assuming that the
same cross-links were formed in both experiments, identification with the Q-ToF Ultima could have
been hampered for several reasons: (1) Due to the lower sensitivity, cross-link precursors might
have been below the detection limit of the instruments. (2) If detected, intensities might not have
been sufficient to trigger MS/MS fragmentation or to produce a fragment spectrum of reasonable
quality. (3) The significantly lower sequencing speed might have prevented low intensity precursors
from being chosen for fragmentation at all. For example, 382 MS/MS spectra were recorded in the
ASH1-short measurement on the Q-ToF Ultima, while the analysis of cross-links from the same
complex on the Orbitrap Velos produced 2677 MS/MS spectra (identical LC gradients). Therefore,
the Orbitrap Velos is considerably more likely to fragment low intensity precursors.
This significant increase in spectra numbers also illustrates that both improvements on the instru-
mental and data analysis side were largely dependent on each other: While analysis of Orbitrap
Velos data would in principle be possible with precursor mass generation by the perl script and
Mascot searches, the high number of spectra would make this approach even more time-consuming,
rendering it unfeasible. Equally, data analysis of Q-ToF data with OpenMS was theoretically pos-
sible, but hampered by several characteristics of the antiquated format of the Q-ToF data and the
low sequencing speed. These disadvantages were not encountered with the Orbitrap Velos data.
The most obvious advantages of the integration of the precursor variant approach into the OpenMS
environment are the automated submission of database searches and the retrieval and summary
of search results. The duration of these steps in the data analysis workflow was substantially
shortened. However, OpenMS included another advantage crucial for straightforward evaluation
and validation of cross-link candidates: TOPPView, the graphical user interface of OpenMS for
viewing MS data, can be used to annotate the database search results in .idXML format onto
the raw data in .mzML format. This procedure has many advantages for validation. Previously,
Mascot search results had to be compared manually to the raw MS data, i.e., two separate programs
had to be used in order to perform one task. TOPPView automatically highlights signals of the
raw data that overlap with theoretical fragments of the peptide match resulting from the database
search. Additional signals, e.g. RNA marker ions, can be easily annotated with the corresponding
m/z and a label. In addition, TOPPView allows for calculation of distances between two signals.
This simple functionality is extremely useful in manual spectra interpretation and not offered by
the programs provided by the mass spectrometer vendors. Suggestions for minor improvements of
annotation collected while evaluating cross-linking search results were integrated into TOPPView
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by our collaborators. Finally, in order to determine the RNA composition of the cross-link candidate
from Mascot search results, the difference between experimental precursor mass and the precursor
variant that gave rise to a match had to be calculated manually. In contrast, TOPPView was set
up to be able to display the RNA composition directly, allowing, for example, quick comparison of
the expected and experimentally observed marker ions. Therefore, TOPPView overall is extremely
useful for validation, greatly improving and speeding up the process.
Table 3.3: Cross-links of the ASH1 complexes identified after analysis on the Orbitrap Velos.
Cross-links of She2p
position peptide aa RNA figure FL short
M1–K3 GPLGSMSK - [U –H2O] B.3 - +
- [AU –H2O] - - +
GPLGSM*SK - [U –H2O] - + -
*oxidized - [AU –H2O] - + +
Y27–K37 YLSSYIH*VLNK - [AAU –HPO3] 3.16 - +
*oxidized
F64–K82 FYNDCVLSYNASE- - [U] - - +
FINEGK C68 [U +152] B.4 - +
C68 [AU +152] - + +
C68 [AAU +152 –HPO3] - - +
C68 [AAU +152] - - +
F64–K94 FYNDCVLSYNASEFINE- C68 [U +152] - - +
GKNELDPEADSFDK C68 [AU +152] - - +
C106–K123 CVETFDLLNYYLTQSLQK C106 [U +152] B.5 - +
C106 [AU +152] - + +
I164–K179 IGSNLLDLEVVQFAIK F176 [U –H3PO4] - + -
F176 [U –H2O] 3.18b + +
F176 [U] 3.15 + +
- [GU] - + +
L223–K240 LSALDEEFDVVATKWHDK W237 [U +152] 3.17 - +
- [AU +152] - - +
Cross-links of She3p
position peptide aa RNA figure FL short
M130–K138 M*DQLSKLAK K135 [U –H2O] B.6 + -
*oxidized
N139–K150 NSSAIEQSCSEK C147 [U +152] B.9 + -
C147 [AU +152] - + -
C147 [AAU +152 –HPO3] - + -
G283–K291 GAVVQTLKK K290 [U –H2O] B.7 + -
T383–R405 TNVTHNNDPSTSPTISV- - [GU] B.8 - +
PPGVTR - [AAU –HPO3] - - +
G334–K340 GPLGSMGNSSNNK - [U] B.3 - +
- [GU] - - +
For results obtained with the Q-ToF Ultima and column labels see 3.2.
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3.2.6 Summary and functional implications of obtained cross-linking results
This section will discuss the results obtained in cross-linking of model complexes for ASH1 mRNA
transport in a biological context. A broader view on technique and method development will be
taken in Chapter 4.
Neither She2p nor She3p show homology to known RNA binding domains. Therefore, identification
of peptides or even amino acids contributes considerably to the knowledge about RNA-interacting
regions for both proteins.
When comparing cross-linking results of ASH1-FL and ASH1-short, there are several differences.
It must be noted that only positive identifications are indicated in Table 3.3. The absence of an
identification does not necessarily imply that a particular cross-link was not formed during UV
irradiation. Due to the low abundance of cross-links in general, the corresponding precursors are
not always chosen for fragmentation during data acquisition or the MS/MS fragment spectra are
not of sufficient quality for confident identification. Therefore, data analysis distinguished between
identified and detected cross-links. The term detected indicates here that the measurement (but
not the corresponding control) contained a species with the same mass-to-charge ratio and retention
time as a cross-link identified in another MS data set of the same or similar protein–RNA complex.
In the case of She2p, all cross-linked peptides were detected in both ASH1-FL and ASH1-short.
This hints that She2p–RNA interactions in both complexes are highly similar. In contrast, all
She3p cross-links were exclusively found in one of the complexes. This could indicate that She3p–
RNA interactions are slightly different in ASH1-FL and ASH1-short. Due to the high specificity of
UV induced cross-linking, even minor changes in the three-dimensional structure could prevent or
enable the formation of cross-links. Therefore, regions or residues identified as cross-linked in one
complex could still participate in protein–RNA interactions in the other. It could be speculated
that none of the She3p peptides found cross-linked are responsible for RNA-binding specificity.
The first publication including our findings about direct interactions as derived from UV induced
protein–RNA cross-linking with mass spectrometric analysis was based on early experiments with
the ASH1-short complex and analysis on the Q-ToF Ultima [96]. The much more detailed results
from the improved Orbitrap Velos/OpenMS setup were not available at that point, but are the basis
for ongoing studies by our collaborators. Therefore, the comparison to functional data is focused
on this and other published studies.
The cross-linked She2p peptide IGSNLLDLEVVQFAIK is part of a helix that is essential for inter-
actions of She2p with She3p and ASH1 -E3, as deletion mutants failed to bind She3p or to form the
ternary complex with RNA. In contrast, deletion of the She2p C-terminus weakens but not prevents
synergistic RNA binding, confirming the observation of the very C-terminus cross-linking to RNA.
Both mutants do not show localization in vivo [96]. Mutation of She2p residue C68, identified as
cross-linked in our study, to tyrosine prevents dimerization and efficient RNA binding [109]. This
confirms the direct interactions of C68 with RNA implied by the cross-linking results. Comparison
of the cross-linking results to the structure of the She2p dimer [109] indicates that the cross-linked
residues C68 and W237 as well as F176 of the respective other monomeric subunit lie adjacent to
the proposed RNA binding surface (data not shown).
The 20 N-terminal amino acids of the She3p-short construct (positions 334–353 of the construct
comprising positions 334–425 of wild type She3p) were found to be essential for formation of the
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ternary She3p-short, She2p and ASH1 -E3 complex [96]. While other residues in this stretch, espe-
cially S348, were found to be important for ASH1 mRNA localization in vivo [110], the identified
direct interactions of residues S337, N338, or N339 with ASH1 mRNA might add to synergistic
binding.
Overall, the significant increase in the number of identified cross-links after measurement on the
Orbitrap Velos and data analysis with OpenMS illustrates that both improvements are crucial in
the advancement of the investigation of UV induced cross-linking by mass spectrometry.
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3.3 Application of the automated data analysis workflow to the
spliceosomal protein Cwc2 in complex with RNA
Cwc2 is a yeast splicing factor and related to the nineteen complex (NTC) that joins the spliceosome
during its activation. In isolated, catalytically active spliceosomes, it cross-links to U6 snRNA [111].
Our collaborators (Macromolecular Crystallography Group, MPI for Biophysical Chemistry) had
solved the crystal structure of the functional core of Cwc2. Comparison to conserved sequence
motifs and physical properties suggested cooperative RNA-binding by several domains (see below
and [97]).
We performed UV cross-linking and mass spectrometry to assess which domains of Cwc2 are involved
in direct interactions with RNA. Analysis on the Orbitrap Velos together with cross-link identifica-
tion after precursor variant generation with OpenMS allowed for comparatively fast evaluation of
several different experiments performed (see below). Therefore, cross-linking of Cwc2 presents an
excellent example for application of the improved mass spectrometry/data analysis workflow.
3.3.1 Cross-linking of Cwc2 to U6 snRNA
UV induced cross-linking of the in vitro reconstituted, binary Cwc2–U6 snRNA complex and analysis
of cross-linking products by mass spectrometry was performed to identify regions of Cwc2 that
directly interact with RNA. To this end, reconstituted complexes were UV irradiated at 254 nm for
10 minutes and enriched according to the standard protocol (see 2.2.8.5). LC-ESI-MS/MS analysis
was carried out with the Orbitrap Velos and data analysis was performed with our newly established
workflow based on OpenMS.
Overall, six regions of the functional core of Cwc2 were found cross-linked (see Table 3.4). Close
inspection of the corresponding spectra enabled identification of the cross-linked amino acid residue
in all cases. Representative spectra for each of the cross-linked region are shown in the Appendix
(Figures B.10 to B.15).
Cross-linked residues in both RNP1 and RNP2 are in excellent agreement with conserved aromatic
residues at these positions that are involved in stacking interactions with RNA [1]. Cross-linked
residue Y138 represents the conserved aromatic residue in RNP2. The first aromatic residue of
RNP1 is replaced by C181 in Cwc2; however, C181 was found cross-linked, suggesting that the
cysteine still participates in important protein–RNA interactions. The second aromatic residue in
the RNP1 consensus sequence corresponds to F183 in Cwc2. Although F183 was not identified as a
cross-linked residue, it is contained in the cross-linked peptide NCGFVK (N180–K185). It cannot
be completely excluded that some of the identified cross-links might stem from F183 instead of C181
as the latter was not unambiguously identified as the cross-linked amino acid in all cross-links of
NCGFVK listed in Table 3.4.
The third cross-linked residue within the RNA recognition motif (RRM) of Cwc2 is K152. Residue
C87, also identified as cross-linked, is one of the three cysteines coordinating to zinc in the CCCH
zinc finger domain, confirming direct RNA interaction in Cwc2 by this canonical RNA-binding
domain.
The connector element (residues 116–133) links the C-terminal part of the Torus domain to the
N-terminus of the RRM. It contains several conserved residues, three aromatic and three positively
90 3 Results
(a) Surface representation. (b) Cartoon representation.
Figure 3.20: Structure of Cwc2. (a) shows the protein surface while (b) shows secondary structure
elements. Domains are colored as indicated in (b): RRM light green, RNP2 dark
green, RNP1 green, zinc finger (ZnF) orange, connector element yellow, and Torus
light gray. Cross-linked residues are highlighted in red and shown as sticks in (b).
(a) All cross-linked residues lie on the surface of Cwc2. The insert shows a represen-
tation of the zinc finger, rotated around 90◦, with C87 slightly buried but nonetheless
solvent-exposed.
(b) Representation of cross-linked residues within secondary structure elements. Side
chains of Y120, Y138, K152 and C181 are exposed and might easily bind RNA. In
contrast, the side chain of F47 is buried. C87 coordinates to zinc (gray sphere).
charged, suggesting a potential RNA-binding property. One of the conserved aromatic residues in
Cwc2, F120, was found cross-linked; therefore, the connector element presents an additional RNA-
binding element of Cwc2. The sixth cross-linked residue, F47, lies within the Torus domain of
Cwc2.
The cross-linked residues all lie on the same side of Cwc2 (see Figure 3.20) and are distributed over
a large, positively charged [97] surface. Residue Y120 in the connector element as well as residues
K152, Y138 and C181 (latter two RNP2 and RNP1, respectively) of the RRM are solvent-exposed
and can therefore easily form interactions to RNA. The side chain of F47, which is part of the Torus
domain, faces away from the protein surface. Since it lies within a loop region, it might flip out
upon RNA binding. Zinc-coordinating residue C87 might bind a nucleotide together with Y89 (not
shown, see [97]).
Our collaborators performed mutation studies on residues identified as directly interacting with
RNA in our cross-linking experiments and tested RNA-binding by electrophoretic mobility shift
assays (EMSAs). Single point mutations did not significantly change RNA-binding affinity. Double
mutants Y138A/Y120A and Y138A/C181A exhibited a significant decrease in RNA affinity, while
RNA-binding was not considerably affected in Y138A/F47A, Y138A/K152A, and Y120A/F47A.
These findings provide evidence for the importance of RNP2 and RNP1 as well as the connector
element for RNA-binding of Cwc2 to U6 snRNA in vitro, while K152 (RRM) and F47 (Torus) did
not appear to be crucial for RNA-binding [97]. Mutation of C87 is not tolerated due to its important
structural role [112].
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Table 3.4: Cross-links of Cwc2 to U6 snRNA
domain position peptide aa RNA spectrum
Torus W37–K61 WSQGFAGNTR- F47 [UU] -
FVSPFALQPQLHSGK [AUU] -
F47–K61 FVSPFALQPQLHSGK F47 [U –H2O] B.10
[U] -
[UU] -
zinc G79–K101 GM(Ox)CCLGPK- C87 [U +152 –H2O] -
finger CEYLHHIPDEEDIGK





ce F117–R131 FADYREDMGGIGSFR Y120 [U] B.12
[AU] -











RRM H150–R159 HLKPAQIESR K152 [U –H2O] B.14
[AU –H2O] -











domain: domain/motif according to [97] (ce: connector element)
position: amino acid position of the cross-linked peptide in the protein sequence
peptide: amino acid sequence of the cross-linked peptide
aa: one-letter code and position of the cross-linked amino acid
RNA: composition of the cross-linked RNA (oligo)-nucleotide with modifications
spectrum: reference to figure showing representative spectrum
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3.3.2 Cross-linking of Cwc2 to U4 snRNA and U6 internal stem loop
In vitro, Cwc2 binds several spliceosomal snRNAs [112]. Therefore, additional experiments were
performed, comparing cross-linking of Cwc2 to U6 snRNA with cross-linking to U4 snRNA. Exper-
iments were performed as described above for U6 snRNA. Irradiation time was usually 10minutes,
and each binary complex was additionally analyzed after UV irradiation for two minutes at 254 nm.
Cross-links identified in the binary Cwc2–U6 snRNA complex (see 3.4) were evaluated in all subse-
quent experiments on two levels: First, it was examined whether the same cross-link was identified
in the new experiment after data analysis with OpenMS. If a previously observed cross-link was
not identified, it was next tested whether a species with the same precursor mass and retention
time was detected. To this end, extracted ion chromatograms were calculated in both the UV ir-
radiated sample and non-irradiated control. The following assumption was made: Detection of a
species with the same precursor mass, charge state, and retention time indicated presence of the
cross-link. Observation in the UV irradiated sample but not in the corresponding control supported
the assumption. Generation of a different species by UV irradiation that had the same mass and
retention time was considered extremely unlikely, especially in the simple binary system. The in-
tensity of the cross-link was believed, however, insufficient to trigger MS/MS fragmentation in the
new experiment. Without fragment information, the cross-link could not be validated completely.
Previously identified cross-links were therefore denoted as either identified, detected, or not detected
in each new experiment. This approach allows for a rough comparison of cross-linking behavior of
one protein to different RNAs.
After cross-linking of Cwc2 to either U6 or U4 snRNA, the number of identified cross-links was
comparable for Y138 (RNP2) and C181 (RNP1) (see Table 3.5 and Supplementary Table 2 in [97]).
In contrast, cross-links of K152 (RRM) and Y120 (connector element) were observed less frequently
with U4 snRNA. Differences in cross-link detection of C87 (zinc finger) and F47 (Torus domain)
were more pronounced. This observation might indicate a preference of the zinc finger and the
Torus domain to bind U6 snRNA, while the RRM could bind RNA with less selectivity.
Comparing the cross-linking results for each complex irradiated for 2 or 10minutes did not reveal
any major differences. As expected, the overall number of identified and detected cross-links was
lower after the shortened time due to decreased cross-linking yield. It was anticipated that cross-
links observed with low abundance after 10minutes irradiation could fall below the detection limit
of the instrument after decreasing the irradiation period. However, for U6 at least one cross-link for
each region was identified, except for the cross-link in the RRM (K152), where it was only detected
but not fragmented. After cross-linking of Cwc2–U4 snRNA for 2minutes, only cross-links in RNP2
(Y138) and RNP1 (C181) were identified, but cross-links of the four other regions were detected.
Overall, the number of identified or detected cross-links decreased to a comparable extent in both
Cwc2–U6 and Cwc2–U4 when irradiation time was shortened.
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Table 3.5: Cross-links of Cwc2 to U6 snRNA, U4 snRNA and U6 internal stem loop
cross-linked RNA U6 U4 ISL
irradiation time (min) 10 2 10 2 10
domain peptide aa RNA
Torus WSQGFAGNTR- F47 [UU] + - - - -
FVSPFALQPQLHSGK [AUU] + - - - -
FVSPFALQPQLHSGK F47 [U –H2O] + + (+) (+) -
[U] + (+) (+) - -
[UU] + (+) (+) - -
zinc GM(Ox)CCLGPK- C87 [U +152 –H2O] + - - - (+)
finger CEYLHHIPDEEDIGK
CEYLHHIPDEEDIGK C87 [U] + (+) (+) (+) -
[U +152] + + + (+) -
[AU +152] + + (+) - (+)
[AAU +152] + - - - -
[GU +152] + (+) (+) (+) -
ce FADYREDMGGIGSFR Y120 [U] + + + (+) (+)
[AU] + (+) (+) (+) (+)
RNP2 TLYVGGIDGALNSK Y138 [U] + + + + +
[AU] + + + + +
[AAU] + + + + (+)
[AUU] + (+) - (+) -
[GU] + + + + +
[GGU] + (+) - - -
[AGU] + (+) (+) (+) +
[UU] + + + + +
[CU] + + - + +
[ACU] + (+) (+) (+) -
[CGU] + (+) (+) (+) -
RRM HLKPAQIESR K152 [U –H2O] + (+) (+) (+) +
[AU –H2O] + - - - -
RNP1 NCGFVK C181 [U] + + + + +
[U +152] + + + + (+)
[AU] + + + + +
[AU +152] + + + + +
[AAU +152] + + + (+) -
[AUU +152] + + (+) (+) -
[GU] + (+) + (+) -
[GU +152] + + + + (+)
[AGU +152] + + (+) (+) (+)
[UU] + (+) (+) + -
[UU +152] + + + + (+)
cross-linked RNA: RNA utilized in the experiment; U6 snRNA, U4 snRNA,
or U6 internal stem loop (ISL)
irradiation time (min): period for which the Cwc2–RNA complex was UV irradiated
+: identified; (+): detected; -: not detected
additional column legends, peptide positions, reference to representative spectra in 3.4
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Cross-links identified after mass spectrometric analysis typically reveal only single nucleotides or
short sequences of the RNA that do not allow for identification of the cross-linking site on the RNA.
Additional cross-linking experiments were performed with a short RNA oligonucleotide resembling
the internal stem loop (ISL) of U6. The aim was to investigate which regions of Cwc2 interact
with U6 snRNA stretches within or outside of the internal stem loop. Interestingly, the results were
similar to those obtained for U4 snRNA: While no substantial differences were observed for RNP2,
RNP1, and the RRM, cross-links to the connector element were only detected and not identified,
indicating lower abundance. This effect was even more pronounced for the zinc finger, while no
cross-links at all were observed for the Torus domain.
Overall, comparative cross-linking of Cwc2 to U6 and U4 snRNA as well as U6 ISL indicated that
Cwc2 might bind U6 snRNA at the internal stem loop with low sequence specificity while the
other RNA binding domains (zinc finger, connector element, and Torus domain) could contribute
to the specificity of binding. As the approach can only be the basis for a rough comparison and
other factors might influence specificity in the complex environment of the spliceosome, further
biochemical experiments should be performed to confirm these observations.
Cross-linking of Cwc2 presented an excellent example of the applicability and advantages of the
novel workflow of mass spectrometric analysis on the Orbitrap Velos and data evaluation based on
OpenMS. Cross-link identification was significantly more straightforward and the novel workflow
provided the tool necessary to quickly assess whether previously observed cross-links were also
identified in a larger number of similar experiments. Data evaluation without any external tools or
based on the perl script would have required considerably more time. Since many cross-links were
of low abundance, it is very likely that they would not have been detectable on the Q-ToF Ultima
instrument.
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3.4 Application of the automated data analysis workflow to
complex systems
After our data analysis approach proved excellent feasibility for simple, in vitro reconstituted bi-
nary and ternary complexes, we wanted to prove its applicability to more extended systems. Since
cross-links from these restricted systems could also be identified in searches against the respective
proteome (E. coli or S. cerevisiae), we expected the same for more complex systems. In order to
verify this assumption, an appropriate protocol for isolation and cross-linking of more extended
protein–RNA complexes and suitable preparation for mass spectrometric analysis had to be devel-
oped.
3.4.1 Isolation of protein–RNA complexes by TAP tag purification
In searching for an appropriate test system for our data analysis workflow, we decided on the
organisms S. cerevisiae. It has a proteome of medium complexity (6 607 predicted proteins in
the Saccharomyces Genome Database, www.yeastgenome.org, according to [113]). In addition, the
yeast proteome does not contain nearly as many phosphorylation sites as the human proteome (3 620
phosphorylation sites identified in yeast compared to 24 262 in human according to PHOSIDA [114]).
Enrichment strategies based on the properties of the RNA phosphate backbone, such as titanium
dioxide enrichment, always co-enrich phosphopeptides. These increase sample complexity, which
might be disadvantageous for MS analysis.
Next, a protocol for isolation of protein–RNA complexes from yeast extracts had to be chosen. The
strategy finally applied was based on the fact that most eukaryotic mRNAs carry a cap structure
that is bound by the cap-binding complex comprising proteins Cbp20 and Cbp80.
One method frequently applied for the purification of a certain protein with its interaction partners
from yeast is inclusion of a tandem affinity purification (TAP) tag on the C- or N-terminus of the
investigated protein. The TAP tag contains two IgG binding domains of protein A (ProtA) from
Staphylococcus aureus and a calmoduline binding peptide (CBP) separated by a cleavage site for
TEV protease. Due to the strong interactions between protein A and IgG, under native conditions
the tagged protein can only be released by TEV protease. In the second affinity purification step,
the complexes are trapped on calmoduline-coated beads in the presence of calcium and released by
incubation with the chelating agent EGTA [93]. We set out to isolate protein–RNA complexes by
TAP tag purification from a yeast strain containing a TAP tag on the cap binding protein Cbp20.
The commercially available strain with a regular TAP tag was obtained by EUROSCARF. However,
in our hands, small-scale experiments failed to elute the complexes from IgG beads by TEV protease
(data not shown). Therefore, an alternative approach had to be found. Dr. Kum-Loong Boon
(Department of Cellular Biochemistry) suggested the introduction of a TAP tag with a PreScission
instead of a TEV cleavage site into a wild type yeast strain. He also provided protocols and
helpful advice for transformation and optimized TAP tag purification. After integration of the TAP
tag cassette with a PreScission cleavage site by homologous recombination, the modified TAP tag
purification protocol was successfully applied.
Figure 3.21 shows a Coomassie stained protein gel of the different purification steps. The decrease
of protein amount in the sample during isolation of protein–RNA complexes is illustrated in Figure
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(a) Protein gel. (b) Western blot.
Figure 3.21: Protein gel and Western blot of different steps of TAP tag purification. Samples were
split in half for two SDS-PAGE gels, one was stained with Coomassie (left image)
and one was used for Western blotting with an anti-Calmoduline binding peptide
antibody (right image). Volumes of samples for each gel relative to overall volume:
Input (yeast cell extract, lane 1) and supernatant after incubation with IgG beads
(lane 2) 0.04%; wash IgG beads (lane 3) 1% of first ml; eluate IgG after incubation
with PreScission (lane 4) and supernatant after incubation with Calmoduline beads
(lane 5) 0.67%; wash Calmoduline beads (lane 6) 2% of first ml; eluate Calmoduline
(lane 7) 3%.
3.21a. The Western blot in Figure 3.21b shows that this decrease is not solely due to isolation of
the mRNA-binding proteins from all proteins in the cell extract. The isolation comes at the cost
of significant sample lost, illustrated by the decreased band intensities in bands 1, 4, and 7. The
fraction of the overall sample volume that was used for the different lanes was increased from 0.04%
(lane 1) to 0.67% (lane 4) and 3% (lane 7); thus, the effect is greater than it appears on the gel. One
of the main reasons for this is that binding to both IgG and Calmoduline beads was not complete,
the supernatant of both purification steps still had significant amounts of the tagged protein (see
lanes 2 and 5). The same is true for the washing step after binding to IgG (lane 3). The band
shift from lanes 1-3 to lanes 4, 5, and 7 is due to the cleavage of the ProtA part of the TAP tag by
PreScission protease.
3.4.2 Optimization of extract preparation, complex isolation, cross-linking, sample
preparation, and LC-ESI-MS/MS
In order to maximize the number of cross-links that could be identified in our experiments, sev-
eral variations and protocols were evaluated and will be described below. In contrast to in vitro
reconstituted complexes, irradiation time was shortened to two minutes in order to prevent RNA
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damage. Since the isolation is based on the purification of capped mRNA, extensive RNA damage
would decrease the amount of isolated complexes.
For initial experiments, protein–RNA complexes were isolated by TAP tag purification; ethanol
precipitated; and hydrolyzed with RNases A and T1, benzonase, and finally trypsin. Samples
were desalted and enriched according to the standard protocol, except that one sample was split
on two C18 columns to prevent overloading. Samples were measured under standard conditions
and analyzed with the RNPxl tool. For each experiment, a corresponding control was prepared in
parallel, treated exactly as the sample except for UV irradiation.
For the decision on the optimal conditions, equal numbers of high confidence cross-links were eval-
uated. Therefore, the numbers mentioned below do not represent the final number of cross-links
contained in the measurement.
3.4.2.1 UV cross-linking
First, the optimal point for UV irradiation within the experimental workflow was evaluated. To this
end, cross-linking was carried out (1) on cell extract, (2) after the first step of TAP tag purification,
i.e. on the IgG eluate, and (3) after the second purification step, i.e. on the Calmoduline eluate.
The yeast extract was prepared in AGK buffer, which contains 10% glycerine. Glycerine is a radical
scavenger and diminishes or prevents cross-linking. Therefore, cross-linking on cell extract was
performed after dialysis against AGK buffer without glycerin. All three samples were purified in
parallel by the complete TAP tag purification protocol and irradiated at the steps of the purification
protocol indicated above. Cross-links were identified in all three samples. However, the highest
number of cross-linked peptides was identified for the sample irradiated after IgG elution (10 cross-
links versus 3 and 2 in extract and Calmoduline eluate, respectively). Therefore, in all following
experiments UV irradiation was performed at this point.
3.4.2.2 Preparation of yeast extract
Initial results showed a high number of cross-links from ribosomal proteins. Therefore, an additional
ultracentrifugation step was carried out in preparation of cell extract to separate polysomes by
sedimentation. However, cross-links of ribosomal proteins were still predominant and the additional
centrifugation was omitted from further experiments to prevent the considerable sample loss of this
step.
3.4.2.3 Sample preparation for LC-ESI-MS/MS analysis
One of the most crucial steps in the investigation of UV cross-linking experiments with mass spec-
trometry is the enrichment of cross-linked peptide–RNA oligonucleotide heteroconjugates prior to
MS analysis. In comparison to small, in vitro reconstituted complexes, the excess of noncross-linked
proteins and, consequently, peptides in this protein–RNA complex purification protocol is larger.
The irradiation time was decreased from ten to two minutes to avoid irradiation damage. This also
decreases the cross-linking yield. In addition, the isolation workflow does not discriminate between
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primary and secondary interactions, i.e., proteins not directly interacting with RNA but with an-
other RNA-binding protein are also isolated. Therefore, we set out to compare strategies for the
enrichment of cross-linked peptide–oligonucleotide heteroconjugates.
In initial experiments carried out to evaluate extract preparation and cross-linking conditions, our
standard protocol for cross-link enrichment with C18 and TiO2 chromatography proved successful.
However, a substantial number of noncross-linked peptides was identified even after enrichment.
Therefore, we wanted to evaluate another protocol frequently employed in large-scale purification of
cross-linked heteroconjugates: the isolation by size exclusion (SE) chromatography. After purifica-
tion of protein–RNA complexes, proteins are hydrolyzed under denaturing conditions. Intact RNA,
a fraction of which has been cross-linked to peptides, is isolated from noncross-linked peptides by
size exclusion chromatography. Fractions absorbing at 254 nm (RNA) and 280 nm (peptides) are
collected, the RNA is hydrolyzed, and cross-linked heteroconjugates are further purified (see 1.3.2).
For comparison of the standard protocol with C18 and TiO2 enrichment and a SE protocol, two
samples were processed in parallel. After the first step of TAP tag isolation with IgG beads, the
samples were UV irradiated. One sample was further processed by binding to Calmoduline beads,
hyrolization, and the standard protocol with C18 and TiO2 chromatography. For the second sample,
further isolation with Calmoduline beads was omitted from the protocol to prevent the associated
sample loss. Complexes were ethanol precipitated and redissolved in the presence of 1% SDS. For
proteolysis with trypsin, the sample was diluted to a final concentration of 0.1% SDS. Afterwards,
the sample was directly injected onto the size exclusion column. A typical elution profile can be
found in Figure 3.22. Importantly, no significant differences were observed between the control and
UV irradiated samples. None were expected, as only a small part of RNA should be cross-linked.
High absorbance at 280 nm for early fractions of the control could indicate incomplete complex
disassembly and/or hydrolysis.
Fractions of the first chromatographic peak, typically fractions 3 to 6 of several runs, were pooled
and ethanol precipitated. Further sample preparation was analogous to the standard protocol, i.e.,
hydrolysis of RNA and proteins/peptides in the presence of urea and desalting with C18 columns
(two columns per sample). As the majority of peptides was removed during size exclusion chro-
matography, titanium dioxide enrichment was omitted from the sample preparation workflow. Com-
parison between the standard workflow (C18, TiO2) and the size exclusion plus C18 preparation
revealed that a higher number of cross-links could be identified after the SE protocol (26 versus 12
cross-links).
We next investigated whether the combination of both sample preparation strategies, i.e. SE, C18,
and TiO2, would be even more beneficial. The sample was prepared as described above, with an
additional titanium dioxide enrichment following the standard protocol after C18 desalting and prior
to LC-MS/MS analysis with a 120min gradient (see below). As expected, the number of noncross-
linked peptides identified decreased dramatically for the combination SE/C18/TiO2. However, this
did not result in an increased number of identified cross-links, but in a greater number of sequencing
events (MS/MS spectra) per cross-link. In both experiments, 93 cross-links were identified. After
SE and C18, the overall number of MS/MS sequencing events combined for these 93 cross-links
was 241. Two cross-links of the 40S ribosomal protein S5 peptide TIAETLAEELINAAK were
identified in 23 and 18 spectra, respectively. All other cross-links had 9 or fewer MS/MS sequencing
events. In the SE/C18/TiO2 workflow, the 93 cross-links were identified in a total of 600 fragment
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Figure 3.22: Size exclusion chromatogram and gel of corresponding fractions. The upper part
shows two size exclusion chromatograms with the absorption at both 254 nm (red,
RNA) and 280 nm (blue, peptides). Left is the absorption profile of a non-irradiated
control, right the chromatogram of a UV irradiated sample. In the lower part, a
protein gel of the most important fractions is shown. Fraction numbers are annotated
at the bottom of the chromatograms and above the gel lanes. Neither chromatograms
nor gel lanes show significant differences between the control and UV samples.
spectra. A single cross-link of 60S ribosomal protein L16-B peptide AEALNISGEFFR was identified
in 107 spectra, and four cross-links had between 20 and 40 sequencing events each. Since a high
number of MS/MS spectra for the same cross-link does not increase confidence and the overall
number of identified cross-links remained the same, titanium dioxide enrichment was not performed
in subsequent experiments.
One interesting observation in comparing both workflows was the frequent identification of cross-
links that had lost water after the SE/C18 sample preparation. This might be due to formation
of cyclic phosphate on the RNA 3’ end and is apparently reversible, since the SE/C18/TiO2 sam-
ple preparation did not display the same effect. The basic elution conditions of titanium dioxide
enrichment might lead to hydrolization of the 3’ phosphates.
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3.4.2.4 Gradient for LC-ESI-MS/MS analysis
In the last experiments for optimization of sample preparation, we also compared the length of
the LC gradient in LC-MS/MS analysis. A longer gradient increases peak separation and enables
the mass spectrometer to collect fragment information for more precursors. On the other hand,
elution profiles are broadened and, consequently, peak intensities drop. Lower intensities decrease
the signal intensities in the mass spectra, and precursors as well as their fragments might fall below
the detection limit. In order to evaluate which effect would outweigh the other, the same sample was
measured with 60- and 120-minute gradients. The number of identified cross-links was significantly
higher for the 120-minute gradient, rising from 32 to 93. Therefore, longer LC gradients should be
performed for complex cross-linking samples.
3.4.2.5 MS instrumentation
All experiments described above were analyzed on a LTQ Orbitrap Velos. Another orbitrap in-
strument, an Orbitrap Exactive, became available for LC-MS/MS analysis towards the end of the
project and was also evaluated. In contrast to the Velos, the Exactive does not contain a linear ion
trap and only allows fragmentation with HCD. The scan speed is significantly faster compared to
the Velos, potentially leading to sequencing of more low abundant precursors. For a comparison of
both instruments, a sample was prepared with the optimized protocol and split for measurements
on both instruments. The Exactive did indeed acquire a significantly higher number of fragment
spectra compared to the Velos (18 914 vs. 11 883). We observed a substantially higher number of
low-quality spectra that did not allow any identification in the Exactive measurement. In a rough
evaluation, the Velos measurement yielded the identification of only 25 cross-links, while the Ex-
active measurement resulted in 35 cross-link IDs. Therefore, the Q Exactive mass spectrometer
should be more closely evaluated and might replace the LTQ Velos as the instrument of choice for
cross-linking experiments in the future.
3.4.3 Data analysis and integration of additional filters
All experiments described above were analyzed with the RNPxl tool. Overall, 18 experiments
(see Table 3.6, each with corresponding controls) were carried out for optimization and with the
optimized protocol. During evaluation of the different variations of the protocol, we began to collect
a library of identified cross-links that was continuously expanded. The majority of cross-links were
identified in detailed analysis of measurements with the optimized protocol.
3.4.3.1 Validation of cross-link candidates: Extracted ion chromatogram and independent
database search
The output of RNPxl contained a long list of peptides and potential cross-links. Particularly low
quality spectra often lead to false positive search results, i.e. random matches, after precursor
variant generation. Therefore, careful validation of cross-link candidates is essential. While sev-
eral validation criteria have been mentioned in previous sections, the validation process was again
optimized for complex samples as described here. The significantly higher number of identified
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Table 3.6: Overview on experiments in yeast
experiment UZ XL IgG CB SE C18 TiO2 MS gradient
1 - extract + + - + + Velos 60 min
2 - extract + + - + + Velos 60 min
3 - CB eluate + + - + + Velos 60 min
4 - CB eluate + + - + + Velos 60 min
5 - IgG eluate + + - + + Velos 60 min
6 - IgG eluate + + - + + Velos 60 min
7 - IgG eluate + + - + + Velos 60 min
8 - IgG eluate + + - + + Velos 120 min
9 + IgG eluate + + - + + Velos 60 min
10 + IgG eluate + + - + + Velos 120 min
11 + IgG eluate + - + + - Velos 60 min
12 + IgG eluate + - + + - Velos 120 min
13 - IgG eluate + - + + - Velos 60 min
14 - IgG eluate + - + + - Velos 120 min
15 - IgG eluate + - + + - Velos 120 min
16 - IgG eluate + - + + + Velos 120 min
17 - IgG eluate + - + + - Exactive 100 min
18 - IgG eluate + - + + + Exactive 100 min
UZ: ultracentrifugation; CB: Calmoduline beads
cross-links compared to previous experiments, together with a considerable increase of experience
in evaluation of cross-link spectra, allowed to derive more general rules for validation as well as
an extended summary of observed RNA signals and RNA adducts (see below). Finally, validation
criteria were integrated in automated filtering tools (see below).
High-scoring cross-links were initially validated by comparison of the extracted ion chromatograms
(XICs) in irradiated sample and the corresponding control (see 3.2.5.1). Typically, the control did
not contain any precursor with the same mass and a comparable retention time, while the sample
XIC showed a clear signal (as exemplified in Figure 3.18a). If the cross-link candidate was only
observed in the irradiated sample, it could be concluded that it had to be a species formed as a
consequence of UV irradiation. Otherwise, the cross-link candidate was discarded as a false positive.
In addition, a search against the entire NCBI database was performed with Mascot as search
engine. Cross-link candidates should not yield any significant, true positive hit in this search,
otherwise they would be false positives. This way, contaminant peptides with sequences included
in the NCBI database used for the Mascot search but not in the UniProt yeast database used for
cross-link identification could be identified. If a sample was contaminated in contrast to the control,
this validation step would exclude them, although they were exclusively observed in the irradiated
sample.
Additionally, post-translational modifications (PTMs), especially phosphorylation, could be con-
sidered in the Mascot search. In principle, PTMs could also be included in the precursor variant
searches for cross-link identification. However, additional PTMs greatly increase analysis time and
number of false positive results. In the case of phosphorylation, ambiguity is introduced, as loss of
HPO3 is usually considered as a modification of RNA in the generation of precursor mass variants.
When including phosphorylation as a PTM for cross-linked peptides, we frequently observed that
102 3 Results
phosphorylated peptides were reported as cross-linked to an RNA oligonucleotide without terminal
phosphate. Manual evaluation revealed that the assignment of the phosphorylation on the peptide
was wrong; the cross-link was manually assigned as the same peptide without phosphorylation cross-
linked to an RNA with terminal phosphate. In principle, the database search considers both options,
i.e. cross-link of unmodified peptide and oligonucleotide, and phosphorylated peptide cross-linked to
RNA without terminal phosphate. Since the unmodified peptide can be clearly identified manually
by the peptide sequence ions and the absence of any sequence ion shifted by the mass of HPO3,
the database search engine should also yield a higher score for the unmodified peptide. It remains
elusive why this was not the case. In order to limit data analysis time, number of false positives,
and ambiguity, the number of PTMs considered was minimized. Only oxidation of methionines and
carbamylation of primary amines, i.e. lysine residues and peptide N-termini, were considered.
3.4.3.2 Validation of cross-link candidates: Mass spectra
After the cross-link candidate was confirmed by manual validation of XICs and comparison to
an independent database search, the corresponding mass spectra were evaluated in detail. Correct
assignment of monoisotopic mass and charge state of the precursor were confirmed on the basis of the
MS spectrum preceding the MS/MS fragment spectrum under investigation. In addition, isotopic
pattern and co-eluting precursors in the selection window were assessed. In case of ambiguities, the
candidate was discarded or an alternative spectrum of the same candidate was chosen for further
analysis.
The last important step in validating a cross-link candidate was the evaluation of the MS/MS frag-
ment spectrum. The search results from the RNPxl tool were annotated onto the raw MS data in
TOPPView. Each cross-link candidate was evaluated individually. MS/MS signals corresponding
to peptide fragments were automatically annotated. Next, the presence of RNA signals was inves-
tigated (observed signals with corresponding m/z values are given in Table B.1). Cross-links to a
single U nucleotide usually do not show RNA marker ions. In contrast, the vast majority of cross-
link spectra with oligonucleotides is dominated by RNA marker ions corresponding to the nucleic
acid bases A, G, and/or C. The only exception are cross-links to poly(U) oligonucleotides due to
the low proton affinity of uracil. Peaks remaining unassigned were further investigated if they were
of high intensity and/or showed the pattern of an amino acid sequence. Peaks in the lower m/z
range are often internal peptide fragments or adducts of immonium ions and RNA (see Table B.3).
Peaks in the higher m/z range often correspond to RNA adducts of peptide fragments; observed
mass shifts are listed in Table B.2.
After manual annotation of unassigned fragments, the final judgment on the peptide candidate was
made according to the following criteria: (1) All high intensity ions, especially in the mass range
m/z >400, should be explained by the cross-link. (2) The a2/b2 ion pair and frequently observed
immonium ions should be present unless the corresponding amino acids were cross-linked. (3) The
C-terminus of the peptide should be covered by corresponding y-ions. Cross-link candidates fulfilling
all criteria described above were considered as true positive, manually validated hits. Candidates
violating any of the rules were disregarded as false positives.
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3.4.3.3 Integration of exclusion criteria into automated filtering tools
The RNPxl tool proved highly useful in data analysis of cross-linking experiments. However, manual
validation by comparison of extracted ion chromatograms and independent database searches was
still necessary and presented a time-consuming task. Therefore, we set out to implement these
two important criteria into the data analysis workflow that are used to exclude spectra of noncross-
linked species. More precisely, we wanted to remove these fragment spectra early in the data analysis
workflow, rather than discarding them as noncross-linked species retrospectively when following the
established procedure. The main benefit would be decreased effort for manual filtering of these false
positives. Additionally, processing time would be decreased, as noncross-linked species do not need
to be considered in the precursor variant searches.
Fragment spectra of noncross-linked peptides are identified as such by the RNPxl tool if their se-
quences and modifications are considered in the corresponding search. However, their identification
in a standard database search is more straightforward, and generation of precursor mass variants
for noncross-linked peptides represents an unnecessary processing step. In addition, the number of
protein sequences and post-translational modifications should be limited in the precursor variant
searches in order to minimize false positive results. To identify noncross-linked peptides, including
those with less frequent PTMs (e.g. phosphorylation, see above) or peptides from contaminating
proteins (e.g. keratins), we included an additional filtering step. A standard database search was
performed on the MS data obtained after the cross-linking experiment with OMSSA in the OpenMS
environment. The database contained the protein sequences anticipated for cross-linked peptides,
i.e. here the S. cerevisiae proteome, and contaminant sequences, e.g. keratins and enzymes. We used
the contaminant sequences distributed with MaxQuant [103]. In order to determine false positive
rates with the target-decoy strategy, a target-decoy version of the database was created. Phospho-
rylation of serine, threonine, and tyrosine; oxidation of methionine; and carbamylation of lysines
and peptide N-termini were considered. All peptide identifications below a false discovery rate of
1% were considered as valid IDs and the corresponding spectra were filtered from the MS data file.
The dedicated OpenMS pipeline for this purpose is described in more technical detail in 2.2.10.6.
The second important validation criterion is the comparison of cross-link candidate XICs in the
UV irradiated sample to XICs of the same precursors in the control sample (see 3.2.5.1). All
species showing comparable intensities in both measurements are not connected to UV irradiation
and can be excluded from further analysis. As no existing OpenMS tool allows such assessment,
our collaborators scripted a new tool called RNPxlXICfilter. This tool calculates extracted ion
chromatograms in both measurements (control and UV) for all precursors fragmented in the UV
irradiated sample. Precursor intensities are summed up in a narrow retention time window. If the
same precursor appears in both measurements with comparable intensity, i.e. difference smaller
than a factor of 2, the corresponding fragment spectrum is not written in the output file. A more
technical and detailed description of the XIC filter pipeline can be found in 2.2.10.6.
Figure 3.23 illustrates the benefit of both ID and XIC filtering. Typically, the ID filter identifies
between 20 and 40% of all spectra as peptides with high confidence (FDR <1%). Obvious outliers
are experiments 16 and 18. In these experiments, isolation of cross-linked heteroconjugates was
achieved with size exclusion, C18, and titanium dioxide chromatography. Therefore, the low number
of confident identifications by the ID filter is in excellent agreement with our previous observation
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Figure 3.23: Effect on spectra numbers after filtering with ID and XIC filter across experiments.
The fraction of spectra excluded from further analysis after application of the respec-
tive filter(s) are shown for each of the 18 experiments. Experiments are numbered
according to Table 3.6. The total number of spectra in each measurement is given
after the experiment number. The ID filter typically removed between 20 and 40%
of spectra, the XIC filter between 50 and 80%. Combination of both filters typically
excludes over 60% of all fragment spectra from further analysis.
that the combination of all three isolation methods dramatically decreases the number of noncross-
linked peptides after enrichment (see 3.4.2.3).
The XIC filter removes a higher fraction of spectra than the ID filter, between 50 and 80% in most
measurements. The XIC filter excludes all spectra of species appearing in both the UV irradiated
sample and negative control. This can be spectra of noncross-linked peptides, RNA oligonucleotides,
or other contaminants. The latter two are not considered in the ID filter. As it does not rely on
identifications, the XIC filter can remove peptides indiscriminant of sequence, PTMs, protease
specificity, and quality of fragment spectra. Thus, the XIC filter excludes more spectra than the ID
filter.
Figure 3.24: Effect on spectra numbers after filtering with ID and XIC filter in a single experiment.
A total number of 9728 MS/MS spectra were acquired for experiment 14. Two thirds
were filtered by XIC, ID, and fractional mass filter. 17% did not yield a potential
cross-link identification in database search after precursor variant generation. 13%
were identified as potentially cross-linked, but with a very low score (E -value above
0.01). The remaining 318 spectra (3%) had a good score (E -value below 0.01) and
were further evaluated manually.
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Figure 3.25: Schematic workflow for automated filtering of cross-linking data. The original MS
data is subjected to a standard database search (ID filter). MS/MS spectra that give
rise to confident peptide identifications with a low false discovery rate are removed
from the data set. Next, extracted ion chromatograms of precursors with remain-
ing MS/MS spectra are calculated in both the control and UV irradiated samples.
MS/MS spectra of species appearing in both samples at comparable intensities are fil-
tered from the MS data set. The reduced data can then be submitted for subsequent
analysis with RNPxl.
The benefit of the applied filters is further illustrated in Figure 3.24. Out of the total number of
9728 MS/MS spectra acquired during MS analysis of experiment 14, only 318 were considered for
manual validation. The vast majority of spectra were excluded as peptides, oligonucleotides, or
contaminants by the ID and XIC filter; or did not yield a potential cross-link hit with a reasonable
score in the database search after precursor variant generation.
The most efficient strategy is the combination of both filters as outlined in Figure 3.25. We first
apply the ID filter because we can retrieve the peptide sequences corresponding to the filtered
spectra. The XIC filter is applied second; this order can be chosen freely. As visible in Figure 3.23,
the combination of both filtering strategies excluded over 60% of all spectra in experiments 1 to
15. On average, the combination of both removed 12% more spectra than the XIC filter alone.
Outliers are experiments 16 and 18, which used SE, C18, and TiO2 enrichment, and experiments
17 and 18, which were analyzed with the Q Exactive mass spectrometer. Due to the low number of
peptide identifications in experiments 16 and 18, the combination of both filters naturally does not
significantly exceed the results of the XIC filter alone. We currently have no explanation why the
XIC filter excluded considerably fewer spectra in the Exactive measurements (experiments 17 and
18), this observation needs to be explored further.
3.4.4 Cross-links identified after TAP tag purification and isolation of cross-linked
heteroconjugates
Overall, we have identified 184 cross-links after TAP tag purification of protein–RNA complexes
from yeast. They are listed in detail with corresponding calculated and experimental masses in
Tables A.5, A.6, A.7, and A.8. In this context, cross-links refers to unique combinations of peptide
and RNA oligonucleotide, thus counting cross-links of several oligonucleotides to the same peptide,
as well as peptides with and without missed cleavage sites covering the same protein region.
The 184 cross-links identified correspond to 64 unique RNA-binding protein regions, i.e. disregarding
cross-links of several oligonucleotides to the same peptide and misscleaved peptides covering the
same region as a peptide without missed cleavage site. These 64 protein regions were mapped to
49 proteins. In 37 of the 64 unique protein regions, the cross-linked amino acid residue could be
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identified. Cysteines were by far the most cross-linked residues with 22 identifications, followed
by phenylalanine with four, histidine and tyrosine with three, tryptophane with two, and finally
threonine, lysine, and isoleucine with one cross-link each.
The applied experimental workflow does not allow for the identification of the cross-linked RNA.
For a confident identification of the cross-linked peptide, the RNA has to be hydrolyzed to single
nucleotides or short oligonucleotides (see 1.3.2). These short sequences are not sufficient to identify
the cross-linked RNA. In addition, protein–RNA complex isolation by TAP tag purification of
capped mRNA bound by Cbp20 was performed under native conditions. Therefore, not only proteins
(or RNA) cross-linked or directly interacting with capped mRNA were purified. Ribonucleoprotein
complexes interacting with mRNA were also isolated. Cross-links within those complexes are also
enriched and can be identified in the mass spectrometric analysis. For example, the high number
of cross-linked ribosomal proteins suggests that large amounts of ribosomes were isolated with this
experimental workflow. Cross-links within the ribosome, e.g. to ribosomal RNA, were thus also
identified (see below).
Finally, the cross-linked proteins were sorted according to their annotated functions. If not noted
otherwise, protein information has been derived from the UniProt database [115] and the Saccha-
romyces Genome Database (Stanford University, www.yeastgenome.org). The majority of cross-
links were found for ribosomal proteins, specifically 11 proteins from the small ribosomal subunit
and 23 proteins from the large ribosomal subunit. In addition, the ribosome-related ribosome bio-
genesis protein RLP7 was identified as cross-linked to RNA. Six proteins were found that have
annotated polynucleotide-binding function to either RNA or DNA. Eight proteins were identified
as cross-linked to RNA that did not have any polynucleotide-binding function annotated in the
UniProt database. Cross-links of the three functional groups will be examined in more detail below
while a general discussion of the technique can be found in chapter 4.
3.4.4.1 Cross-links of ribosomal proteins
Protein–RNA complex isolation by TAP tag purification with a tagged version of the cap-binding
protein Cbp20 was carried out under native conditions. Consequently, all macromolecules with pri-
mary or secondary interactions with capped RNA were isolated with the applied protocol. Isolation
of ribosomes, e.g. in the process of translating a capped mRNA, was therefore expected. The high
number of identified cross-links of ribosomal proteins was, at least in part, a consequence of their
high abundance within the cell. Since the applied protocol might have isolated intact ribosomes,
observed cross-links could have resulted from interactions with messenger RNA (mRNA), ribosomal
RNA (rRNA), or even transfer RNA (tRNA, see above).
A high resolution structure of the S. cerevisiae ribosome is available [116], and cross-linking results
could be compared with structural data. Sebastian Klinge (laboratory of Prof. Nenad Ban, ETH
Zurich) provided helpful advice about visualization of the ribosomal structure within PyMOL.
Due to the large number of cross-links in the ribosome (see Table 3.7), only four representative
examples are described below and shown in the structure of the ribosome. Cross-links of riboso-
mal proteins were roughly sorted into three categories after comparison with the three-dimensional
structure: Most cross-linked amino acid residues are in close proximity to nucleotides of the ribo-
somal RNA in the available structure. Several cross-linked residues are in flexible regions on the
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Table 3.7: Cross-linked ribosomal proteins
proteins of the 40S subunit proteins of the 60S subunit
protein cross-linked residue protein cross-linked residue
S1-A/-B W117 L1-A/-B C80
S3 C134 L2-A/-B Y133
S5 T189 L3 C251
S11-A/-B C128 L4-A/-B C94, H243, I290
S14-A/-B - L5 -
S16-A/-B H74 L6-A W9
S17-A/-B C35, H56 L6-B W9
S24-A/-B K117 L8-A -
S29-A C24 L8-B -
S29-B C24 L16-A/-B Y149














*guanine nucleotide-binding protein subunit beta-like protein
**ubiquitin 60S ribosomal protein L40
surface of the ribosome. In the crystal structure, no nucleotides are in close proximity to these amino
acids. Therefore, it is not clear whether the cross-link was to flexible rRNA regions not resolved in
the structure, or to mRNA or tRNA. The smallest group of cross-links lies in proximity to RNA,
but distances between amino acid residues and nucleotides appear to be too large for cross-link
formation.
Examples for cross-links within the ribosome are shown in Figure 3.26. Peptide KWQTLIEAN-
VTVK (K116–K128) of ribosomal protein S1 was found to cross-link via W117 (see Figure B.16).
In the three-dimensional structure, W117 was found in a loop of S1 and close to nucleotide U1799
of 18S rRNA (see Figure 3.26a). The spatial arrangement of W117 and U1799 suggests that both
participate in stacking interactions. In addition, one cross-link of the peptide was to RNA with the
composition [AU –HPO3]. This is in excellent agreement with A1800 being the 3’ end of 18S rRNA
and not containing a 3’ phosphate.
Another protein from the small ribosomal subunit, S29, was found to cross-link via C24 (see spectra
in Figures B.28 and B.29). Comparison to the crystal structure indicates that C24 coordinates to
zinc and is in close spatial proximity to nucleotide U1434 of 18S rRNA (see Figure 3.26b). Formation
of a covalent bond between C24 and U1434 as a consequence of UV irradiation would be possible,




Figure 3.26: Representative examples for cross-links in the ribosome. Ribosomal proteins are
shown in gray, cross-linked peptides in orange, and cross-linked amino acid residues
in red. Ribosomal RNA is shown in light blue, highlighted nucleotides in dark blue.
Zinc ions are depicted as gray spheres.
(a) W117 of ribosomal protein S1 stacks with U1799 of 18S rRNA.
(b) Zinc-coordinating residue C24 of ribosomal protein S29 is in close spatial prox-
imity to U1434 of 18S rRNA.
(c) Ribosomal protein L35 residue C53 is in proximity to 5.8S rRNA, e.g. nucleotides
U60 and U64.
(d) Residue C140 of the protein Rack1 lies within a flexible region of the ribosome,
the crystal structure does not show any RNA in spatial proximity.
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In contrast to the previous examples, cross-linked residue C53 of ribosomal protein L35 (see spectrum
shown in Figure B.58) lies within an α-helix, and the three dimensional structure does not show
any uridines in close spatial proximity (see Figure 3.26c). The 5.8S rRNA lies adjacent to the
cross-linked peptide and contains two uridines (U60 and U64) in this stretch, one of which might be
the cross-linked nucleotide. However, formation of a covalent bond upon UV irradiation probably
requires smaller distances between the nucleotide and the amino acid residue. One possibility would
be that the structure of the active ribosome in solution might rearrange in this area to bring C53
closer to the RNA.
Rack1 (guanine nucleotide-binding protein subunit beta-like protein) peptide GQCLATLLGHND-
WVSQVR (G138–R155) was found cross-linked via C140 (spectrum shown in Figure B.30). The
protein lies at the head of the small ribosomal subunit and close to the mRNA exit channel. In the
structure, no RNA is found in proximity to residue C140 (see Figure 3.26d). No final conclusion
can be drawn whether the protein cross-links to flexible regions of the rRNA that are not resolved
in the crystal structure, or to mRNA in actively translating ribosomes.
3.4.4.2 Cross-links of RNA-/DNA-binding proteins
Overall, six proteins were identified as cross-linked that had annotated functions as RNA- (or
DNA-) binding proteins. These proteins are listed in Table 3.8. Unfortunately, no structural data
is available which would allow comparison of the cross-linking data with protein–RNA contacts on
a molecular level.
Table 3.8: Cross-linked RNA-/DNA-binding proteins
recommended name gene synonym motif
1 cruciform DNA-recognizing protein 1 CRP1 Crp1p
2 elongation factor 1-alpha TEF1/TEF2 eEF1A
3 nucleolar protein 3 NPL3 Nop3 RRM
4 nucleolar protein 13 NOP13 Nop13 RRM
5 polyadenylate-binding protein PAB1 PABP RRM
6 single-stranded nucleic acid-binding protein SBP1 Sbp1p RRM
Numbers are indicated at the corresponding paragraphs in the text.
(1) Peptide IPEAGGLLCGKPPR (I105–R118) was found to be cross-linked to RNA via residue
C113 (spectrum see B.64). This peptide is found in a protein termed cruciform DNA-recognizing
protein 1 because it was isolated with DNA templates resembling cruciform DNA [117]. There are
no reports about additional functional roles of this protein. Crp1p is cleaved into an approximately
160 amino acid long N-terminal, DNA-binding subpeptide; residues 120 to 141 are necessary for
DNA binding. Neither the DNA-binding region nor the protein show significant homology to other
cruciform DNA-binding domains or proteins [117]. The identification of Crp1p as an RNA-binding
protein indicated an additional function of the protein, more specifically, to the region directly
upstream of the DNA-binding region.
(2) A protein related to ribosomal translation that was found cross-linked to RNA was elongation
factor 1-alpha. eEF1A is a component of the eukaryotic elongation factor 1 complex and delivers
aminoacyl-tRNA to the A-site of the ribosome. Peptide FVPSKPMCVEAFSEYPPLGR (F402–
R421; spectrum see B.65) was found to directly interact via C409. In the primary as well as the
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tertiary structure (data not shown), the cross-linked region is on the opposite side to the GTP
binding residues (14–21, 91–95, 153–156). The cross-linked RNA cannot be identified from the
mass spectrometry data (see above), but one possibility is that eEF1A cross-linked to tRNA and
was purified while bound to ribosomes translating capped mRNA.
The other four proteins with annotated RNA-binding function that were found cross-linked all
contain RNA recognition motifs (RRMs). Interestingly, in all cases, the cross-linked peptides were
within these RRMs:
(3) Two regions of nucleolar protein 3 were found cross-linked. The first, peptide ILNGFAFVE-
FEEAESAAK (I156–K173, spectrum shown in B.66), lies within the first RRM of the protein
(positions 125–195). The second cross-linked peptide, ENSLETTFSSVNTR (E222–R235, spectrum
see B.67), is part of the second RRM (positions 200–275). Nop3 has various functions, including
nuclear export of poly(A) mRNA and in splicing.
(4) Nucleolar protein 13 cross-links via peptide ILFVGNLSFDVTDDLLR (I240–R256), more pre-
cisely via F242 (see spectrum in B.68). The peptide is at the N-terminus of the second RRM domain
of the protein (positions 239–317). The protein is found in preribosomal complexes.
(5) Polyadenylate-binding protein peptide YQGVNLFVK (Y319–K327) was found to cross-link via
F325 (spectrum shown in B.69). The cross-linked residue lies within the fourth RRM of the protein
(positions 322–399). Interactions between PABP and polyadenylated RNA are important for mRNA
export into the cytoplasm, mRNA stability, and translation.
(6) Peptide SKDTLYINNVPFK (S184–K196) of single-stranded nucleic acid-binding protein was
found cross-linked (see spectrum in B.70). This region lies at the N-terminus of the second RRM
of Sbp1p (positions 186–274). The protein plays a role in translational repression and decapping.
3.4.4.3 Cross-links of proteins without annotated polynucleotide binding function
The third group of proteins found cross-linked to RNA contains proteins without annotated RNA (or
DNA) binding properties. Interestingly, this group contains exclusively metabolic enzymes (sum-
marized in Table 3.9). Three of those enzymes, adenosylhomocysteinase, alcohol dehydrogenase,
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) contain a Rossmann fold domain. Since
this domain has been proposed to have RNA-binding properties (discussed in 4.1.5), the structure
and function of these three proteins will be described in more detail.
(1) Adenosylhomocysteinase (Sah1p) peptide ECINIKPQVDR (position E320–R330) was found to
cross-link via C321 (spectrum shown in Figure B.71). Sah1p hydrolyzes S-adenosyl-homocystein
(AdoHcy) into homocystein and adenosine. AdoHcy is a competitive inhibitor of S-adenosyl-L-
methionine-dependent methyl transferase reactions. As the latter are important for formation of
the cap structure on viral mRNAs, Sah1p inhibition leads to antiviral activity. A structure of the
human homolog S-adenosylhomocystein hydrolase is available and shown in Figure 3.27. Yeast and
human protein share 70% sequence identity, and the cross-linked peptide is almost identical to the
human sequence EKVNIKPQVDR (E320–R330). The only exception is the cross-linked C321, the
human protein has a lysine residue at this position. The peptide lies within the NAD binding
Rossmann fold domain but does not contact the cofactor directly (see Figure 3.27b) [118].
(2) A cross-linked peptide of the sequence YSGVCHTDLHAWHGDWPLPVK was identified (see
Figure B.72). This sequence can be found in two highly homologous alcohol dehydrogenases (around
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Table 3.9: Cross-linked proteins without annotated RNA-binding function
recommended name gene synonym protein feature
1 adenosylhomocysteinase SAH1 Sah1p Rossmann fold
2 alcohol dehydrogenase 1/3 ADH1/ADH3 ADH1/ADH3 Rossmann fold
3 glyceraldehyde-3-phosphate TDH2/TDH3 GAPDH 2/ Rossmann fold
dehydrogenase 2/3 GAPDH 3
4 enolase 1/2 ENO1/ENO2 Eno1p/Eno2p
5 inorganic pyrophosphatase IPP1 IPP1
6 peroxiredoxin TSA1 TSA1 Tsa1p
7 phosphoglycerate kinase PGK1 PGK
8 pyruvate kinase 1 CDC19 PK
Numbers are indicated at the corresponding paragraphs in the text.
(a) Overview of the tetrameric structure. (b) Zoom on the cross-linked peptide.
Figure 3.27: Structure of human S-adenosylhomocysteine hydrolyase in complex with nicotin-
amide-adenine-dinucleotide (NAD, light green) and the inhibitor fluoroneplanocin
A (dark green). In the tetrameric structure, each subunit binds one molecule NAD
and inhibitor.
pdb 3NJ4 [118]
80% amino acid identity), namely, alcohol dehydrogenases 1 and 3 (Adh1p: Y40–K60, Adh3p: Y67–
K86). Alcohol dehydrogenases catalyze the oxidation of an alcohol to its corresponding aldehyde
or ketone by NADH. In yeast fermentation, they additionally catalyze the reverse reaction, e.g. the
reduction of acetaldehyde to ethanol. Adh1p is the main ADH expressed and active during anaerobic
fermentation; Adh3p is a mitochondrial protein. A crystal structure for Adh1p is available (B.V.
Plapp, B.R. Savarimuthu, S. Ramswamy; PDB ID 2HCY; no related publication). In the tetramer
(see Figure 3.28a), each subunit binds two zinc ions although only one is catalytically active. The
cross-linked cysteine residue C44 (Adh3p: C71) lies in a catalytic pocket and coordinates zinc
together with H67 and C154 (see Figure 3.28b). All these residues are conserved between Adh1p
and Adh3p [119]. The cross-linked peptide does not lie within the C-terminal Rossmann fold.
(3) Another pair of highly homologous metabolic enzymes, glyceraldehyde-3-phosphate dehydroge-
nases (GAPDH) 2 or 3, are identified by the common peptide ETTYDEIKK (E250–K258) cross-
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(a) Overview of the homotetrameric structure. (b) Zoom on one catalytic pocket.
Figure 3.28: Structure of yeast alcohol dehydrogenase 1 in complex with nicotinamide-8-iodo-
adenine-dinucleotide (light green) and trifluoroethanol (dark green). The cross-linked
peptide is shown in orange, and the cross-linked cysteine residue in red. Additional
Zn-coordinating residues are in dark blue, with residues involved in NAD-binding in
light blue.
(pdb 2HCY, B.V. Plapp, B.R. Savarimuthu, S. Ramaswamy, no related publication.)
linked to [AU –HPO3] (spectrum in Figure B.74). GAPDH is involved in the sixth reaction of glyco-
lysis, namely, the oxidation and phosphorylation of glyceraldehyde-3-phosphate to 1,3-bisphospho-
glycerate by NAD+ and orthophosphate. It was shown that the 43 N-terminal amino acids of the
human protein are sufficient to preserve RNA-binding activity of the respective GST fusion protein,
but do not preserve the protein’s preference to AU-rich elements [120]. A structure is available for
GAPDH 3 (I. Garcia-Saez, F. Kozielski, D. Job, C. Boscheron; PDB ID 3PMY; no related publica-
tion). The structure shows a homodimer, with each subunit containing a NAD binding Rossmann
fold (see Figure 3.29a); however only tetramers are catalytically active. The cross-linked peptide
can be found on the surface of the protein, with the peptide N-terminus in a loop region containing
amino acids E250, T251, and T252 (see Figure 3.29b). It is proximal to the Rossmann fold of the
respective other subunit. The N-terminal protein region homologous to the human protein fragment
sufficient for RNA-binding is highlighted in yellow in Figure 3.29a. The cross-link identified could
point to the protein region responsible for RNA binding selectivity.
In addition to GAPDH, three other glycolytic enzymes were found to cross-link to RNA, namely
enolase, phosphoglycerate kinase, and pyruvate kinase. While these proteins are best known for
their role in glycolysis, several other functions and interactions have been described (reviewed in
[121]).
(4) Both yeast enolases Eno1p and Eno2p are highly homologous (96% sequence identity). There-
fore, the peptide IGLDCASSEFFK (I244–K255) found cross-linked to [U +152 –H2O] via C248
(see spectrum in Figure B.73) could be of either or both enolases. Enolase partakes in the ninth
step of the glycolytic pathway, catalyzing the dehydration of 2-phosphoglycerate (2PG) to phos-
phoenolpyruvate (PEP).
3.4 Application of the automated data analysis workflow to complex systems 113
(a) Overview of the dimeric structure. (b) Zoom on the cross-linked peptide.
Figure 3.29: Structure of yeast glyceraldehyde-3-phosphate dehydrogenases (GAPDH) 3 in com-
plex with meso-erythritol (dark green), sodium and NAD (light green). The 41
N-terminal amino acids connected with RNA-binding are shown in yellow. The cross-
linked peptide is shown in orange.
(pdb 3PYM, I. Garcia-Saez, F. Kozielski, D. Job, C. Boscheron, no related publica-
tion.)
(5) Yeast inorganic pyrophosphatase is a cytoplasmic protein and hydrolyzes phosphoanhydride. Its
peptide NCFPHHGYIHNYGAFPQTWEDPNVSHPETK (N83–K112) was found cross-linked via
residue C84 (see spectrum in B.75).
(6) Peroxiredoxin TSA1 is a cytoplasmic protein and belongs to a family of thiol-specific peroxidases.
Interestingly, C171, the cross-linked residue in the peptide NGTVLPCNWTPGAATIKPTVEDSK
(N165–K188; spectrum shown in B.76), is the resolving cysteine in the catalytic reaction. After
the peroxidatic cysteine (C47 in TSA1) is oxidized, it reacts with the resolving cysteine to form a
disulfide bond which, in turn, is reduced by thioredoxin to complete the catalytic cycle [122].
(7) Phosphoglycerate kinase (PGK) catalyzes the seventh reaction of glycolysis, transferring a phos-
phate group from 1,3-bisphosphoglycerate (1,3-BPG) to ADP, yielding 3-phosphoglycerate (3PG)
and ATP. PGK peptide YVLEHHPR (Y49–R56) was found cross-linked to RNA; the cross-linked
amino acid residue could not be determined (spectrum shown in Figure B.77).
(8) Pyruvate kinase (PK) catalyzes the tenth and final step of glycolysis, conversion of phospho-
enolpyruvate (PEP) to pyruvate, thereby transferring phosphate from PEP to ADP to yield ATP.
Two regions of pyruvate kinase were identified to interact with RNA: Peptide NCTPKPTSTTET-
VAASAVAAVFEQK (N370–K394) was found cross-linked via C371 and peptide YRPNCPIILVTR
(Y414–R425) via C418 (see spectra in Figures B.78 and B.79).
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3.4.5 Summary
This study is the first report of UV induced protein–RNA cross-linking with identification of in-
teraction sites on a peptide or amino acid level in a complex system. In contrast to the in vitro
reconstituted particles described in the previous sections, sample complexity presented the major
challenges for both experimental and data analysis procedures. We have successfully developed
an experimental workflow for isolation and enrichment of cross-linked peptide–RNA oligonucleotide
heteroconjugates after TAP tag purification of protein–RNA complexes. Key steps of the procedure,
i.e. extract preparation, cross-linking, protein–RNA complex isolation, enrichment of cross-linked
heteroconjugates and mass spectrometric analysis, were optimized. Most importantly, the data
analysis approach based on precursor variant generation proved to be feasible in the identification
of cross-links in searches against the entire yeast proteome.
The extent of the collected data on cross-links is unprecedented. Never before has such a high
number of proteins been shown to directly interact with RNA on a peptide or even amino acid
level from a single set of very similar experiments. In addition, the data has considerably increased
the knowledge about the induced dissociation of cross-linked heteroconjugates in the gas phase.
Validation criteria for cross-link candidates have been refined, and an extended list of RNA adducts
observed after fragmentation has been collected (see Tables B.2 and B.3).
Overall, this feasibility study paves the way for future experiments of UV induced protein–RNA
cross-linking with identification of direct interaction sites on a peptide or amino acid level based on
mass spectrometric analysis as it will be described in the following chapter.
4 Discussion
UV induced protein–RNA cross-linking with mass spectrometric analysis:
advantages, limitations, and future perspectives
The presented work focused on the investigation of protein–RNA interactions by UV cross-linking
and mass spectrometry. The obtained results have been discussed in terms of biological context
and methodological advances in the previous chapter. In this chapter, the different steps of the
experimental methodology and technical aspects will be recapitulated, highlighting prerequisites,
challenges and future directions.
In the past, UV induced cross-linking and the identification of protein regions, peptides or amino
acids directly interacting with RNA by mass spectrometry had been proven to yield valuable in-
sights into contact sites on a molecular level. In contrast to methods based on DNA sequencing that
focus on binding sites on the RNA, the MS based approach has been limited to relatively simple
macromolecules; human U1 and U2 snRNPs were the most extended complexes investigated [78].
The long-term goal, the identification of contact sites after in vivo cross-linking, does require sig-
nificant advancements of the method on many levels. In the presented work, considerable progress
towards this application was achieved. In addition, valuable experience and knowledge was collected
in investigations of different protein–RNA complexes.
The successful identification of protein–RNA interaction sites by mass spectrometry depends on
a large number of factors, concerning the biological system under investigation, the experimental
strategy and technical aspects of the bioanalytical approach. If a cross-link is observed, it clearly
points at a direct protein–RNA interaction due to the high specificity of the UV induced reaction.
The reverse conclusion, i.e. that the absence of cross-links corresponds to the lack of binding, is
incorrect. Not all proteins that bind RNA form cross-links upon UV irradiation. One example is
the protein 15.5K of the human spliceosome. The protein was shown to bind the 5’ stem-loop of U4
snRNA [123], and the structure of 15.5K co-crystallyzed with an oligonucleotide resembling the U4 5’
stem-loop was solved [124]. However, no cross-link between 15.5K and U4 snRNA was observed, since
none of the amino acids interacting with U4 is reactive in UV cross-linking [49]. Similarly, if none of




4.1 Experimental insights and potentials of UV induced
protein–RNA cross-linking
The unprecedented number of protein–RNA cross-links reported in this work allows a more detailed
evaluation of the UV induced reaction. The acquired insights on cross-linking on the molecular level
will be described, as well as questions that will remain to be answered.
4.1.1 Reactivity of nucleotides
There are considerable differences in the reactivities of nucleic acid bases in UV induced cross-
linking. Among all cross-links reported in this work, there is only one example of a cross-link to
an oligonucleotide that does not contain a single uridine, namely peptide SKDTLYINNVPFK of
the single stranded nucleic acid binding protein (positions S184–K196) cross-linked to a [AC] or
[CA] dinucleotide. Cytosine is in general more reactive than adenosine (see 1.3). However, the
MS/MS fragment spectrum (shown in Figure B.70) does not contain any signals that would allow
conclusions about the cross-linked nucleotide.
Since all except one of the over 250 cross-links reported in this work were observed to uridine
or uridine-containing RNA, it is concluded that the difference in reactivity between uridine and
the other nucleotides is substantial. Consequently, it would be unlikely to identify cross-linked
heteroconjugates by mass spectrometry if the protein–RNA interactions are based on contacts of
adenosine, guanosine or cytidine with amino acid residues. If protein–RNA interactions are assumed
to involve regions with little or no uridines, incorporation of photoreactive nucleotides might be
considered, for example 6-thio-guanine or 5-bromo-cytosine.
For in vivo cross-linking approaches, the incorporation of 4-thio-uracil (and 6-thio-guanine; 4SU
and 6SG) also provides considerable advantages: In many cases, the cross-linking yield is increased.
Since 4SU and 6SG have absorption maxima at a longer wavelength (330 and 340 nm compared
to 250–270 nm for unsubstituted nucleotides), irradiation is typically carried out at 365 nm. At
this wavelength, UV damage is significantly reduced. Therefore, UV irradiation periods can be
increased, potentially raising the yield even further.
Very recently, several MS based studies identified RNA binding proteins after in vivo cross-linking.
Cells were grown in the presence of 4SU [14] or 4SU and 6SG [15]. After cross-linking and cell lysis,
proteins covalently linked to polyadenylated RNA were purified under stringent conditions with
oligo(dT). The RBPs were finally identified by mass spectrometry. The study published by the
Hentze laboratory (EMBL Heidelberg) compared cross-linking of unlabeled and 4SU-labeled cells.
The overlap of identified RBPs between both approaches was approximately two thirds [14]. This
implies that the different strategies yield complementary results. A later study identified yeast
RBPs following the same complex isolation workflow but without incorporation of photoreactive
nucleotides [16]. These surveys demonstrate that mass spectrometry can be applied to identify RNA
binding proteins after in vivo cross-linking. The technical differences between identification of entire
RBPs and cross-linking sites on a peptide or amino acid level will be described in more detail below.
After incorporation of 4SU and cDNA sequencing, thymidine to cytidine transitions were frequently
observed [54]. The observations that the sulfur is lost upon cross-linking (see 3.1.3 and Figure 3.8)
provides a possible explanation: A hydrogen bond acceptor site is missing in the reaction product,
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altering base pairing properties. If the cross-linked amino acid residue is covalently attached to
the 4 position on the pyrimidine through an hydrogen bond donor, e.g. the amine of lysine, the
resulting product resembles cytosine.
4.1.2 Reactivity of amino acids
The reactivity of amino acids in UV induced cross-linking also differs. Interestingly, the chemical
functionalities do not seem to be a reliable indicator for cross-linking reactivity. Functional groups
might be assumed to increase reactivity, in consequence aliphatic residues would be expected to
be rather unreactive. In contrast, one of the most prominent cross-links in the human U1 small
ribonucleoprotein particle is L175 of the U1 70K protein (first reported in [65]).
Combining the cross-linking results of the model complex for ASH1 -mRNA transport, the spliceo-
somal protein Cwc2 and the yeast RNA binding proteins, 81 unique protein regions were found
cross-linked. In 50 of these regions, the cross-linked amino acid could be identified, i.e. in more
than 60%. About half of the cross-links (27) were formed via cysteine residues. The other residues
identified as cross-linked were phenylalanine (6x), tyrosine (5x), lysine (4x), histidine (3x), trypto-
phane (3x), threonine (1x), and isoleucine (1x).
The high number of observed cross-links involving cysteine is very interesting. The identity of the
other residues indicates a high reactivity in UV induced cross-linking for all aromatic residues.
Importantly, the majority of cross-links to cysteine residues involved the 152Da mass adduct whose
origin and composition is still unclear (see also 1.3.4). For each cross-link, an experimental value
for this mass adduct can be determined by subtracting the calculated peptide and (oligo)nucleotide
masses from the experimental precursor mass. Based on 38 cross-links identified in yeast, the
average mass of this adduct was calculated to be 151.9938Da. The fractional mass proves that
the species must have a high content of atoms with a mass deficiency, e.g. oxygen or phosphorus
(see 1.3.4). After fragmentation, the adduct was found to shift the mass of peptide fragment ions
together with uracil (e.g. spectrum shown in Figure B.24). This indicates that the species links
the amino acid residue and the nucleic acid base. Despite tremendous efforts, the identity of the
species producing this mass shift could not be determined (F. Richter, C. Endler, K.K., U. Zaman,
H. Urlaub, Bioanalytical Mass Spectrometry group, unpublished).
Without this knowledge, no final conclusions about the reactivity of cysteines and the structural
interpretation of the resulting cross-links can be drawn. The species could correspond to a nucleic
acid base derivative and result from formation of two covalent bonds, i.e. between two bases as well
as a base and a residue. In this case, the cross-link would still be highly specific. Alternatively, the
adduct could originate from incorporation of a small molecule. This would mean that the molecule
could bridge a distance between cysteine and base much greater than one covalent bond. In addition,
the reaction could take place on a slower timescale. Increased distance and lower reaction speed
would decrease specificity.
In some cases, both cross-links with and without the 152Da adduct were observed for the same
cysteine. For example, cross-links of cysteine residues in Cwc2 (C87 and C181) were found both
with and without the additional mass of 152Da (see Table A.4). This suggests that at least some
if not all cross-links with this adduct exhibit the same specificity as regular cross-links. Several
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efforts to clarify the origin and nature of the adduct are presently taken in our laboratory and will
hopefully enable full interpretation of the obtained results in the near future.
It would be desirable to extend the knowledge about relative amino acid reactivity based on a higher
number of cross-links in a variety of biological systems. In addition, the type of interactions between
the nucleic acid base and the amino acid residue might affect cross-link formation and reactivity
(see below).
4.1.3 Influence of the three-dimensional structure
Studies on the reactivity of nucleotides and amino acids as well as the reaction mechanism are based
on simplified systems, e.g. polynucleotides and single amino acids or even bases with small molecules
resembling amino acid residues (e.g. [35] and references therein). In protein–RNA complexes, many
interactions might have an additional influence on both reactivity and mechanism. Systematic
experimental investigation in these complex environments is very challenging. This is mainly due
to the low cross-linking yield and the fact that often samples are only available in limited amounts.
It is generally accepted that UV induced cross-linking is highly specific and occurs between nu-
cleotides and amino acid residues that are involved in direct interactions, i.e. which are in close
spatial proximity. However, nothing is known whether the type of interaction has an influence. For
example, aromatic residues can stack with or in between nucleic acid bases. Alternatively, hydrogen
bonds are formed, e.g. involving amine, carbonyl and alcohol functionalities. It is possible that the
type and strength of interaction influences the mechanism and consequently or independently the
yield of the cross-linking reaction.
In addition, the involvement of a nucleotide or amino acid residue in intramolecular interactions
might influence cross-link formation. For example, nucleotides within double-stranded stem loops
are involved in both hydrogen bonds and stacking interactions with opposite and neighboring bases,
respectively. Consequently, proteins bind to double-stranded DNA or RNA mostly without any
sequence specificity as there is no space for corresponding interactions. Protein secondary structure
might also prevent or hinder cross-link formation, and most cross-linked residues are found within
flexible loop regions [49].
The relation between UV cross-linking and the type of interactions could be investigated in cross-
linking experiments of protein–RNA complexes with available three-dimensional structures, ideally
in various complexes from different origins.
4.1.4 Identification of the cross-linking site on the RNA level
In MS/MS fragment spectra of cross-linked heteroconjugates, longer RNAmoieties lead to increasing
suppression of peptide sequence ions while mostly dominating RNA fragments are observed (see for
example Figure 3.14). Therefore, thorough RNA hydrolysis is part of the sample preparation for
MS analysis. Consequently, cross-linked RNA typically contains one to three nucleotides. In rare
cases, cross-links to four nucleotides can be identified. However, the corresponding spectra typically
show such a low number of peptide fragments that the cross-link can only be validated in simple
systems or by comparison to cross-links of the same peptide to shorter RNA (data not shown).
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In most cases, only the RNA composition but not the order of nucleotides can be derived from
the MS data. Only if the RNA employed in the experiment is short and a single stretch within
corresponds to the oligonucleotide composition determined by MS, the cross-linking site can be
determined unambiguously. The cross-linked nucleotide can be derived if an RNA is labeled with
photoreactive nucleotides site-specifically and UV irradiation is performed at a wavelength that
excludes cross-linking of the native nucleotides. An example for both cases is cross-linking of the
NusB–S10 complex to short, BoxA containing nucleotides. In the first study, the cross-linked RNA
region could be determined in several cases where longer oligonucleotides were identified [71]. In the
experiments described in 3.1, only the stretch of three 4SU nucleotides was excited by irradiation
at 365 nm and could form cross-links.
The cross-linking site on the RNA can usually only be deduced by complementary experiments such
as primer extension. Longer RNA stretches have been sequenced by MALDI-MS after preparative
isolation of peptide–oligonucleotide heteroconjugates and limited alkaline hydrolysis. However, the
available sample amounts are often not sufficient for purification on a preparative scale. The recent
advances in sensitivity and sequencing speed of MS instruments might enable a similar approach
without extensive isolation workflows. For example, full-length RNA with cross-linked peptides
could be separated by size exclusion chromatography as described. The sample could then be split
for complete and limited RNA hydrolysis, e.g. treating one half with both RNases A and T1 and
the other only with RNase T1. Cross-linked peptides could be identified after MS analysis of the
first sample. The second sample could then be checked for cross-links of the same peptide to longer
oligonucleotides, i.e. by adding the masses of nucleotides to the mass of the cross-link identified in
the first sample.
This strategy should first be tested and might be limited to small complexes. The sample complexity
increases with the size and number of proteins and RNAs. It might reach a limit above which
validation of cross-links is impossible. An increasing oligonucleotide length considerably decreases
the number and intensity of observed peptide fragments. If only a small number of low intensity
peptide fragments is observed, the derived information might not be sufficient for unambiguous
identification of the peptide in a complex system. Therefore, combination of a similar approach
with in vivo cross-linking does not seem feasible at this point. In this context, the combination of
DNA sequencing methods and mass spectrometry for the identification of the cross-linking site on
the RNA and protein, respectively, might be pursued.
4.1.5 RNA-binding metabolic enzymes: Rossmann fold domains as RNA-binding
motifs
Several metabolic enzymes have been found cross-linked to RNA by UV induced cross-linking with
mass spectrometry (see 3.4.4.3). This illustrates the advantage of the method as an unbiased
approach capable of identifying novel RNA-binding domains. Here, the example of RNA-binding
metabolic enzymes in general and the Rossmann fold in particular will be shortly described.
RNA-binding properties have been reported for several metabolic enzymes. However, the rela-
tionship between metabolic and RNA-related function is mostly unclear. The multifunctionality
of metabolic enzymes might result from changes in the oligomeric state. For example, GAPDH
functions as a tetramer in glycolysis and as a monomer in transcriptional regulation. Changes in
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post-translational modifications and molecular interactions might also induce different protein func-
tions. In addition, an unexpected localization of several glycolytic enzymes in the nucleus has been
reported and further suggests a role in transcription or DNA replication (see [125] and references
therein).
RNA-binding capabilities have been reported for several NAD+ dependent dehydrogenases with
(di)nucleotide-binding Rossmann fold domains. We found two such dehyrogenases, alcohol dehy-
drogenase (ADH) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), cross-linked to RNA.
RNA-binding in GAPDH is competitive with NAD-binding, and increasing RNA concentration
decrease the enzyme’s activity (see [120] and references therein). The same study also provides ev-
idence for RNA-binding abilities of ADH. Recently, Barbas et al. investigated RNA binding of the
UDP-glucose dehydrogenase (UgdG) from Sphingomonas elodea [126]. They demonstrate that RNA
and NAD+ binding regions do not overlap and that UgdG exhibits ribonuclease activity. However,
this enzyme contains a second, catalytically inactive Rossmann fold, which could be responsible
for RNA-binding. Another Rossmann fold containg enzyme, adenosylhomocysteinase (Sah1p), was
found cross-linked to RNA in our study. Therefore, our results support the suggestion to add Ross-
mann fold containing metabolic enzymes to the list of RNA-binding proteins and the Rossmann
fold to RNA-binding domains [120].
In general, in vivo cross-linking and identification of RNA-binding sites on a peptide or amino acid
level would enable the unbiased identification of RNA-binding domains. This would add valuable
knowledge about protein–RNA interactions, as many RNA-binding proteins do not contain classical
RNA-binding motifs. This adds a valuable application to the approach of UV induced cross-linking
with mass spectrometric analysis.
4.2 Mass spectrometry and data analysis
4.2.1 Instrumentation
The performance of UV induced cross-linking with mass spectrometric analysis has been tightly
connected to improvements on the instrumental side. The low cross-linking yield presents the
major challenge in collecting MS information of a cross-linked sample. Sensitivity, sequencing speed
and resolution/mass accuracy have a great influence on MS analysis of cross-linking experiments:
(1) Instrument sensitivity, especially in MS/MS acquisition, is very important. Failure to detect
cross-links or to record MS/MS spectra of sufficient quality prevents cross-link identification.
(2) Higher sequencing speed of instruments enables the collection of fragment information on more
precursors. Therefore, sequencing of a low abundant cross-link in data-dependent acquisition is
more likely.
(3) The resolution and consequently mass accuracy of the instrument influences cross-link identifi-
cation significantly. For example, the mass accuracy of the precursor (intact cross-link) determines
the search space for peptide identification in the precursor variant approach. Higher mass deviation
leads to evaluation of more candidates which can increase the number of false positive results.
In this work, cross-link identification after analysis on a Q-ToF Ultima or a LTQ Orbitrap Velos
was compared. Due to the rapid technological advances, the Q-ToF Ultima has to be considered an
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outdated instrument although it is only ten years old. Therefore, it was not surprising that it was
outperformed by the Orbitrap Velos. Several vendors offer Q-ToF instruments that can compete
with orbitraps in terms of sensitivity, resolution and sequencing speed. It will be interesting to
compare modern Q-ToF and orbitrap instruments for analysis of cross-linking experiments. The
influence of future instrumental advances on bioanalytics in general and more dedicated applications
as UV induced cross-linking will be interesting to follow.
Further insight into the cross-linked amino acid residues in cases where no RNA-adduct was observed
would be desirable. After a fast data analysis workflow has been established, this might be addressed
in more detail with mass spectrometry. Investigation of fragmentation conditions on observability
of adducts could be approached, e.g. by varying the collision energy. In addition, fragmentation
patterns of the unmodified and the cross-linked peptide could be compared in detail. In some cases,
expected peptide fragments were not observed or of very low intensity if they contained a potentially
cross-linked amino acid. For example, the a2-/b2-ion pair is typically observed at medium to
high intensity after beam-type CID of peptides or cross-linked heteroconjugates. Absence or low
intensity of this ion pair sometimes correlated with an amino acid reactive in cross-linking at the
corresponding positions in the peptide. However, these observations have to be investigated in
more detail and subsequently confirmed biochemically before they could be included as criteria for
identification of the cross-linked amino acid.
Alternative fragmentation techniques such as electron capture dissociation (ECD [127]) and electron
transfer dissociation (ETD [128]) could be evaluated for the identification of cross-linked heterocon-
jugates. Both methods are based on activation of the precursor ion by generation of an odd-electron
species. The predominant fragments are c- and z-ions that result from cleavage of the amino alkyl
(N-Cα) bond. In comparison to CID, ECD and ETD are more likely to leave labile peptide modifica-
tions intact. For example, the loss of phosphoric acid is frequently observed after CID fragmentation
of phosphopeptides and presents a challenge for the identification of the exact phosphorylation site.
In contrast, the phosphate group is mostly retained during ECD and ETD fragmentation. There-
fore, ECD and ETD have been demonstrated to yield valuable information complementary to that
of CID in phosphopeptide analysis (see [129] and references therein).
Both ECD and ETD were demonstrated to increase the peptide fragment information in MS/MS
spectra of a model peptide–oligonucleotide heteroconjugate compared to ion trap CID [73]. However,
the model heteroconjugate used in this study contained five arginine residues on the 14 amino acid
long peptide moiety. In addition, the synthetic (CH2)6 link between peptide and oligonucleotide
connected the carboxyl group of an aspartic acid residue to the 5’ phosphate of the RNA. Neither
properties of the peptide and the linking bond are well comparable to heteroconjugates originating
from UV induced protein–RNA cross-linking experiments. Peptides obtained after hydrolysis with
the endoproteinase trypsin are unlikely to contain five basic residues as trypsin cleaves C-terminal
to lysine and arginine. The cross-linking bond formed as a consequence of UV irradiation connects
the nucleic acid base and not the phosphate backbone to the amino acid residue. Therefore, the
comparison of fragmentation techniques could be repeated with more appropriate model molecules
or heteroconjugates derived from irradiated complexes to obtain more meaningful results.
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4.2.2 Development and feasibility of the precursor variant approach
The novel workflow for automated identification of cross-linked heteroconjugates from mass spec-
trometry data is based on the subtraction of calculated RNA masses from the experimental precursor
mass. Therefore, it was termed precursor variant approach. The basic idea arose during manual as-
signment of fragment spectra in the beginning of this project. Practical realization of the approach
was initially accomplished in close collaboration with Petra Hummel (IT & Eletronics Service, MPI
for Biophysical Chemistry). The approach was proven feasible in cross-linking studies of the NusB–
S10 complex to 4-thio-uracil substituted RNA (Section 3.1) as well as a model complex for ASH1
mRNA transport in budding yeast (Section 3.2).
Further automatization was achieved by integration of the approach into a novel tool in the OpenMS
environment. The necessary bioinformatic knowledge for programming was provided by our col-
laborators, the Applied Bioinformatics Group (Prof. Oliver Kohlbacher, Universität Tübingen).
Reinvestigation of the ASH1 complex (Section 3.2), comparative cross-linking of the spliceosomal
protein Cwc2 to U6 and U4 snRNA (Section 3.3) as well as the identification of a large number
of RNA binding proteins after isolation of protein–RNA complexes by TAP tag purification of the
cap-binding protein Cbp20 (Section 3.4) proved feasibility and improvements of the approach.
This recapitulation of development and application of the precursor variant approach illustrates that
testing and optimization of data analysis workflows was a constant process during most of the pre-
sented project. This included extensive testing of different developmental versions of the algorithms
in application to actual cross-linking data. The collaborators were responsible for programming the
necessary algorithms in the respective environments (perl and C++) and provided helpful sugges-
tions. However, the major concepts from the basic idea to the framework for functionalities and
parameters were solely developed as part of this project.
The precursor variant approach was developed based on the assumption that fragment spectra of
cross-links exhibit great similarity to spectra of noncross-linked peptides. For the majority of cross-
links, the corresponding unmodified peptide is not observed within the same measurement since it
was separated during titanium dioxide enrichment or size exclusion chromatography. Therefore, the
assumption could only be tested systematically by either measuring the sample prior to enrichment
or by fragmenting synthetic peptides. However, comparison between fragmentation of the cross-
linked and the unmodified peptide was possible in a few cases, one example is shown in Figure
4.1. Here, the fragment spectra of the unmodified and cross-linked peptide exhibit only minor
differences.
Shifts of peptide sequence ions by covalently linked RNA (fragments) increase the differences be-
tween spectra. More importantly, the corresponding signals are not recognized by the database
search engine. Therefore, the scores given to these spectra underestimate the agreement between
the cross-linked peptide and the spectrum. Interestingly, the cross-linked peptides are nonetheless
identified with reasonable scores, provided the quality of the spectrum is high.
Frequently observed shifts could be defined as post-translational modifications (PTMs) for a stan-
dard database search. For example, shifts of uridine (fragments) with the 152Da adduct could be
defined as PTMs of cysteines. In Mascot searches, cross-links to [U –H2O] or [4SU –H2S] producing
an extensive shift of 94Da due to the corresponding base remaining on the peptide fragment have
been identified successfully after definition of a corresponding modification. Initial tests have shown
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that shifts can be integrated as PTMs in OMSSA searches and annotated in TOPPView (data not
shown). This approach requires further testing and optimization. Especially the integration into
the data analysis workflow has to be optimized. Parallel searches with various parameters produce
different results, the scores are not necessarily comparable. Therefore, this step has to be integrated
carefully to avoid bias as well as false positive or false negative results.
Figure 4.1: Comparison of MS/MS fragment spectra of the unmodified S24-A/-B peptide DAV-
SVFGFR (D53–R61, upper panel) and the same peptide cross-linked to uridine (lower
panel). Both spectra are strikingly similar. The number of observed peptide fragments
is exactly the same and relative fragment intensities do not show significant differences
except for the phenylalanine immonium ion (drop of 40% to 20% relative intensity in
the fragment spectrum of the cross-link). In the spectrum of the cross-linked peptide,
additional signals corresponding to the RNA fragment [U –H3PO4] as well as the intact
peptide are observed.
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The precursor variant approach is based on subtracting masses of anticipated nucleotide combina-
tions. Consequently, cross-links with mass adducts that were not expected cannot be identified.
For example, cross-links of the cap binding protein Cbp20 to the cap structure could not have been
identified because methylated guanine was not defined as a nucleotide for precursor variant gener-
ation. The observation of this cross-link seemed highly unlikely. First, guanine is rather unreactive
in UV induced cross-linking. Secondly, the three phosphate groups connecting the 5’ position of
the 7-methyl-guanine to the 5’ position of the next nucleotide would considerably hinder ionization
in positive ion mode. However, the structure and consequently mass of 7-methyl-guanine is known
and could have been integrated if desired.
Unexpected variations from the masses of the common cross-links cannot be identified automatically.
These can result from unanticipated modifications of the protein and RNA as well as loss (or gain)
of atoms or molecules during the cross-linking reaction. Novel cross-linking products reported in
this thesis were identified manually, e.g. the cross-linking product of uracil and 4-thio-uracil which
originates from loss of oxygen or sulfur, respectively, from the 4 position of the base (see 3.1.3.2
and 3.2.5.2). However, the additional filters developed to rule out spectra of pure peptides and
spectra of species appearing in the non-irradiated control (see 3.4.3.3) would be extremely useful
for further manual identification of novel modifications or cross-linking products. High quality
spectra remaining after filtering and identification of anticipated cross-links are good candidates
for a manual search. While this strategy has not been applied, it will be considered for future
experiments.
The developed data analysis strategy represents one key development that finally enables unbiased
identification of cross-linked peptides after UV irradiation in vivo.
4.3 Mass spectrometry and in vivo cross-linking
One of the major limitations of UV induced protein–RNA cross-linking in combination with mass
spectrometric analysis is the required sample amounts. For example, immunodetection of cross-
linked proteins exhibits a considerably higher sensitivity. The same applies to cross-linking exper-
iments with radiolabeled RNA. Both methods therefore require lower sample amounts. Methods
based on reverse transcription and sequencing of the resulting DNA have the advantage that the
cross-linking signal is enhanced. Consequently, several protocols have been established for in vivo
cross-linking and the analysis of contact sites on the RNA level by DNA sequencing. These can
be combined with incorporation of photoreactive nucleotides, as it is done in the approach termed
Photoactivatable-Ribonucleoside-Enhanced Cross-Linking (PAR-CLIP) [54].
Nonetheless, several studies published in the past 12 months demonstrate the ability of mass
spectrometry to identify several hundred RNA-binding proteins after UV cross-linking (see also
above, [14–16]). The common experimental approach is based on isolation of proteins cross-linked to
polyadenylated RNA by hybridization with oligo(dT). This procedure permits stringent purification
conditions, i.e. interruption of all non-covalent protein–RNA interactions and selective isolation of
proteins cross-linked to RNA. After hydrolyzation of both RNA and proteins, the latter were iden-
tified by mass spectrometry.
There are several crucial differences between the identification of the cross-linking site on a peptide
or amino acid level and this approach. The cross-linked protein is identified by unmodified peptides.
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Therefore, standard proteomics data analysis algorithms can be utilized, avoiding the challenges in-
volved in identification of peptides covalently linked to RNA. In addition, disadvantages due to less
efficient ionization of cross-linked heteroconjugates are circumvented. On the contrary, fragmenta-
tion of one unique peptide might yield sufficient information for unambiguous identification of the
cross-linked protein. Therefore, a low abundant protein might be detectable by mass spectrome-
try if it comprises a peptide with properties advantageous for ionization and fragmentation, e.g.
containing a few basic residues that are easily protonated and having a length between 10 and 20
amino acids. Consequently, the required sample amounts are expected to be lower compared to the
approach described in this thesis. However, the obtained information is limited to the protein level
and these approaches should be considered as complementary to the method described in this work.
As a follow-up of the presented work, a collaboration was started between the Hentze laboratory
(EMBL Heidelberg) and our group. Dr. Benedikt Beckmann performed in vivo cross-linking of
4SU labeled yeast cells and isolated polyadenylated RNA with cross-linked proteins by oligo(dT).
Enrichment with C18 and titanium dioxide chromatography as well as mass spectrometric and data
analysis were performed in our laboratory. Since the results are very preliminary, they were not
included in this work, but they indicate that it is indeed possible to identify peptides and amino
acids interacting with RNA after cross-linking in vivo. Optimization of this and other in vivo
approaches will be important future projects of the laboratory.
Other members of the Bioanalytical Mass Spectrometry Group have been conducting experiments
with proteome-wide searches for cross-linked peptides enabled by the data analysis approach re-
ported here. Importantly, Saadia Qamar demonstrated that cross-links can be identified in searches
against the human proteome. The UniProt database for the human proteome is roughly ten times
larger than that of S. cerevisiae which was used in the presented work. Dr. Uzma Zaman carried
out experiments with yeast cells grown in the presence of 4SU and proved that the data analysis ap-
proach is also feasible for RNA labeled with photoreactive nucleotides. The data analysis approach,
the cross-links obtained for yeast RNA binding proteins without 4SU labeling which were presented
in this work, and the two surveys mentioned above are currently summarized for publication.
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Appendices
A Masses of identified cross-links
On the following pages, all cross-links identified in the course of this thesis are listed with the
corresponding calculated and experimental mass values. Mass values were calculated with online
tools listed in Section 2.2.10.3. Experimental masses were determined by averaging several MS
survey scans, if possible all spectra exceeding 50% intensity of the extracted ion chromatogram
signal, otherwise around the time point when the MS/MS fragment spectrum was recorded. m/z
values and mass deviation were calculated according to the following equations:
m/z =
m + z ∗m(H)
z
(A.1)
m(H) corresponds to the mass of a hydrogen atom (proton).




The columns of the following tables are described in more detail below. Theoretical masses of
cross-links with the 152Da adduct were calculated assuming the exact mass to be 151.9938Da.
protein protein name
in case of yeast proteins identified after TAP tag purification:
recommended name according to UniProt [115]
UniProt unique UniProt ID (for yeast proteins identified after TAP tag purification)
position position of cross-linked peptide in the protein sequence
peptide amino acid sequence of the cross-linked peptide
aa position of cross-linked amino acid residue
RNA composition of cross-linked RNA
fig reference to figure of annotated MS/MS fragment spectrum
m(peptide) calculated mass of cross-linked peptide
m(RNA) calculated mass of cross-linked RNA
m(XL) calculated mass of cross-link
z charge state in which cross-link was observed
m/z calculated m/z with observed charge state
m/z exp experimentally observed m/z
Δm mass deviation between calculated and experimental cross-link mass
in ppm for all regular cross-links
absolute deviation in Da for cross-links with the 152 Da adduct
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Table A.1: Overview of cross-links of NusB and S10 and the corresponding mass values.
protein position peptide aa RNA fig m(peptide) m(RNA) m(XL) z m/z m/z exp Δm
NusB I87–R95 IALYELSKR K94 258 adduct B.1 1091.6338 - - 2 - 675.8458 258.0422 Da
S96–K112 SDVPYKVAINEAIELAK K101 258 adduct 3.10 1859.0039 - - 2 - 1059.5396 258.0597 Da
K101 [4SU –H2S] - 1859.0039 306.0253 2165.0292 2 1083.5224 1083.5555 30.5 ppm
S113–K129 SFGAEDSHKFVNGVLDK - 258 adduct - 1848.9005 - - 3 - 703.3201 258.0364 Da
F122? [4SU –H2S] 3.6 1848.9005 306.0253 2154.9258 3 719.3164 719.3298 18.6 ppm
- [(4SU)A –H2S] - 1848.9005 635.0778 2483.9783 3 829.0006 829.0264 31.1 ppm
- [(4SU)C –H2S] - 1848.9005 611.0666 2459.9671 3 820.9968 821.0108 17.1 ppm
SFGAEDSHKFVNGVLDK (carbamylated) - [4SU –H2S] - 1891.9063 306.0253 2197.9316 3 733.6517 733.6676 21.7 ppm
- [(4SU)(4SU) –HPO3] 3.5 1891.9063 582.0491 2473.9554 3 825.6596 825.6838 29.3 ppm
- [(4SU)A –H2S] - 1891.9063 635.0778 2526.9841 3 843.3358 843.3553 23.1 ppm
S10 L17–R31 LIDQATAEIVETAKR K30 [4SU –H2S] 3.7 1656.9046 306.0253 1962.9299 3 655.3178 655.3242 9.8 ppm
G38–R44 GPIPLPTR G38 [4SU –H2S] 3.9 849.5072 306.0253 1155.5325 2 578.7741 578.7913 29.7 ppm
L73–R89 LVDIVEPTEKTVDALMR - 258 adduct B.2 1928.0288 - - 3 - 729.6940 258.0298 Da








Table A.2: Overview of cross-links of She2p and She3p identified after measurement on the Q-ToF Ultima and the corresponding mass values.
protein position peptide aa RNA fig m(peptide) m(RNA) m(XL) z m/z m/z exp Δm
She2p I164–K179 IGSNLLDLEVVQFAIK F181 [U] 3.13 1757.9926 324.0359 2082.0285 2 1042.0221 1041.9695 50.5 ppm
IGSNLLDLEVVQFAIK (carbamylated) F181 [U] - 1800.9984 324.0359 2125.0343 2 1063.5250 1063.4763 45.8 ppm
She3p-short G334–K340 GPLGSMGNSSNNK S337–N339 [AAU –HPO3] 3.14b 1261.5720 902.1746 2163.7466 2 1082.8811 1082.8723 8.1 ppm
GPLGSMGNSSNNK (carbamylated) - [U] 3.14a 1304.5778 324.0359 1628.6137 2 815.3147 815.3373 27.7 ppm
GPLGSM(Ox)GNSSNNK - [U] - 1277.5669 324.0359 1601.6028 2 801.8092 801.8643 69.7 ppm
Table A.3: Overview of cross-links of She2p and She3p identified after measurement on the Orbitrap Velos and the corresponding mass values.
protein position peptide aa RNA fig m(peptide) m(RNA) m(XL) z m/z m/z exp Δm
She2p M1–K3 GPLGSMSK - [U –H2O] B.3 775.3898 306.0253 1081.4151 2 541.7154 541.7147 1.3 ppm
- [AU –H2O] - 775.3898 635.0778 1410.4676 2 706.2416 706.2408 1.1 ppm
GPLGSM(Ox)SK - [U –H2O] - 791.3847 306.0253 1097.4100 2 549.7128 549.7119 1.6 ppm
- [AU –H2O] - 791.3847 635.0778 1426.4625 2 714.2391 714.2380 1.5 ppm
Y27–K37 YLSSYIH(Ox)VLNK - [AAU –HPO3] 3.16 1349.6979 902.1746 2251.8725 3 751.6320 751.6308 1.6 ppm
F64–K82 FYNDCVLSYNASEFINEGK - [U] - 2211.9782 324.0359 2536.0141 2 1269.0149 1269.0138 0.87 ppm
C68 [U +152] B.4 2211.9782 476.0297 2688.0079 3 897.0104 897.0116 151.9973 Da
C68 [AU +152] - 2211.9782 805.0822 3017.0604 3 1006.6946 1006.6960 151.9980 Da
C68 [AAU +152 –HPO3] - 2211.9782 1054.1684 3266.1466 3 1089.7233 1089.7249 151.9985 Da
C68 [AAU +152] - 2211.9782 1134.1347 3346.1129 3 1116.3788 1116.3802 151.9981 Da
F64–K94 FYNDCVLSYNASEFINEGKNELDPEADSFDK C68 [U +152] - 3572.5565 476.0297 4048.5862 3 1350.5365 1350.5366 151.9940 Da
C68 [AU +152] - 3572.5565 805.0822 4377.6387 3 1460.2207 1460.2207 151.9938 Da
C106–K123 CVETFDLLNYYLTQSLQK C106 [U +152] B.5 2177.0714 476.0297 2653.1011 3 885.3748 885.3761 151.9976 Da
C106 [AU +152] - 2177.0714 805.0822 2982.1536 3 995.0590 995.0603 151.9977 Da
I164–K179 IGSNLLDLEVVQFAIK F176 [U –H3PO4] - 1757.9926 226.0590 1984.0516 3 662.3583 662.3576 1.8 ppm
F176 [U –H2O] 3.18b 1757.9926 306.0253 2064.0179 3 689.0138 689.0135 0.44 ppm
F176 [U] - 1757.9926 324.0359 2082.0285 3 695.0173 695.0178 0.72 ppm
- [GU] - 1757.9926 669.0833 2427.0759 3 810.0331 810.0328 0.37 ppm
L223–K240 LSALDEEFDVVATKWHDK W237 [U +152] 3.17 2102.0319 476.0297 2578.0616 3 860.3617 860.3622 151.9954 Da
- [AU +152] - 2102.0319 805.0822 2907.1141 4 727.7863 727.7868 151.9957 Da
She3p M130–K138 M(Ox)DQLSKLAK K135 [U –H2O] B.6 1048.5586 306.0253 1354.5839 2 678.2998 678.2979 2.8 ppm
N139–K150 NSSAIEQSCSEK C147 [U +152] B.9 1281.5506 476.0297 1757.5803 2 879.7980 879.7984 151.9947 Da
C147 [AU +152] - 1281.5506 805.0822 2086.6328 2 1044.3242 1044.3260 151.9974 Da
C147 [AAU +152 –HPO3] - 1281.5506 1054.1684 2335.7190 3 779.5808 779.5807 151.9933 Da
G283–K291 GAVVQTLKK K290 [U –H2O] B.7 942.5861 306.0253 1248.6114 2 625.3135 625.3105 4.8 ppm
T383–R405 TNVTHNNDPSTSPTISVPPGVTR - [GU] B.8 2390.1825 669.0833 3059.2658 3 1020.7631 1020.7627 0.39 ppm
- [AAU –HPO3] - 2390.1825 902.1748 3292.3573 3 1098.4602 1098.4598 0.36 ppm
She3p-short G334–K340 GPLGSMGNSSNNK - [U] - 1261.5720 324.0359 1585.6079 2 793.8118 793.8105 1.6 ppm
- [GU] - 1261.5720 669.0833 1930.6553 2 966.3355 966.3368 1.3 ppm
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Table A.4: Overview of cross-links of Cwc2 and the corresponding mass values.
domain position peptide aa RNA fig m(peptide) m(RNA) m(XL) z m/z m/z exp Δm
Torus W37–K61 WSQGFAGNTRFVSPFALQPQLHSGK F47 [UU] - 2759.3931 630.0611 3389.4542 3 1130.8259 1130.8278 1.7 ppm
[AUU] - 2759.3931 959.1137 3718.5068 3 1240.5101 1240.5109 0.64 ppm
F47–K61 FVSPFALQPQLHSGK F47 [U –H2O] B.10 1654.8830 306.0253 1960.9083 2 981.4620 981.4644 2.4 ppm
[U] - 1654.8830 324.0359 1978.9189 3 660.6474 660.6451 3.5 ppm
[UU] - 1654.8830 630.0611 2284.9441 3 762.6558 762.6529 3.8 ppm
zinc finger G79–K101 GM(Ox)CCLGPKCEYLHHIPDEEDIGK C87 [U +152 –H2O] - 2602.1323 458.0191 3060.1514 4 766.0457 766.0461 151.9956 Da
C87–K101 CEYLHHIPDEEDIGK C87 [U] - 1796.8039 324.0359 2120.8398 3 707.9544 707.9526 2.5 ppm
[U +152] - 1796.8039 476.0297 2272.8336 3 758.6190 758.6209 151.9995 Da
[AU +152] B.11 1796.8039 805.0822 2601.8861 3 868.3032 868.3057 152.0014 Da
[AAU +152] - 1796.8039 1134.1347 2930.9386 4 733.7425 733.7439 151.9996 Da
[GU +152] - 1796.8039 821.0771 2617.8810 3 873.6348 873.6370 152.0004 Da
connector element F117–R131 FADYREDMGGIGSFR Y120 [U] B.12 1719.7674 324.0359 2043.8033 2 1022.9095 1022.9121 2.5 ppm
[AU] - 1719.7674 653.0884 2372.8558 3 791.9597 791.9588 1.1 ppm
RNP2 T136–K149 TLYVGGIDGALNSK Y138 [U] B.13 1406.7405 324.0359 1730.7764 2 866.3960 866.3984 2.8 ppm
[AU] - 1406.7405 653.0884 2059.8289 3 687.6174 687.6177 0.44 ppm
[AAU] - 1406.7405 982.1409 2388.8814 3 797.3016 797.3022 0.50 ppm
[AUU] - 1406.7405 959.1137 2365.8542 3 789.6259 789.6241 2.3 ppm
[GU] - 1406.7405 669.0833 2075.8238 2 1038.9197 1038.9208 1.1 ppm
[GGU] - 1406.7405 1014.1307 2420.8712 3 807.9649 807.9637 1.5 ppm
[AGU] - 1406.7405 998.1358 2404.8763 3 802.6332 802.6319 1.6 ppm
[UU] - 1406.7405 630.0611 2036.8017 2 1019.4087 1019.4069 1.8 ppm
[CU] - 1406.7405 629.0772 2035.8177 2 1018.9167 1018.9154 1.3 ppm
[ACU] - 1406.7405 958.1297 2364.8702 3 789.2979 789.2960 2.4 ppm
[CGU] - 1406.7405 974.1246 2380.8651 3 794.6295 794.6267 3.5 ppm
RRM H150–R159 HLKPAQIESR K152 [U –H2O] B.14 1177.6567 306.0253 1483.6820 3 495.5685 495.5680 1.0 ppm
[AU –H2O] - 1177.6567 635.0778 1812.7345 3 605.2526 605.2525 0.17 ppm
RNP1 N180–K185 NCGFVK C181 [U] - 666.3159 324.0359 990.3518 2 496.1837 496.1826 2.2 ppm
[U +152] B.15 666.3159 476.0297 1142.3456 2 572.1806 572.1823 151.9972 Da
[AU] - 666.3159 653.0884 1319.4043 2 660.7100 660.7098 0.30 ppm
[AU +152] - 666.3159 805.0822 1471.3981 2 736.7069 736.7100 152.0001 Da
[AAU +152] - 666.3159 1134.1347 1800.4506 2 901.2331 901.2363 152.0002 Da
[AUU +152] - 666.3159 1111.1075 1777.4234 2 889.7195 889.7199 151.9946 Da
[GU] - 666.3159 669.0833 1335.3992 2 668.7074 668.7055 2.8 ppm
[GU +152] - 666.3159 821.0771 1487.3930 2 744.7043 744.7059 151.9970 Da
[AGU +152] - 666.3159 1150.1296 1816.4455 2 909.2306 909.2303 151.9933 Da
[UU] - 666.3159 630.0611 1296.3770 2 649.1963 649.1958 0.77 ppm








Table A.5: Overview of cross-links from the 40S small ribosomal subunit and the corresponding mass values.
protein UniProt position peptide aa RNA fig m(peptide) m(RNA) m(XL) z m/z m/z exp Δm
40S ribosomal protein S1-A/-B P33442/ K116–K128 KWQTLIEANVTVK W117 [U –H2O] B.16 1528.8613 306.0253 1834.8866 2 918.4511 918.4503 0.87
P23248 - [AU –HPO3] - 1528.8613 573.1221 2101.9834 3 701.6689 701.6686 0.48
40S ribosomal protein S3 P05750 G95–K108 GLSAVAQAESMKFK - [GU] B.17 1465.7598 669.0833 2134.8431 3 712.6222 712.6211 1.50
- [UU] - 1465.7598 630.0612 2095.8210 3 699.6148 699.6144 0.57
G133–K141 GCEVVVSGK C134 [U +152 –H2O] B.18 876.4374 458.0191 1334.4565 2 668.2361 668.2366 151.9949
40S ribosomal protein S5 P26783 N186–K203 NIKTIAETLAEELINAAK - [U –H2O] - 1941.0782 306.0253 2247.1035 3 750.0423 750.0426 0.40
- [GU –H2O] - 1941.0782 651.0727 2592.1509 3 865.0581 865.0582 0.12
T189–K203 TIAETLAEELINAAK T189 [U –H3PO4] - 1585.8562 226.0590 1811.9152 3 604.9795 604.9788 1.21
T189 [U –H2O] - 1585.8562 306.0253 1891.8815 3 631.6350 631.6342 1.21
T189 [U] - 1585.8562 324.0359 1909.8921 2 955.9539 955.9514 2.56
T189 [GU –HPO3] - 1585.8562 589.1170 2174.9732 3 725.9989 725.9988 0.09
T189 [GU –H2O] B.19 1585.8562 651.0727 2236.9289 3 746.6508 746.6512 0.58
T189 [GU] - 1585.8562 669.0833 2254.9395 3 752.6543 752.6537 0.80
- [ACGU] - 1585.8562 1303.1771 2889.0333 3 964.0189 964.0182 0.73
40S ribosomal protein S11-A/-B P0CX47/ V117–K133 VQVGDIVTVGQCRPISK C128 [U –H2O] - 1797.9770 306.0253 2104.0023 3 702.3419 702.3400 2.71
P0CX48 C128 [AU –H2O] B.20 1797.9770 635.0778 2433.0548 3 812.0261 812.0257 0.45
40S ribosomal protein S14-A/-B P06367/ I19–K36/ IYASFNDTFVHVTDLSGK - [CU] - 2012.9843 629.0772 2642.0615 3 881.6950 881.6939 1.21
P39516 I20–K37 - [GU] - 2012.9843 669.0833 2682.0676 3 895.0303 895.0294 1.04
- [UU] B.21 2012.9843 630.0612 2643.0455 3 882.0230 882.0220 1.10
A50–K70/ ADRDESSPYAAMLAAQDVAAK - [GU] B.22 2179.0215 669.0833 2848.1048 3 950.3761 950.3746 1.54
A51–K71
40S ribosomal protein S16-A/-B P0CX51/ V69–R82 VTGGGHVSQVYAIR H74 [U –H2O] B.23 1442.7629 306.0253 1748.7882 3 583.9372 583.9366 1.03
P0CX52 H74 [U] - 1442.7629 324.0359 1766.7988 3 589.9407 589.9399 1.41
40S ribosomal protein S17-A/-B P02407/ L34–K44 LCDEIATIQSK C35 [U +152] B.24 1219.6118 476.0297 1695.6415 2 848.8286 848.8292 151.9951
P14127 C35 [AAU +152] - 1219.6118 1134.1347 2353.7465 3 785.5900 785.5899 151.9936
I50–K59 IAGYTTHLMK H56 [U –H2O] B.25 1133.5902 306.0253 1439.6155 2 720.8156 720.8147 1.18
- [U] - 1133.5902 324.0359 1457.6261 3 486.8832 486.8824 1.57
IAGYTTHLM(Ox)K H56 [U] - 1149.5851 324.0359 1473.6210 3 492.2148 492.2138 2.03
40S ribosomal protein S24-A/-B P0CX31/ D53–R61 DAVSVFGFR - [U] B.26 996.5028 324.0359 1320.5387 2 661.2772 661.2767 0.68
P0CX32 D115–K123 DKKIFGTGK K117 [U –H2O] - 992.5654 306.0253 1298.5907 2 650.3032 650.3015 2.54
K117 [U] - 992.5654 324.0359 1316.6013 3 439.8749 439.8743 1.36
K117 [CU] B.27 992.5654 629.0772 1621.6426 2 811.8291 811.8289 0.25
40S ribosomal protein S29-A P41057 V23–R32 VCSSHTGLIR C24 [U +152 –H2O] B.28 1071.5495 458.0191 1529.5686 2 765.7921 765.7914 151.9924
40S ribosomal protein S29-B P41058 V23–R32 VCSSHTGLVR C24 [U +152 –H2O] B.29 1057.5338 458.0191 1515.5529 2 758.7843 758.7819 151.9891
C24 [AU +152 –H2O] - 1057.5338 787.0716 1844.6054 3 615.8763 615.8770 151.9960




Table A.6: Overview of cross-links from the 60S large ribosomal subunit (proteins L1 to L8) and the corresponding mass values.
protein UniProt position peptide aa RNA fig m(peptide) m(RNA) m(XL) z m/z m/z exp Δm
60S ribosomal protein L1-A/-B P0CX43/ S79–K91 SCGVDAMSVDDLK C80 [U +152 –H2O] - 1338.5795 458.0191 1796.5986 2 899.3071 899.3074 151.9944
P0CX44 S79–K92 SCGVDAMSVDDLKK C80 [U +152 –H2O] B.31 1466.6744 458.0191 1924.6935 3 642.5723 642.5729 151.9956
C80 [U +152] - 1466.6744 476.0297 1942.7041 3 648.5758 648.5759 151.9940
60S ribosomal protein L2-A /-B P0CX45/ A129–K145 ASGNYVIIIGHNPDENK Y133 [U] B.32 1839.9114 324.0359 2163.9473 3 722.3236 722.3225 1.48
P0CX46 G201–K221 GVAMNPVDHPHGGGNHQHIGK - [AAGU –H2O] B.33 2158.0238 1309.1778 3467.2016 4 867.8082 867.8088 0.70
60S ribosomal protein L3 P14126 V249–R266 VACIGAWHPAHVMWSVAR C251 [U –H2O] B.34 1989.9817 306.0253 2296.0070 3 766.3435 766.3433 0.22
60S ribosomal protein L4-A/-B P10664/ S85–R95 SGQGAFGNMCR C94 [U –H2O] B.35 1126.4647 306.0253 1432.4900 2 717.2528 717.2521 0.98
P49626 C94 [U] - 1126.4647 324.0359 1450.5006 2 726.2581 726.2570 1.51
C94 [U +152 –H2O] - 1126.4647 458.0191 1584.4838 2 793.2497 793.2503 151.9950
C94 [AU –H2O] - 1126.4647 635.0778 1761.5425 2 881.7791 881.7783 0.85
N221–R246 NVPGVETANVASLNLLQLA- H243 [AU –H2O] B.36 2610.4241 635.0778 3245.5019 3 1082.8418 1082.8425 0.68
PGAHLGR
I289–K308 IINSSEIQSAIRPAGQATQK I290 [GU] B.37 2111.1334 669.0833 2780.2167 3 927.7467 927.7455 1.29
60S ribosomal protein L4-A P10664 T347–K360 TGTKPAAVFTETLK - [AU –H2O] B.38 1462.8031 635.0778 2097.8809 3 700.3014 700.3012 0.33
- [AU] - 1462.8031 653.0884 2115.8915 3 706.3050 706.3044 0.80
- [AAU] - 1462.8031 982.1409 2444.9440 3 815.9891 815.9880 1.39
- [AAAU –HPO3] - 1462.8031 1231.2271 2694.0302 3 899.0179 899.0172 0.74
60S ribosomal protein L4-B P49626 T347–K360 TGTKPAAVFAETLK - [AU –H2O] B.39 1432.7925 635.0778 2067.8703 3 690.2979 690.2975 0.58
- [AU] - 1432.7925 653.0884 2085.8809 3 696.3014 696.3005 1.34
- [AAAU –HPO3] - 1432.7925 1231.2271 2664.0196 4 667.0127 667.0128 0.15
60S ribosomal protein L5 P26321 S197–R218 SYIFGGHVSQYMEELADDDEER - [U –H2O] - 2589.0965 306.0253 2895.1218 3 966.0484 966.0481 0.31
- [U] B.40 2589.0965 324.0359 2913.1324 3 972.0519 972.0510 0.96
SYIFGGHVSQYM(Ox)EELADD- - [U] - 2605.0914 324.0359 2929.1273 3 977.3836 977.3825 1.09
DEER
S197–K224 SYIFGGHVSQYMEELADDDEER- F [U –H2O] - 3340.4869 306.0253 3646.5122 3 1216.5119 1216.5121 0.19
FSELFK
60S ribosomal protein L6-A/-B Q02326/ L30–R48 LRASLVPGTVLILLAGRFR - [GU –H2O] B.41 2051.2730 651.0727 2702.3457 3 901.7897 901.7901 0.44
P05739 A32–R48 ASLVPGTVLILLAGRFR - [GU –H2O] - 1782.0879 651.0727 2433.1606 3 812.0613 812.0611 0.29
A32–K50 ASLVPGTVLILLAGRFRGK - [GU –H2O] - 1967.2043 651.0727 2618.2770 3 873.7668 873.7681 1.49
60S ribosomal protein L6-A Q02326 A6–K19 APKWYPSEDVAALK - [AU] - 1573.8139 653.0884 2226.9023 3 743.3086 743.3072 1.84
W9–K19 WYPSEDVAALK - [AU] - 1277.6291 653.0884 1930.7175 3 644.5803 644.5792 1.71
W9–K20 WYPSEDVAALKK W9 [AU –H2O] B.42 1405.7241 635.0778 2040.8019 3 681.2751 681.2739 1.76
W9 [AU] - 1405.7241 653.0884 2058.8125 3 687.2786 687.2774 1.79
H57–K70 HLEDNTLLISGPFK - [U –H2O] B.44 1582.8354 306.0253 1888.8607 2 945.4382 945.4375 0.69
- [U] - 1582.8354 324.0359 1906.8713 2 954.4435 954.4419 1.62
- [GU] - 1582.8354 669.0833 2251.9187 3 751.6474 751.6470 0.49
60S ribosomal protein L6-B P05739 T2–K19 TAQQAPKWYPSEDVAAPK - [AU] - 1985.9846 653.0884 2639.0730 3 880.6988 880.6977 1.25
W9–K19 WYPSEDVAAPK W9 [AU –H2O] B.43 1261.5978 635.0778 1896.6756 3 633.2330 633.2324 0.95
- [AU] - 1261.5978 653.0884 1914.6862 3 639.2365 639.2369 0.57
- [AGU] - 1261.5978 998.1358 2259.7336 3 754.2523 754.2523 0.04
H57–K70 HLEDNTLLVTGPFK - [U –H2O] B.45 1582.8354 306.0253 1888.8607 2 945.4382 945.4378 0.37
- [U] - 1582.8354 324.0359 1906.8713 2 954.4435 954.4418 1.73
- [AAU –H2O] - 1582.8354 964.1303 2546.9657 3 849.9964 849.9956 0.90
- [AAU] - 1582.8354 982.1409 2564.9763 3 855.9999 855.9990 1.05
60S ribosomal protein L8-A P17076 Y134–K146 YGLNHVVALIENK - [GU –H2O] - 1468.8037 651.0727 2119.8764 3 707.6333 707.6331 0.44
Y134–K147 YGLNHVVALIENKK - [U] - 1596.8987 324.0359 1920.9346 3 641.3193 641.3188 1.49
- [GU –H2O] B.46 1596.8987 651.0727 2247.9714 3 750.3316 750.3312 1.76
60S ribosomal protein L8-B P29453 Y134–K146 YGLNHVVSLIENK - [U –H2O] - 1484.7986 306.0253 1790.8239 3 597.9491 597.9486 0.69
- [U] - 1484.7986 324.0359 1808.8345 2 905.4251 905.4269 0.95
- [GU –H2O] B.47 1484.7986 651.0727 2135.8713 3 712.9649 712.9644 0.37
- [GU] - 1484.7986 669.0833 2153.8819 3 718.9684 718.9671 1.73
- [UU –H2O] - 1484.7986 612.0506 2096.8492 3 699.9575 699.9589 0.90
- [UU] - 1484.7986 630.0612 2114.8598 3 705.9611 705.9597 1.05








Table A.7: Overview of cross-links from the 60S large ribosomal subunit (proteins L16 to L42) and RPL7 and the corresponding mass values..
protein UniProt position peptide aa RNA fig m(peptide) m(RNA) m(XL) z m/z m/z exp Δm
60S ribosomal protein L16-A/-B P26784/ L141–K155/ LSTSVGWKYEDVVAK Y149 [U –H2O] B.48 1680.8722 306.0253 1986.8975 3 663.3070 663.3068 0.25
P26785 L140–K154 Y149 [U] - 1680.8722 324.0359 2004.9081 3 669.3105 669.3098 1.05
- [UU] - 1680.8722 630.0612 2310.9334 3 771.3189 771.3179 1.34
60S ribosomal protein L16-A P26784 A38–R49 AEELNISGEFFR - [AU] - 1410.6779 653.0884 2063.7663 3 688.9299 688.9280 2.76
- [ACU] - 1410.6779 958.1297 2368.8076 3 790.6103 790.6097 0.80
A38–K51 AEELNISGEFFRNK - [AU] - 1652.8158 653.0884 2305.9042 3 769.6425 769.6420 0.69
- [CU] - 1652.8158 629.0772 2281.8930 3 761.6388 761.6380 1.03
- [ACU –HPO3] - 1652.8158 878.1633 2530.9791 3 844.6675 844.6663 1.44
- [ACU] B.49 1652.8158 958.1297 2610.9455 3 871.3230 871.3229 0.08
60S ribosomal protein L16-B P26785 A37–R48 AEALNISGEFFR - [U] - 1352.6724 324.0359 1676.7083 2 839.3620 839.3600 2.32
- [AU] - 1352.6724 653.0884 2005.7608 3 669.5947 669.5938 1.39
F38 [CU] B.50 1352.6724 629.0772 1981.7496 3 661.5910 661.5906 0.58
- [ACU] - 1352.6724 958.1297 2310.8021 3 771.2752 771.2733 2.42
A37–K50 AEALNISGEFFRNK - [AU –H2O] - 1594.8103 635.0778 2229.8881 3 744.3038 744.3031 0.99
- [AU] - 1594.8103 653.0884 2247.8987 3 750.3074 750.3066 1.02
- [CU] - 1594.8103 629.0772 2223.8875 3 742.3036 742.3031 0.70
- [ACU –HPO3] - 1594.8103 878.1633 2472.9736 3 825.3323 825.3317 0.78
- [ACU] - 1594.8103 958.1297 2552.9400 3 851.9878 851.9864 1.64
60S ribosomal protein L18-A/-B P0CX49/ A51–K56 ALFLSK - [AU –H2O] - 677.4111 635.0778 1312.4889 2 657.2523 657.2517 0.84
P0CX50 - [AU] B.51 677.4111 653.0884 1330.4995 2 666.2576 666.2566 1.43
- [AGU –H2O] - 677.4111 980.1253 1657.5364 2 829.7760 829.7755 0.60
- [AGU] - 677.4111 998.1358 1675.5469 2 838.7813 838.7802 1.26
A117–R130 AGGECITLDQLAVR C121 [U +152 –H2O] B.52 1444.7343 458.0191 1902.7534 2 952.3845 952.3873 151.9994
60S ribosomal protein L23-A/-B P0CX41/ E121–R128 ECADLWPR C122 [U +152 –H2O] B.53 988.4436 458.0191 1446.4627 2 724.2392 724.2391 151.9937
P0CX42
60S ribosomal protein L26-B P53221 K17–R27 KAYFTAPSSER - [GU] B.54 1255.6196 669.0833 1924.7029 3 642.5754 642.5745 1.45
60S ribosomal protein L28 P02406 I43–K55 INMDKYHPGYFGK Y48 [U –H2O] B.55 1568.7445 306.0253 1874.7698 3 625.9311 625.9310 0.11
60S ribosomal protein L31-A/-B P0C2H8/ L20–K26 LHGVSFK - [U –H2O] - 786.4388 306.0253 1092.4641 2 547.2399 547.2391 1.37
P0C2H9 - [U] - 786.4388 324.0359 1110.4747 2 556.2452 556.2440 2.07
- [GU] - 786.4388 669.0833 1455.5221 2 728.7689 728.7675 1.85
F25 [UU –H2O] B.56 786.4388 612.0506 1398.4894 2 700.2525 700.2517 1.14
- [UU] - 786.4388 630.0612 1416.5000 2 709.2578 709.2567 1.55
- [UUU] - 786.4388 936.0865 1722.5253 2 862.2705 862.2705 0.06
L20–K27 LHGVSFKK F25 [U –H2O] - 914.5337 306.0253 1220.5590 3 407.8608 407.8603 1.23
- [U] - 914.5337 324.0359 1238.5696 3 413.8643 413.8635 2.01
- [UU –H2O] - 914.5337 612.0506 1526.5843 3 509.8692 509.8685 1.44
- [UU] - 914.5337 630.0612 1544.5949 3 515.8728 515.8721 1.29
- [UUU] - 914.5337 936.0865 1850.6202 2 926.3179 926.3172 0.76
60S ribosomal protein L33-A/-B P05744/ I49–R60 IAYVYRASKEVR - [AU –H2O] B.57 1453.8041 635.0778 2088.8819 3 697.3018 697.3024 0.91
P41056 - [AU] - 1453.8041 653.0884 2106.8925 3 703.3053 703.3042 1.56
60S ribosomal protein L35-A/-B P0CX84/ S50–R63 SIACVLTVINEQQR C53 [U –H2O] B.58 1572.8293 306.0253 1878.8546 2 940.4351 940.4341 1.06
P0CX85 - [U] - 1572.8293 324.0359 1896.8652 2 949.4404 949.4378 2.74
60S ribosomal protein L37-A P49166 R73–K85 RFKNGFQTGSASK - [ACU] - 1426.7316 958.1297 2384.8613 3 795.9616 795.9624 1.05
RFKN(deamidated)GFQTGSASK - [ACU] - 1427.7157 958.1297 2385.8454 3 796.2896 796.2881 1.88
F74–K85 FKNGFQTGSASK - [ACU] B.59 1270.6305 958.1297 2228.7602 3 743.9279 743.9263 2.11
FKN(deamidated)GFQTGSASK - [ACU] - 1271.6145 958.1297 2229.7442 3 744.2559 744.2537 2.91
60S ribosomal protein L37-B P51402 F74–K84 FKNGFQTGSAK - [ACU] B.60 1183.5985 958.1297 2141.7282 3 714.9172 714.9162 1.40
Ubiquitin-60S ribosomal P0CH08/ C115–K124 CGHTNQLRPK - [U –H2O] - 1152.5822 306.0253 1458.6075 2 730.3116 730.3107 1.16
protein L40 P0CH09 C115 [U +152 –H2O] B.61 1152.5822 458.0191 1610.6013 3 537.8749 537.8739 151.9908
60S ribosomal protein L42-A/-B P0CX27/ C88–K97 CKHFELGGEK C88/K89 [U –H2O] B.62 1146.5491 306.0253 1452.5744 2 727.2950 727.2944 0.82
P0CX28 C88/K89 [AU] - 1146.5491 653.0884 1799.6375 3 600.8870 600.8858 1.94
C88/K89 [UU] - 1146.5491 630.0612 1776.6103 2 889.3130 889.3123 0.73
Ribosome biogenesis protein P40693 G149–K161 GPLAVNIPNKAFK - [CUU] B.63 1367.7924 935.1025 2302.8949 3 768.6394 768.6394 0.04
RLP7
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Table A.8: Overview of cross-links of enzymatic and RNA-binding proteins (excluding ribosomal) and the corresponding mass values.
protein UniProt position peptide aa RNA fig m(peptide) m(RNA) m(XL) z m/z m/z exp Δm
Cruciform DNA-recognizing P38845 I105–R118 IPEAGGLLCGKPPR C113 [U –H2O] B.64 1406.7703 306.0253 1712.7956 2 857.4056 857.4047 1.05
protein 1
Elongation factor 1-alpha P02994 F402–R421 FVPSKPM(Oxidation)CVEAFSEY- C409 [U +152] B.65 2269.0910 476.0297 2745.1207 3 916.0480 916.0476 151.9925
PPLGR
Nucleolar protein 3 Q01560 I156–K173 ILNGFAFVEFEEAESAAK F [U –H2O] B.66 1970.9624 306.0253 2276.9877 3 760.0037 760.0039 0.26
E222–R235 ENSLETTFSSVNTR - [U] B.67 1583.7427 324.0359 1907.7786 2 954.8971 954.8956 1.57
Nucleolar protein 13 P53883 I240–R256 ILFVGNLSFDVTDDLLR F242 [GU –H2O] B.68 1936.0305 651.0727 2587.1032 3 863.3755 863.3756 0.08
Polyadenylate-binding P04147 Y319–K327 YQGVNLFVK F325 [U –H2O] - 1066.5811 306.0253 1372.6064 2 687.3110 687.3096 2.04
protein F325 [U] B.69 1066.5811 324.0359 1390.6170 2 696.3163 696.3158 0.72
F325 [AU –H2O] - 1066.5811 635.0778 1701.6589 2 851.8373 851.8365 0.88
F325 [AU] - 1066.5811 653.0884 1719.6695 2 860.8426 860.8416 1.10
F325 [UU] - 1066.5811 630.0612 1696.6423 2 849.3290 849.3282 0.88
F325 [AAU] - 1066.5811 982.1409 2048.7220 3 683.9151 683.9141 1.51
Single-stranded P10080 S184–K196 SKDTLYINNVPFK - [U] - 1537.8140 324.0359 1861.8499 3 621.6244 621.6236 1.34
nucleic-acid - [AC] B.70 1537.8140 652.1044 2189.9184 3 730.9806 730.9801 0.68
binding protein - [AU –H2O] - 1537.8140 635.0778 2172.8918 3 725.3051 725.3041 1.33
- [AU] - 1537.8140 653.0884 2190.9024 3 731.3086 731.3078 1.09
- [GU] - 1537.8140 669.0833 2206.8973 3 736.6402 736.6388 1.95
- [UU] - 1537.8140 630.0612 2167.8752 3 723.6329 723.6320 1.20
- [AUU] - 1537.8140 959.1137 2496.9277 3 833.3170 833.3163 0.88
- [UUU] - 1537.8140 936.0865 2473.9005 3 825.6413 825.6410 0.36
Adenosylhomocysteinase P39954 E320–R330 ECINIKPQVDR C321 [U +152] B.71 1313.6761 476.0297 1789.7058 3 597.5764 597.5761 151.9929
C321 [AU +152] - 1313.6761 805.0822 2118.7583 3 707.2606 707.2610 151.9951
Alcohol dehydrogenase 1/3 P00330/ Y40–K60/ YSGVCHTDLHAWHGDWPLPVK C44/71 [U +152 –H2O] B.72 2417.1374 458.0191 2875.1565 4 719.7969 719.7972 151.9949
P07246 Y67–K86 C44/71 [U +152] - 2417.1374 476.0297 2893.1671 4 724.2996 724.2968 151.9827
Enolase 1/2 P00924/ I244–K255 IGLDCASSEFFK C248 [U] - 1315.6118 324.0359 1639.6477 2 820.8317 820.8316 0.06
P00925 C248 [U +152 –H2O] B.73 1315.6118 458.0191 1773.6309 2 887.8233 887.8223 151.9919
C248 [U +152] - 1315.6118 476.0297 1791.6415 2 896.8286 896.8318 152.0003
C248 [AU +152] - 1315.6118 805.0822 2120.6940 2 1061.3548 1061.3540 151.9922
C248 [GU +152] - 1315.6118 821.0771 2136.6889 3 713.2374 713.2369 151.9922
C248 [AAU +152] - 1315.6118 1134.1347 2449.7465 3 817.5900 817.5893 151.9918
Glyceraldehyde-3-phosphate P00358/ E250–K258 ETTYDEIKK - [AU –HPO3] B.74 1125.5553 573.1221 1698.6774 2 850.3465 850.3468 0.38
dehydrogenase 2/3 P00359
Inorganic pyrophosphatase P00817 N83–K112 NCFPHHGYIHNYGAFPQTWED- C84 [U +152 –H2O] B.75 3521.5635 458.0191 3979.5826 5 796.9243 796.9234 151.9892
PNVSHPETK
Peroxiredoxin TSA1 P34760 N165–K188 NGTVLPCNWTPGAATIKPTVEDSK C171 [U +152] B.76 2498.2474 476.0297 2974.2771 3 992.4335 992.4326 151.9911
Phosphoglycerate kinase P00560 Y49–R56 YVLEHHPR - [AU –HPO3] B.77 1049.5406 573.1221 1622.6627 2 812.3392 812.3396 0.55
Pyruvate kinase 1 P00549 N370–K394 NCTPKPTSTTETVAASAVAAVFEQK C371 [U +152 –H2O] B.78 2550.2635 458.0191 3008.2826 3 1003.7687 1003.7679 151.9915
C371 [U +152] - 2550.2635 476.0297 3026.2932 3 1009.7722 1009.7711 151.9905
C371 [AU +152 –H2O] - 2550.2635 787.0716 3337.3351 3 1113.4528 1113.4537 151.9964
C371 [AU +152] - 2550.2635 805.0822 3355.3457 3 1119.4564 1119.4543 151.9876
C371 [GU +152 –H2O] - 2550.2635 803.0666 3353.3301 3 1118.7845 1118.7837 151.9915
C371 [GU +152] - 2550.2635 821.0771 3371.3406 3 1124.7880 1124.7865 151.9893
C371 [UU +152 –H2O] - 2550.2635 764.0444 3314.3079 3 1105.7771 1105.7791 151.9998
C371 [UU +152] - 2550.2635 782.0550 3332.3185 3 1111.7806 1111.7790 151.9889
Y414–R425 YRPNCPIILVTR C418 [U +152 –H2O] B.79 1443.8020 458.0191 1901.8211 3 634.9482 634.9485 151.9948
C418 [U +152] - 1443.8020 476.0297 1919.8317 3 640.9517 640.9521 151.9950
C418 [AU +152 –H2O] - 1443.8020 787.0716 2230.8736 2 1116.4446 1116.4462 151.9970
C418 [AU +152] - 1443.8020 805.0822 2248.8842 3 750.6359 750.6364 151.9954
C418 [UU +152] - 1443.8020 782.0550 2225.8570 3 742.9601 742.9595 151.9919
B MS/MS fragment spectra of identified
cross-links
B.1 Annotation of MS/MS spectra of cross-linked peptides
B.1.1 Peptide sequence ions
Peptide sequence ions are annotated according to the established nomenclature (see 1.2.1.3).
Neutral losses of sequence ions are annotated with an asterisk for ammonia and a superscripted 0
for water. Annotations are only given if the signal without neutral loss is not detected.
Internal ions are annotated with capital letters and usually not indicated within the peptide se-
quence unless they provide evidence for the peptide sequence not covered by the a-, b-, and y-ions.
Immonium ions are annotated as IM X where X is the one letter code of the corresponding amino
acid.
Signals corresponding to the intact peptide are annotated as peptide+, peptide2+ etc. This simply-
fies the commonly used nomenclature that would also give the additional protons responsible for
the charge, e.g. [peptide +2H]2+. Similarly, the precursor ion is annotated without the additional
protons, e.g. [M]4+ instead of [M +4H]4+.
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B.1.2 RNA marker ions and fragments
RNA marker ions (see Table B.1) are annotated as X’ for the nucleic acid bases and as X0 for the
nucleotide minus water. The corresponding m/z value is underlined. As for intact peptides, the
additional protons that produce the charge are ommitted from the annotation.
Table B.1: Calculated monoisotopic masses of RNA (marker) ions
RNA marker ions of the nucleic acid bases





RNA marker ions of the nucleotides






formula symbol calculated m/z
[U –H2O –U’] [U0 –U’] 195.0058
[C –H3PO4] C0-p 226.0828
[U –H3PO4] U0-p 227.0667
[U’ +152] 265.0289**
[A] 348.0709
[U +152 –H3PO4] [U0-p +152] 379.0606**
[G –H2O +HPO3] G0+p 426.0216
[U +152 –H2O] [U0 +152] 459.0269**
[AX –H2O –X’] [AX0 –X’] 524.0584
[GX –H2O –X’] [GX0 –X’] 540.0533
[AU –H3PO4] [AU0-p] 556.1193
[AU –HPO3] 574.1299
X: any nucleotide
* with loss of water
** assuming 151.9938 for 152Da adduct
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B.1.3 RNA adducts of peptides and their sequence ions
RNA adducts of intact peptides or their fragment ions are given in an abbreviated code described in
Table B.2. Loss of metaphosphoric acid HPO3 is indicated with "-p". The m/z values of peptide–
RNA adducts are underlined.
Table B.2: Annotation of peptide–RNA adducts
adduct calculated abbreviated amino example
adduct mass annotation acid
[C3O] 51.9949 y5# K B.27, p. 163
Y B.55, p. 175
[U’ –H2O] 94.0167 y5U’0 F B.56, p. 175
[U’] 112.0273 y5U’ I B.37, p. 168
K B.27, p. 163
Y B.32, p. 165
[U –H3PO4] 226.0590 y5U0-p T B.19, p. 160
F B.50, p. 173
[U’ +152] 264.0211* y5# C B.24, p. 162
[U –H2O] 306.0253 y5U0 C B.20, p. 160
H B.23, p. 161
F B.50, p. 173
Y B.48, p. 172
W B.16, p. 159
[4SU –H2S] 306.0253 y5# K 3.7, p. 66
G 3.9, p. 68
[U] 324.0359 y5U F 3.13, p. 78
[U +152 –H3PO4] 378.0528 y5# C B.5, p. 154
W 3.17, p. 82
[U +152 –HPO3] 396.0633 y5# C B.9, p. 155
[U +152 –H2O] 458.0191* y5# C B.72, p. 182
W 3.17, p. 82
[U +152] 476.0297* y5# C B.4, p. 153
W 3.17, p. 82
[AU –H2O –A’] 500.0233 y5# C B.20, p. 160
W B.42, p. 170
[XU –H2O –X’] 500.0233 y5#
* assuming 151.9938 for 152Da adduct
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In some cases, immonium or other internal ions of single amino acids are observed as shifted by
the cross-linked RNA or fragments thereof. Table B.3 summarizes the observed ions and gives the
calculated m/z values of the respective ions.
Table B.3: RNA-adducts of single amino acids
adduct symbol calculated m/z example
IM F + [U’ –H2O] IM FU’0 214.0980 B.56, p. 175
IM Y + [U’] IM YU’ 248.1035 B.32, p. 165
IM C + [U –H2O] IM CU0 382.0474 B.58, p. 176
IM H + [U –H2O] IM HU0 416.0971 B.23, p. 161
IM F + [U –H2O] IM FU0 426.1066 B.66, p. 180
(IM W –CHNH2) + [U –H2O] (IM W –CHNH2)U0 436.0910 B.16, p. 159
IM W + [U –H2O] IM WU0 465.1175 B.16, p. 159
IM C + [U +152 –H2O] IM C# 534.0412* B.31, p. 165
IM C + [U +152] IM C# 552.0518* B.5, p. 154
IM W + [AU –H2O –A’] IM W# 659.1155 B.42, p. 170
* assuming 151.9938 for 152Da adduct
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B.2 MS/MS fragment spectra of NusB–S10 peptides observed as
adducts with 258 Da
Figure B.1: MS/MS fragment spectrum (smoothed and centroided) of NusB peptide IALYELSKR (I87–R95) observed as
adduct with 258Da. All y-ions except for y1 are observed as partially shifted by the adduct mass, 258Da.
This leads to the conclusion that K94 was the amino acid that reacted to yield the 258Da adduct.
Figure B.2: MS/MS fragment spectrum (smoothed and centroided) of S10 peptide LVDIVEPTEKTVDALMR (L73–R89)
observed as adduct with 258Da. The spectrum does not contain any hint of the adduct mass, no shifted
peptide fragments are observed.
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B.3 MS/MS fragment spectra of cross-links from the ASH1
complexes
Figure B.3: MS/MS fragment spectrum of She2p peptide GPLGSMSK (M1–K3) cross-linked to [U –H2O]. The underlined
part of the peptide sequence is not part of She2p but remains after cleavage of a GST tag. The spectrum does
not contain any hint towards the cross-linked amino acid.
Figure B.4: MS/MS fragment spectrum of She2p peptide FYNDCVLSYNASEFINEGK (F64–K82) cross-linked to
[U +152]. The shift of b5 and b6 by [U +152] as well as the presence of a 152 Da adduct in general identify
C68 as the cross-linked amino acid.
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Figure B.5: MS/MS fragment spectrum of She2p peptide CVETFDLLNYYLTQSLQK (C106–K123) cross-linked to
[U +152]. The observation of the immonium ion as adduct with [U +152] as well as the presence of a
152 Da adduct in general identify C103 as the cross-linked amino acid.
Figure B.6: MS/MS fragment spectrum of She3p peptide MDQLSKLAK (M130–K138), oxidized at M130, cross-linked to
[U –H2O]. The complete shift of the y-series by [U’ –H2O] starting with y4 identifies K135 as the cross-linked
amino acid.
Figure B.7: MS/MS fragment spectrum of She3p peptide GAVVQTLKK (G283–K291) cross-linked to [U –H2O]. Peptide
fragments y2 to y6 are completely shifted by [U’ –H2O], pointing at K290 as the cross-linked amino acid.
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Figure B.8: MS/MS fragment spectrum of She3p peptide TNVTHNNDPSTSPTISVPPGVTR (T383–R405) cross-linked
to [GU]. An intense RNA marker ion for guanine is observed. RNA adducts of b8 place the cross-link on the
N-terminal part of the peptide, the exact cross-linking site cannot be determined.
Figure B.9: MS/MS fragment spectrum of She3p peptide NSSAIEQSCSEK (N139–K150) cross-linked to [U +152]. Several
observations identify C147 as the cross-linked amino acid: The immonium ion of cystein is observed as adduct
with [U –H2O] and all y-ions containing C147 are shifted by the cross-linked RNA. In addition, the 152Da
adduct in general points at cysteine as the cross-linked amino acid.
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B.4 MS/MS fragment spectra of cross-links from Cwc2
Figure B.10: MS/MS fragment spectrum of Cwc2 peptide FVSPFALQPQLHSGK (F47–K61) cross-linked to [U –H2O].
F47 was identified as the cross-linked amino acid due to observation of its immonium ion as an adduct with
[U’ –H2O].
Figure B.11: MS/MS fragment spectrum of Cwc2 peptide CEYLHHIPDEEDIGK (C87–K101) cross-linked to [AU +152].
The spectrum is dominated by the adenine marker ions, peptide fragments are suppressed. The observation
of the 152Da adduct suggests C87 as the cross-linked amino acid. The absence of any a- or b-ions confirms
this assumption.
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Figure B.12: MS/MS fragment spectrum of Cwc2 peptide FADYREDMGGIGSFR (F117–R131) cross-linked to [U]. y12
is observed as an adduct with several fragments of [U], therefore Y120 is identified as the cross-linked amino
acid.
Figure B.13: MS/MS fragment spectrum of Cwc2 peptide TLYVGGIDGALNSK (T136–K149) cross-linked to [U]. Adducts
of the immonium ion of tyrosine with [U] and several of its fragments unambiguously identify Y138 as the
cross-linked amino acid.
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Figure B.14: MS/MS fragment spectrum of Cwc2 peptide HLKPAQIESR (H150–R159) cross-linked to [U –H2O]. All
observed peptide fragments containing K152, i.e. b-ions starting with b3 and y8, are shifted by [U’ –H2O].
Therefore, K152 is the cross-linked amino acid.
Figure B.15: MS/MS fragment spectrum of Cwc2 peptide NCGFVK (N180–K185) cross-linked to [U +152]. The ob-
servation of the overall mass adduct of 152Da as well as all peptide fragments containing C181 shifted by
[U’ +152] point at C181 as the cross-linked amino acid.
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B.5 MS/MS fragment spectra of cross-links from yeast after TAP
tag isolation
B.5.1 Cross-links of the 40S small ribosomal subunit
Figure B.16: MS/MS fragment spectrum of 40S ribosomal protein S1-A/-B peptide KWQTLIEANVTVK (K116–K128)
cross-linked to [U –H2O]. Intense signals of the tryptophan immonium ion and one of its internal fragments
shifted by the cross-linked RNA [U –H2O] as well as the shifted b-ion-series pinpoint to W117 as the cross-
linked amino acid.
Figure B.17: MS/MS fragment spectrum of 40S ribosomal protein S3 peptide GLSAVAQAESMKFK (G95–K108) cross-
linked to [GU]. A dominant G’ marker ion is observed, as well as a weaker ion for [U –H3PO4]. However,
no RNA adducts of peptide fragments are observed that would allow the identification of the cross-linked
amino acid.
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Figure B.18: MS/MS fragment spectrum of 40S ribosomal protein S3 peptide GCEVVVSGK (G133–K141) cross-linked
to [U +152 –H2O]. The immonium ion of cysteine as well as the majority of a- and b-ions are observed as
shifted by [U +152 –H2O], thus it can be concluded that C134 is the cross-linked amino acid.
Figure B.19: MS/MS fragment spectrum of 40S ribosomal protein S5 peptide TIAETLAEELINAAK (T189–K203) cross-
linked to [GU –H2O]. The spectrom is dominated by the G’ marker ion, all peptide fragment ions are
supressed below 25%. b-ions 2–10 are shifted by [U –H3PO4]. Therefore, either T189 or I190 could be the
cross-linked amino acid. As isoleucine is expected to be much less reactive in UV cross-linking, T189 is likely
to be cross-linked.
Figure B.20: MS/MS fragment spectrum of 40S ribosomal protein S11-A/-B peptide VQVGDIVTVGQCRPISK (V117–
K133) cross-linked to [AU –H2O]. An intense A’ marker ion is observed with all peptide fragment ions below
40% relativ intensity. All y-ions, starting with y6, are shifted by RNA fragments, identifying C128 as the
cross-linked amino acid.
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Figure B.21: MS/MS fragment spectrum of 40S ribosomal protein S14-A/-B peptide IYASFNDTFVHVTDLSGK (A:
I19–K36, B: I20–K37) cross-linked to [UU]. RNA-marker ions for [U –H3PO4] and [U –H2O] are observed.
However, the cross-linked amino acid cannot be identified.
Figure B.22: MS/MS fragment spectrum of 40S ribosomal protein S14-A/-B peptide ADRDESSPYAAMLAAQDVAAK
(A: A50–K70, B: A51–K71) cross-linked to [GU]. The spectrum is dominated by the G’ marker, the peptide
fragments are supressed below 10% relative intensity. The actual cross-linked amino acid residue cannot be
identified.
Figure B.23: MS/MS fragment spectrum of 40S ribosomal protein S16-A/-B peptide VTGGGHVSQVYAIR (V69–R82)
cross-linked to [U –H2O]. The immonium ion of histidine and the a6/b6 ion pair is shifted by the mass of
the cross-linked RNA, as are a number of internal ions. This points at H74 as the cross-linked amino acid.
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Figure B.24: MS/MS fragment spectrum of 40S ribosomal protein S17-A/-B peptide LCDEIATIQSK (L34–K44) cross-
linked to [U +152]. All peptide fragments containing the cross-linked C35 residue are shifted by [U’ +152].
In addition, several internal ions are observed, which originate from cleavage C-terminal to the cross-linked
cysteine. Finally, several RNA-signals are observed, namely signals corresponding to [U –H3PO4], [U’ +152],
and [U +152 –H3PO4].
Figure B.25: MS/MS fragment spectrum of 40S ribosomal protein S17-A/-B peptide IAGYTTHLMK (I50–K59) cross-
linked to [U –H2O]. The only peptide fragment shifted by RNA is the immonium ion of histidine, thus
identifying H56 as the cross-linked amino acid. The observation of U’ and U0 marker are unusual for a
cross-link to a single U nucleotide, as well as the large number of internal ions.
Figure B.26: MS/MS fragment spectrum of 40S ribosomal protein S24-A/-B peptide DAVSVFGFR (D53–R61) cross-
linked to [U]. An RNA marker for [U –H3PO4] was observed but no adduct that would allow to derive the
cross-linked amino acid.
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Figure B.27: MS/MS fragment spectrum of 40S ribosomal protein S24-A/-B peptide DKKIFGTGK (D115–K123) cross-
linked to [CU]. The peptide is identified by a full b-ion series shifted by [C3O] and [U’]; the y-series is
complete until the cross-linked amino acid, K117. RNA markers of C’ and C0 are clearly observable, the
peptide fragments are below 15% relative intensity.
Figure B.28: MS/MS fragment spectrum of 40S ribosomal protein S29-A peptide VCSSHTGLIR (V23–R32) cross-linked
to [U +152 –H2O]. Additional description see Figure B.29.
Figure B.29: MS/MS fragment spectrum of 40S ribosomal protein S29-B peptide VCSSHTGLVR (V23–R32) cross-linked
to [U +152 –H2O]. S29-A peptide VCSSHTGLIR (spectrum shown in B.28) and S29-B peptide VCSSHT-
GLVR (position V23–R32 in both proteins) differ in position 31, S29-A containing isoleucine and S29-B
valine. Therefore, both peptides have a different mass and also different y-ion-series which allows a con-
fident discrimination of both protein forms. Both spectra contain a y9 ion shifted by [U +152 –H2O],
confirming C24 as the cross-linked amino acid. In both cases, no a- or b-ions are observed, possibly due to
the cross-link to the peptides’ second position.
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Figure B.30: MS/MS fragment spectrum of guanine nucleotide-binding protein subunit beta-like protein (Rack1) peptide
GQCLATLLGHNDWVSQVR (G138–R155) cross-linked to [U +152 –H2O]. C140 is identified as the cross-
linked amino acid by the immonium ion, b3 and y16 shifted by [U +152 –H2O]. The peptide spans between
the WD repeats 3 (aa 105–145) and 4 (aa 147–191) of the protein.
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B.5.2 Cross-links of the 60S large ribosomal subunit
Figure B.31: MS/MS fragment spectrum of 60S ribosomal protein L1-A/-B peptide SCGVDAMSVDDLKK (S79–K92)
cross-linked to [U +152 –H2O]. Observed a- and b-ions are completely shifted by the mass of the cross-linked
RNA, as is the immonium ion of cysteine. Thus it can be concluded that C80 is the cross-linked amino
acid. Interestingly, beside an ion corresponding to the cross-linked RNA, signals of uridine are observed that
result from cleavage from the 152 adduct.
Figure B.32: MS/MS fragment spectrum of 60S ribosomal protein L2-A/-B peptide ASGNYVIIIGHNPDENK (A129–
K145) cross-linked to [U]. Y133 is the actual cross-linked amino acid as is shown by its immonium ion
observed as adduct with [U’] and a shift of the corresponding b- and y-ions. The b-series is shifted by
190.04 Da, a mass that cannot be explained.
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Figure B.33: MS/MS fragment spectrum of 60S ribosomal protein L2-A/-B peptide GVAMNPVDHPHGGGNHQHIGK
(G201–K221) cross-linked to [AAGU –H2O]. The spectrum is shown in two views due to the high complexity.
The upper pane shows the mass range up to m/z 350, the lower pane shows the higher mass range where
the maximum intensity is 2.6% relative to the signal of the A’ marker ion. While the fragments in the lower
mass range (upper pane) show high intensity RNA marker ions and a few peptide fragments with reasonable
intensity, all other fragments in the higher mass range are of low intensity (lower pane). Importantly,
fragments resulting from cleavage N-terminal to proline are observed (y12, y16) and both peptide termini
are covered by the corresponding sequence ions. The signal at 1093.9276 corresponds to a doubly charged
RNA adduct of y16 with the composition [UX0 –X’]; since the base of the second nucleotide is cleaved off, its
nature cannot be determined. Since proline itself is thought to be rather unreactive towards UV cross-linking
and no y15 is observed, no clear conclusion about the cross-linked amino acid can be drawn.
Figure B.34: MS/MS fragment spectrum of 60S ribosomal protein L3 peptide VACIGAWHPAHVMWSVAR (V249–R266)
cross-linked to [U –H2O]. All peptide fragments containing C251 are shifted by [U –H2O], pinpointing the
cross-link to this residue.
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Figure B.35: MS/MS fragment spectrum of 60S ribosomal protein L4-A/-B peptide SGQGAFGNMCR (S85–R95) cross-
linked to [U –H2O]. The y-series is completely shifted by [U –H2O] starting with y2, clearly identifying C94
as the cross-linked amino acid.
Figure B.36: MS/MS fragment spectrum of 60S ribosomal protein L4-A/-B peptide NVPGVETANVASLNLLQLAP-
GAHLGR (N221–R246) cross-linked to [AU –H2O]. From cleavage N-terminal of P223 originate a great
number of internal ions. The amino acid stretches contained in each of these internal fragments are indi-
cated as individual lines above the peptide sequence and add confidence to the identification as only two
a-/b-ion pairs are observed. y7 and y8 are partially shifted by RNA. However, this does not allow a clear
conclusion about the cross-linked amino acid. The RNA-adducts are of much lower intensity than the origi-
nal sequence ions, therefore RNA-adducts of smaller, less intense y-ions might be below the detection limit.
The normally well observable immonium ion of histidine was not detected, which could be a consequence of
a cross-linked H243. Overall, the observed shifts only allow the conclusion that the cross-link must be on
the C-terminal part of the peptide.
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Figure B.37: MS/MS fragment spectrum of 60S ribosomal protein L4-A/-B peptide IINSSEIQSAIRPAGQATQK (I289–
K308) cross-linked to [GU]. Interestingly, y19 is observed as an adduct with [U’]. A cross-link at this position
could also explain the absence of the usually well observable a2/b2 ion pair. Therefore, I290 is likely to be
the cross-linked amino acid.
Figure B.38: MS/MS fragment spectrum of 60S ribosomal protein L4-A peptide TGTKPAAVFTETLK (T347–K360)
cross-linked to [AU –H2O]. Further description below Figure B.39.
Figure B.39: MS/MS fragment spectrum of 60S ribosomal protein L4-B peptide TGTKPAAVFAETLK (T347–K360)
cross-linked to [AU –H2O]. The two cross-linked peptides of L4-A and -B (spectrum of L4-A shown in
B.38) differ by only one amino acid, namely T356 (A-form) or A356 (B-form). Both peptides differ in their
overall mass; also the different masses of the corresponding peptide sequence ions, i.e. y5 to y11, are clearly
observable. Apart from this, both cross-link spectra share many similarities: Both are cross-links to the same
RNA, [AU –H2O]. The A’ marker ion is dominant with the peptide fragments below 20% relative intensity.
Finally, only RNA-adducts of the intact peptide are observed, therefore the cross-linked amino acid cannot
be determined.
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Figure B.40: MS/MS fragment spectrum of 60S ribosomal protein L5 peptide SYIFGGHVSQYMEELADDDEER (S197–
R218) cross-linked to [U]. The spectrum shows no trace of the cross-linked RNA. Consequently, the cross-
linked amino acid cannot be identified.
Figure B.41: MS/MS fragment spectrum of 60S ribosomal protein L6-A/-B peptide LRASLVPGTVLILLAGRFR (L30–
R48) cross-linked to [GU –H2O]. All y-ions starting with y4 are observed as RNA-adducts, which places
the cross-link either on G45 or R46. In addition, the spectrum shows a number of RNA adducts of the
intact peptide. The G’ marker ion has an relative intensity well below 10% which is very unusual, typically
adenine, cytosine and guanine produce high intensity marker ions.
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Figure B.42: MS/MS fragment spectrum of 60S ribosomal protein L6-A peptide WYPSEDVAALKK (W9–K20) cross-
linked to [AU –H2O]. Further description below Figure B.43.
Figure B.43: MS/MS fragment spectrum of 60S ribosomal protein L6-B peptide WYPSEDVAAPK (W9–K19) cross-
linked to [AU –H2O]. Peptide WYPSEDVAALKK (W9–K20) of L6-A (spectrum shown in B.42) contains
a leucine at position 18 which is missing in L16-B peptide WYPSEDVAAPK (W9–K19). In addition, the
L6-A peptide contains a missed cleavage site. In both cases, the spectrum is dominated by the A’ marker
ion. Both peptides are identified by a full y-series and a2 shifted by the cross-linked RNA. In addition,
the immonium ion of tryptophan is observed with the same shift, unambiguously identifying W9 as the
cross-linked amino acid.
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Figure B.44: MS/MS fragment spectrum of 60S ribosomal protein L6-A peptide HLEDNTLLISGPFK (H57–K70) cross-
linked to [U –H2O]. More detailed description below Figure B.45.
Figure B.45: MS/MS fragment spectrum of 60S ribosomal protein L6-B peptide HLEDNTLLVTGPFK (H57–K70) cross-
linked to [U –H2O]. The cross-linked peptides of L6-A (spectrum shown in B.44) and L6-B differ at positions
65 and 66, the A-form containing IS and the B-form VT at these positions. Interestingly, both peptides are
isobaric, i.e. they have exactly the same elemental composition and consequently the same mass. However,
both peptides can be clearly distinguished in the corresponding spectra of their cross-links to [U –H2O]
(compare Figures B.44 and B.45). The peptide sequence ion between the residues 65 and 66, i.e. y5 (and
additionally a9/b9 in Figure B.45) allows differentiation of both homologs. Apart from that, both spectra
are very similar, containing a relatively complete y-series and a number of a- and b-ions, a very intense
histidine immonium ion and a uridine marker ion. However, no RNA adducts of peptide fragments are
observed that would allow the identification of the cross-linked amino acid.
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Figure B.46: MS/MS fragment spectrum of 60S ribosomal protein L8-A peptide YGLNHVVALIENKK (Y134–K147)
cross-linked to [GU –H2O] More detailed description below Figure B.47.
Figure B.47: MS/MS fragment spectrum of 60S ribosomal protein L8-B peptide YGLNHVVSLIENK (Y134–K146) cross-
linked to [GU –H2O]. The peptides of 60S ribosomal proteins L8-A and -B differ at position 141. L8-
A peptide YGLNHVVALIENKK (Y134–K147, spectrum in B.46) contains a leucine while L8–B peptide
YGLNHVVSLIENK (Y134–K146) contains a serine at this position. The cross-link of the A-form peptide
contains a missed cleavage site. However, both spectra of the cross-links to [GU –H2O] are very similar:
Both are dominated by the G’ marker ion and contain two additional RNA signals. The peptides’ N- and
C-termini are confidently identified by a series of the corresponding sequence ions. No RNA-adducts of
peptide signals are observed, therefore the cross-linked amino acid cannot be identified.
Figure B.48: MS/MS fragment spectrum of 60S ribosomal protein L16-A/-B peptide LSTSVGWKYEDVVAK (A: L141–
K155, B: L140–K154) cross-linked to [U –H2O]. The y-series is shifted by the mass of the cross-linked RNA
starting with y7, identifying Y149 as the cross-linked amino acid.
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Figure B.49: MS/MS fragment spectrum of 60S ribosomal protein L16-A peptide AEELNISGEFFRNK (A38–K51) cross-
linked to [ACU]. As expected, the fragment spectrum is dominated by RNA marker ions, namely A’, C’,
and the corresponding nucleotides minus water, confirming the cross-linked RNA. However, the cross-linked
amino acid cannot be determined. See also Figure B.50.
Figure B.50: MS/MS fragment spectrum of 60S ribosomal protein L16-B peptide AEALNISGEFFR (A37–R48) cross-
linked to [CU]. This cross-link of L16-B covers the same region as the cross-link of L16-A shown in B.49.
In comparison, the spectrum exhibits some substantial differences, it shows an intense C’ marker ion and
additionally the [C –H2O] and [U –H3PO4] marker ions. The y-series is observed as partially shifted by
RNA starting with y2, identifying F38 as the cross-linked amino acid residue. A spectrum very similar to
the cross-link of the homologue L16-A peptide was also identified (data not shown).
Figure B.51: MS/MS fragment spectrum of 60S ribosomal protein L18-A/-B peptide ALFLSK (A51–K56) cross-linked to
[AU]. The cross-linked peptide is not unique. It appears in both 60S ribosomal proteins L18-A and -B and
in the glycolipid 2-alpha-mannosyltransferase. Since another cross-link of the L18 proteins was identified
and the majority of cross-links originate from ribosomal proteins, we assume that this cross-link is indeed
from the L18 proteins. As expected from the cross-linked RNA [AU], an intense A’ marker is identified. No
adducts are observed which would allow the identification of the cross-linked amino acid.
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Figure B.52: MS/MS fragment spectrum of 60S ribosomal protein L18-A/-B peptide AGGECITLDQLAVR (A117–R130)
cross-linked to [U +152 –H2O]. The immonium ion of cysteine, y10, and an internal ion CI are all found
shifted by the mass of the cross-linked RNA, thus identifying C121 as the cross-linked amino acid residue.
Figure B.53: MS/MS fragment spectrum of 60S ribosomal protein L23-A/-B peptide ECADLWPR (E121–R128) cross-
linked to [U +152 –H2O]. All ions containing the N-terminus are shifted by [U +152 –H2O], the cross-linked
RNA. Since the immonium ion of cysteine is shifted by the same mass, it can be concluded that C122 is the
cross-linked amino acid.
Figure B.54: MS/MS fragment spectrum of 60S ribosomal protein L26-B peptide KAYFTAPSSER (K17–R27) cross-
linked to [GU]. The cross-linked RNA is confirmed by the intense G’ marker and a signal for [U –H3PO4].
However, no peptide–RNA adduct is observed that would allow the identification of the cross-linked amino
acid.
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Figure B.55: MS/MS fragment spectrum of 60S ribosomal protein L28 peptide INMDKYHPGYFGK (I43–K55) cross-
linked to [U –H2O]. All y-ions from y8 on are observed as completely shifted by RNA adducts, either uracil
fragment [C3O] or the cross-linked RNA [U –H2O]. This puts the cross-link on Y48.
Figure B.56: MS/MS fragment spectrum of 60S ribosomal protein L31-A/-B peptide LHGVSFK (L20–K26) cross-linked
to [UU –H2O]. F25 is the cross-linked amino acid residue because all y-ions containing this residue are
observed as an adduct with [U’ –H2O].
Figure B.57: MS/MS fragment spectrum of 60S ribosomal protein L33-A/-B peptide IAYVYRASKEVR (I49–R60) cross-
linked to [AU –H2O]. The spectrum is dominated by the A’ marker ion and only a limited number of peptide
fragments (y1–y4, a2/b2, b3–b4, and b6) are observed. In addition, fragmentation of the cross-linked RNA
on the intact peptide is observed, leading to a number of peptide adduct with RNA fragments (see higher
m/z range).
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Figure B.58: MS/MS fragment spectrum of 60S ribosomal protein L35-A/-B peptide SIACVLTVINEQQR (S50–R63)
cross-linked to [U –H2O]. The immonium ion of cysteine shifted by [U –H2O] clearly identifies C53 as the
cross-linked residue. Interestingly, no regular peptide sequence ions containing the cross-linked C53 are
observed. Instead, a number of internal ions with said cysteine are observed, all shifted by the cross-linked
RNA.
Figure B.59: MS/MS fragment spectrum of 60S ribosomal protein L37-A peptide FKNGFQTGSASK (F74–K85) cross-
linked to [ACU]. More detailed description below Figure B.60.
Figure B.60: MS/MS fragment spectrum of 60S ribosomal protein L37-B peptide FKNGFQTGSAK (F74–K84) cross-
linked to [ACU]. The L37-A peptide FKNGFQTGSASK (F74–K85, spectrum see B.59) contains a serine at
position 84 which is missing from L37-B peptide FKNGFQTGSAK (F74–K84). Both peptides are identified
by almost complete y-series and a number of b-ions. Apart from the different overall masses, both peptides
can be easily distinguished by their y-series differing from y2. As expected from the cross-linked RNA [ACU],
an intense A’ marker is observed, while the C’ marker is clearly visible but only at 40% relative intensity.
The C0 and A0 marker ions are also observed. Both spectra do not contain any shifted peptide fragments
but only RNA adducts of the intact peptide, therefore the cross-linked amino acid cannot be identified.
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Figure B.61: MS/MS fragment spectrum of Ubiquitin-60S ribosomal protein L40 peptide CGHTNQLRPK (C115–K124)
cross-linked to [U +152 –H2O]. The a- and b-ions are partially shifted by either the cross-linked RNA or
its cleavage product [U’ +152]. A signal for [U +152 –H2O] is also observed. The 152 adduct as well as its
immonium ion shifted by the cross-linked RNA point to C115 as the cross-linked amino acid.
Figure B.62: MS/MS fragment spectrum of 60S ribosomal protein L42-A/-B peptide CKHFELGGEK (C88–K97) cross-
linked to [U –H2O]. All observed a- and b-ions are partially shifted by uracil fragment [C3O]. This places the
cross-link on either C88 or K89. The absence of y9 and the observation of several internal fragments origi-
nating from cleavage C-terminal to K89 might hint to it being cross-linked, however there is no unambiguous
proof.
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B.5.3 Cross-links of ribosome-related proteins
Figure B.63: MS/MS fragment spectrum of ribosome biogenesis protein RLP7 peptide GPLAVNIPNKAFK (G149–K161)
cross-linked to [CUU]. The spectrum is dominated by the C’ marker ion, the peptide fragments are suppressed
below 15% relative intensity. Additional RNA marker ions for [U –H3PO4] and C0 are observed. However,
there is no observable shift of peptide fragments that would allow to pinpoint to the cross-linked amino acid.
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B.5.4 Cross-links of polynucleotide-binding proteins
Figure B.64: MS/MS fragment spectrum of cruciform DNA-recognizing protein 1 peptide IPEAGGLLCGKPPR (I105–
R118) cross-linked to [U –H2O]. All y-ions from y6 on are shifted by the mass of [U –H2O], which points at
C113 as the cross-linked amino acid.
Figure B.65: MS/MS fragment spectrum of elongation factor 1-alpha peptide FVPSKPMCVEAFSEYPPLGR (F402–
R421) cross-linked to [U +152]. The oxidation on M408 as well as the cross-linked RNA sequence [U +152]
are derived from the difference between experimental precursor and calculated peptide mass. The mass shift
of 152 points at C409 as the cross-linked amino acid.
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Figure B.66: MS/MS fragment spectrum of nucleolar protein 3 peptide ILNGFAFVEFEEAESAAK (I156–K173) cross-
linked to [U –H2O]. An intense U0 marker is observed. The immonium ion of phenylalanine is observed
partially shifted by the cross-linked RNA. However, the spectrum does not allow to distinguish whether the
cross-link is via F160, F162, or F165. The peptide lies within RRM 1 of Nop3p (positions 125–195).
Figure B.67: MS/MS fragment spectrum of nucleolar protein 3 peptide ENSLETTFSSVNTR (E222–R235) cross-linked
to [U]. The spectrum does not contain any RNA signals, the cross-linked nucleotide is solely deduced from
the difference between the experimental precursor and the calculated peptide mass. The cross-linked amino
acid cannot be determined. The peptide lies within RRM 2 (positions 200–275) of Nop3p.
Figure B.68: MS/MS fragment spectrum of nucleolar protein 13 peptide ILFVGNLSFDVTDDLLR (I240–R256) cross-
linked to [GU –H2O]. b3 is observed as an adduct with [U –H3PO4], thus F242 is the cross-linked amino acid
residue. The G’ marker is the most intense signal, the peptide fragments are below 40% relative intensity. In
addition, marker ions for [U –H3PO4] and [G –H2O +HPO3] are observed at 35% and 40% relative intensity,
respectively. The peptide lies at the beginning of the protein’s RRM 2 (position 239–317).
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Figure B.69: MS/MS fragment spectrum of polyadenylate-binding protein peptide YQGVNLFVK (Y319–K327) cross-
linked to [U]. An RNA marker ion for [U –H3PO4] is observed. y3 to y7 are partially shifted by the same
RNA. Thus, F325 is the cross-linked amino acid.
Figure B.70: MS/MS fragment spectrum of single-stranded nucleic-acid binding protein peptide SKDTLYINNVPFK
(S184–K196) cross-linked to [AC]. This cross-link represents the only example for a cross-link without uridine
in this experiment. The A’ marker is the most intense signal, C’ is observed at 70% relative intensity. In
addition, the C0 marker is observed. No peptide–RNA adduct is visible that would allow identification of
the cross-linking site on the peptide or the cross-linked nucleotide.
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B.5.5 Cross-links of proteins without any annotated polynucleotide-binding
function
Figure B.71: MS/MS fragment spectrum of adenosylhomocysteinase peptide ECINIKPQVDR (E320–R330) cross-linked
to [U +152]. The observation of the 152Da adduct hints at C321 as the cross-linked amino acid and is
confirmed by the b-ion series shifted by [U’ +152].
Figure B.72: MS/MS fragment spectrum of alcohol dehydrogenase 1/3 peptide YSGVCHTDLHAWHGDWPLPVK
(Adh1p: Y40–K60, Adh3p: Y67–K86) cross-linked to [U +152 –H2O]. Fragment ions containing the cross-
linked cysteine (Adh1p: C44, Adh3p: C71), i.e. y-ions y17 to y20 and a-/b-ions starting with b6, are shifted
by the cross-linked RNA fragment, [U +152 –H2O].
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Figure B.73: MS/MS fragment spectrum of enolase 1/2 peptide IGLDCASSEFFK (I244–K255) cross-linked to [U +152
–H2O]. C248 is identified as the cross-linked amino acid by its immonium ion observed as adduct with
the cross-linked RNA, [U +152 –H2O]. Interestingly, no peptide sequence ions containing the cross-linked
cysteine are observed, but two internal ion which exhibit the same shift as the immonium ion. The most
intense cross-link fragment is an RNA signal corresponding to [U +152 –H2O].
Figure B.74: MS/MS fragment spectrum of glyceraldehyde-3-phosphate dehydrogenase 2/3 peptide ETTYDEIKK (E250–
K258) cross-linked to [AU –HPO3]. The adenine marker ion dominates the spectrum, peptide fragments are
supressed below 5% relative intensity. The cross-linked amino acid cannot be determined.
Figure B.75: MS/MS fragment spectrum of inorganic pyrophosphatase peptide NCFPHHGYIHNYGAFPQTWEDPN-
VSHPETK (N83–K112) cross-linked to [U +152 –H2O]. All observed a- and b-ions are completely shifted
by the cross-linked RNA. The 152 adduct identifies C84 as the cross-linked amino acid which is confirmed
by the shift of a- and b-ions. Due to high number of signals, several signals are just highlighted and not
annotated: if a fragment was observed in several charge states, only the most abundant signal is annotated.
In addition, internal ions except for immonium ions are marked with an "i" only and are not annotated
further.
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Figure B.76: MS/MS fragment spectrum of peroxiredoxin TSA1 peptide NGTVLPCNWTPGAATIKPTVEDSK (N165–
K188) cross-linked to [U +152]. The overall intensity of the observed fragments is low, the cross-link
is apparently of very low abundance. As a consequence, only very few peptide fragments are observed.
Importantly, fragments from cleavage N-terminal to proline residues, here y7 and y14, are highly abundant
as expected. The mass adduct of 152 points at C171 as the cross-linked amino acid.
Figure B.77: MS/MS fragment spectrum of phosphoglycerate kinase peptide YVLEHHPR (Y49–R56) cross-linked to
[AU –HPO3]. The spectrum is dominated by the A’ marker ion, the peptide fragments are suppressed well
below 10% relative intensity. In addition, a signal for the intact peptide with over 50% relative intensity is
observed. This can explain why only a small number of peptide fragments is observed (y2–y4, b2, and b5–
b6). No shifted peptide sequence ions are observed which would allow the identification of the cross-linked
amino acid residue.
B.5 MS/MS fragment spectra of cross-links from yeast after TAP tag isolation 185
Figure B.78: MS/MS fragment spectrum of pyruvate kinase 1 peptide NCTPKPTSTTETVAASAVAAVFEQK (N370–
K394) cross-linked to [U +152 –H2O]. All observed b-ions are shifted by the cross-linked RNA, confirming
C371 as the cross-linked amino acid.
Figure B.79: MS/MS fragment spectrum of pyruvate kinase 1 peptide YRPNCPIILVTR (Y414–R425) cross-linked to
[U +152 –H2O]. The 152 mass adduct points towards C418 as the cross-linked amino acid, which is confirmed
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